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Abstract 
The context of this work in Pemba was (i) the initial reestablishment of School-Based 
Treatment (SBT) with praziquantel (PZQ) and albendazole (ALB) for control of 
urogenital schistosomiasis and soil-transmitted helminths (STH), respectively, and (ii) 
the subsequent implementation of mass drug administration (MDA) with or without 
additional snail control or behavioural modification which was aimed at evaluation of 
the possibility of elimination of schistosomiasis. The prime focus of the work described 
was to use regular parasitological monitoring to evaluate and compare control strategies 
with regard to the effects of intervention on transmission or morbidity.  
Chapters 1 and 2: General Introduction and Material and Methods respectively 
Chapter 3: Urogenital schistosomiasis.  (i) Use of single annual SBT with PZQ:  By 
assessing urine egg output in new-entry standard (Std)-1 children, neither the intensity 
nor baseline prevalence of 9.5% was lowered over a two year period of intervention. 
However, prevalences in St-3 children who had received SBT showed lower 
prevalences than Std-1 children presumably reflecting PZQ-mediated worm reductions. 
This supports the WHO recommended use of SBT treatment once/year for areas with 
prevalence <20% for morbidity control but demonstrates its lack of effect in 
transmission control. (ii) Use of MDA (twice/year) alone or combined with snail control 
or behavioural modification:. Testing of Std-3 and Std-4 children in each of 15 shehias 
allocated to the three different intervention arms revealed an overall reduction in the 
prevalence of schistosomiasis from 8.3% in 2012 to 5.4% in 2014 (impact:- behavioural 
control > snail control>MDA). There was a downward trend in the overall mean 
intensity across all interventions (from 2.71    1.83    1.71) but no consistent reduction in 
the proportion of heavy infections among the infected children. Recommendations: 
Integrated interventions are likely to be necessary for interrupting transmission of 
schistosomiasis and eventually leading to elimination. In poor resource areas, such as 
Zanzibar, it would be difficult to implement fully integrated control measures and so 
focusing on PC in areas with high transmission coupled with behavioural changes and 
strengthening of diagnostic capability of health facilities could be essential. 
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Chapter 4: STH. Faecal examination of the Std-1 children, as above, for the eggs of 
Ascaris lumbricoides, Trichuris trichiura and hookworm, showed a high frequency of 
polyparasitism.  Neither SBT nor intense MDA significantly reduced prevalence of any 
STH worm in the communities. The worm specific prevalences were slightly reduced 
overall, most consistently for Trichuris. However, there were no significant changes in 
intensity of infection, which remained light in the majority of infected children. 
Recommendations: No impact of either SBT or MDA on transmission to Std-1 children 
was observed.  Integrated approaches e.g. WASH (water, sanitation and hygiene), 
education and PC are likely to be essential for reduction in transmission. 
Chapter 5: The efficiency of drug distribution and associated compliance were 
monitored during the MDA by individual questionnaire and reports from the community 
drug distributors (CDDs). Overall coverage rate was high (~80%) but variable between 
the districts (69.3-88.2%). Based on questionnaire, a significant proportion of 
individuals were non-compliant with the MDA especially regarding PZQ (10.2%) 
although this did not associate with knowledge about disease transmission, 
signs/symptoms or risk factors for schistosomiasis. Only mild adverse effects were 
reported. Recommendations: For any future MDA careful thought needs to be given to 
understanding the variation in compliance observed across the different areas of Pemba. 
There is a need of intensifying sensitization meetings in the communities with focus of 
discussion on potential side effects which may develop. Engage religious and other 
influential leaders during sensitization meetings.  
Chapter 6: Since the intensive enhanced MDA for schistosomiasis was aimed at 
evaluating the possibility of elimination of transmission, the role in transmission of the 
preschool (>3<5yr) children, who were not previously included in PC in Pemba, was 
assessed. A substantial proportion of these children was infected (7.04%), the 
prevalence steadily increasing with age. By questionnaire to mothers/care-givers, 
contact with stream/pond water through washing and visiting with the children were 
significant risk factors for pre-school infection. Recommendations: In view of the pre-
school prevalence demonstrated, the community MDA was extended to <3yr olds. The 
government should be ready to register and order paediatric formulation of PZQ once it 
becomes available. Diagnostic capability of the respective health facilities has to be 
strengthened in terms of training of laboratory personnel and purchase of essential 
laboratory equipment. 
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Chapter 7: Implementation of snail control in Pemba prompted study of transmission 
of schistosomiasis by the snail intermediate host, Bulinus spp. Only ~1% of field-
collected snails shed cercariae but 56% of tested snails were found infected by PCR. 
DNA sequencing confirmed the presence of B. nasutus and B. globosus, both of which 
transmitted schistosomes as judged by cercarial shedding and molecular techniques. 
Recommendations: Further studies are needed to confirm the potential role of the B. 
nasutus in the transmission of urogenital schistosomiasis in Pemba. For monitoring of 
schistosomiasis transmission, it would be essential to assess the presence of infection in 
snail host using molecular techniques especially when elimination is achieved or 
targeted. 
Chapter 8: Increasing intensity of PZQ administration raises concerns about possible 
selection of drug resistance in S. haematobium and prompted studies on the efficacy of 
PZQ and its effects on parasite genetic diversity in Pemba. It was found that PZQ 
efficacy was comparable to previous trials. Miracidial samples collected from Std-1 
children in 2011 showed diverse, and some novel, haplotypes of the Cox-1 gene of S. 
haematobium. Clustering of the different haplotypes from different areas indicated the 
role of internal/external migration in the spread of infection.  Recommendations: 
Praziquantel remains effective and should still be used for the treatment of 
schistosomiasis at the individual, community or school level in Pemba. More studies are 
needed to assess susceptibility to PZQ of different S. haematobium haplotypes and of 
the groups (G1 and G2) with which they associate. 
Chapter 9: General Discussion: Overall it was concluded that S. haematobium and 
STH infections remain a public health problem in Pemba and that, although PC using 
SBT helps control parasite burdens, integrated control measures were more effective 
and would be required to reduce transmission to approach elimination. Valuable 
experience in implementation and monitoring of such measures (MDA±snail 
control/behavioural modification) and application of modern genetic analysis tools was 
gained during the work and further studies on the snail hosts and population genetics of 
S. haematobium proposed.   
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Chapter 1: Introduction  
1.1 General introduction 
Infections with schistosomes (the main three human species being Schistosoma 
mansoni, S. haematobium and S. japonicum) and Soil Transmitted Helminths (STH), 
Ascaris lumbricoides, Trichuris trichiura and hookworms (Ancylostoma duodenale and 
Necator americanus) pose a major public health problem in tropical and subtropical 
countries (de Silva et al., 2003). These infections are estimated to afflict 2 billion people 
(Hotez et al., 2003) resulting in disability-adjusted life-years (DALYs) of 5.18 million 
for STH (Pullan et al., 2014)) and 70 million for schistosomiasis (Hotez and Fenwick, 
2009). In endemic areas, infection with the STHs, A. lumbricoides and T. trichiura, and 
with schistosomiasis can be acquired during infancy (Goodman et al., 2007).  
With STHs, prevalence tends to increase with age to adulthood whilst schistosome 
prevalence often peaks in the mid teenage years (Figure 1.). However, intensity of both 
STHs and schistosomes is high in school-aged children between 5-15yrs (Figure 1), 
who are often the most infected population and harbour a high number of parasites 
(Hotez et al., 2006b). Albeit, the egg pattern in stool samples is influenced by the 
diagnostic technique to be used and sometimes multiple samples would be needed to 
improve the diagnosis (Knopp et al., 2008). However, hookworm infection exhibits a 
different pattern by often being more common in older people (Hotez et al., 2003). Both 
males and females are infected although in most studies males are mostly infected 
particularly in the case of schistosomiasis (Guerra-Silveira and Abad-Franch, 2013). For 
example, in Egypt, it has been reported that males are five times more commonly 
infected with S. haematobium than females (Hicks, 1983). A number of factors are 
implicated in the acquisition and transmission of schistosomiasis and STH infections 
such as: 1) environment 2) socio-economic status 3) access to safe water supply and 4) 
sanitation.  It has been shown that increasing frequency of water contact, in particular, 
increases the risk of acquisition of schistosomiasis (Sow et al., 2011).   
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Figure 1: Distribution of prevalence A. lumbricoides, T. trichiura, hookworms and S. 
haematobium in different age groups in the population.  
Source: (Hotez et al., 2006b) 
 
1.2 Life cycle for common STHs 
Following ingestion of infective eggs of A. lumbricoides or T. trichiura, these hatch to 
liberate larvae which find their preferential sites. The larvae of A. lumbricoides 
penetrate the blood stream and move through a heart- lung migration, breaking out of 
the lung capillaries into the alveoli. Upon reaching to the upper respiratory tract, the 
larvae can be swallowed back to the small intestine where adult parasite stages reside. 
The larvae of T. trichiura move directly to the large intestine. For hookworms, soon 
after penetrating the human skin, the larvae follow a similar route to that of Ascaris and 
eventually live in the small intestine. The adult worms reproduce sexually and produce 
eggs, which are passed in human faeces and deposited in the external environment, for 
example soil. Adult worms survive for several years and produce large numbers of eggs 
or larvae after 4–6 weeks. Geohelminth eggs or larvae need a period of maturation in 
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the soil to become infective. The eggs can remain viable in the soil for several months 
or years (T. trichiura and A. lumbricoides) and larvae a few weeks (hookworms), 
depending on existing environmental conditions such as warmth and moisture (Brooker 
et al., 2006b). 
 
Figure 2: Life cycle of the common soil transmitted Helminth, Ascaris, Trichuris and 
hookworms 
 (Source: http://www.who.int/wormcontrol/statistics/en/cycle.jpg)  
 
1.3 Life cycle of S. haematobium  
S. haematobium is the only schistosome species transmitted in Pemba and so description 
is focused on this species. Acquisition of urogenital schistosomiasis, caused by S. 
haematobium, requires contact with freshwater infested with aquatic snail hosts of the 
genus Bulinus. Infected individuals contaminate (during micturition) freshwater with 
infective eggs which immediately hatch to produce ciliated miracidia. These free-
swimming larvae cannot survive longer than a few hours unless they find their suitable 
intermediate host, a Bulinus snail. Within the snail tissue, a miracidium undergoes 
several developmental stages and eventually produce cercariae, the human-infective 
stage. Infected snails release cercariae which penetrate human host skin, transform to 
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schistosomula and enter the blood stream. After an intravascular lung migration a 
proportion reaches the liver where they mature in a few weeks and pair up. Males and 
females (mature schistosomes) remain paired and are estimated to live between 5-20 
years. The pairs migrate against the portal blood flow to reach the venous plexus of the 
urinary bladder. The gravid female moves to venules in the wall of the urinary bladder 
for deposition of eggs which pass through the bladder wall and are passed in the urine 
(Shebel et al., 2012).  
 
Figure 3: Diagrammatic representation of the life cycle of S. haematobium.  
Source: http://www.who.int/wormcontrol/statistics/en/cycle.jpg  
 
1.4 Pathogenesis of schistosomiasis 
The consequences of Schistosoma infections are dependent on the stages of maturation 
and on the migration of the parasite in human tissues and organs. Following penetration 
of schistosome cercariae into human skin, micro-papular dermatitis, sometimes referred 
as swimmer’s itch, can be noticed but the symptoms are transient and self-healing 
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(Corachan, 2002). Acute schistosomiasis, or Katayama fever, is most commonly seen 
following initial infection in travellers and is believed to be caused by serum sickness 
associated with antibody complexes with antigen derived from the developing worms or 
eggs. This condition may require medical attention and treatment. Generally, infection 
with these parasites tends to be chronic, building up over a period of years and to have 
detrimental effects to human host depending largely on their intensity (Hicks, 1983).  
Schistosomes like most helminths show an over-dispersed distribution i.e. many people 
are infected by light infections but some people get heavy infection and more severe 
disease. In Africa, each year, 300,000 people are estimated to lose their lives as a result 
of schistosomiasis (Hotez and Fenwick, 2009). There are two clinical types of 
schistosomiasis (i) intestinal/hepatosplenic caused principally by S. mansoni and (ii) 
urogenital schistosomiasis caused solely by S. haematobium. The chronic stage of 
urogenital schistosomiasis, caused by S. haematobium, is associated with obstructive 
uropathy, hydronephrosis, calcified fibrotic bladder and/or ureter, carcinoma of the 
urinary bladder (Hicks, 1983) and even infertility (Kjetland et al., 1996, Balasch et al., 
1995, Swai et al., 2006). In schistosomiasis endemic areas, the incidence of bladder 
carcinoma occurs at a younger age (~ 46yrs) compared to non-endemic areas (60yrs) 
(Hicks, 1983).  
The pathogenesis of schistosomiasis is caused by the eggs trapped in the tissues which 
become surrounded by a host granulomatous response (Pearce and MacDonald, 2002) 
and there is a clear association of the presence of infection and the development of 
pathologies (Forsyth and Macdonald, 1965). In S.mansoni and S. japonicum infections it 
is the eggs carried to the liver in the portal blood which most commonly give rise to 
serious hepatosplenic disease. The eggs become lodged in the liver sinusoids and this 
begins to block the portal blood flow. Potent antigens (soluble egg antigen, SEA) leak 
out from the living miracidium larva through micropores in the egg shell and stimulate 
formation of the granuloma. The schistosome egg granuloma is made up of 
lymphocytes, macrophages, epithelioid cells, giant cells, eosinophils and fibroblasts 
although the relative proportions of these cell types changes as the granuloma ages. The 
miracidium eventually dies (or is killed by the immune cells) and the old granuloma 
consists of the empty egg shell surrounded by a small fibrotic reaction. In longstanding 
infections with constant egg deposition extensive fibrosis occurs and may give rise to 
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irreversible calcification of the portal vessels. In S. haematobium infections the 
granulomatous response results in fibrosis and later to calcification of the bladder and 
ureters. Studies in mice have shown the granuloma to be a T helper-cell dependent 
immune response caused by the eggs inducing strong Th2 responses. Of particular 
importance for the pathogenesis is IL-13 which is responsible for the fibrosis 
(Chiaramonte et al., 1999).  
1.5 Pathogenesis of STHs 
During the larval stage of A. lumbricoides and hookworms, when the parasites enter the 
blood circulation and migrate through heart, lung, upper respiratory tract and eventual 
return to the small intestine, they cause symptoms which can resemble asthma, cough, 
eosinophilic pneumonitis, nausea and sometimes vomiting. The different STHs when 
developed into adult worms cause different pathologies. Hookworms are the most 
important in terms of public health since they cause blood loss by biting onto the 
mucosa of the small intestine pumping blood through their intestines and also leaving 
bleeding haemorrhages. Where iron intake is low this causes hypochromic microcytic 
iron-deficiency anaemia (Pearson et al., 2012). A. lumbricoides which lives in the lumen 
of the small intestine, often cause malabsorption and abdominal discomfort but in heavy 
infections can cause life threatening intestinal obstruction in infants and ectopic 
infections in various locations. T. trichiura living embedded in the mucosa of the large 
intestine causes colitis and in heavy infection, dysentery and/or rectal prolapse (Cooper 
et al., 1992, Genta, 1993). Overall, chronic infections with STHs are associated with 
malnutrition, iron deficiency anaemia, growth stunting during childhood, impaired 
physical and cognitive capacity, and intestinal obstruction (Musgrove and Hotez, 2009) 
impeding working capacity resulting to economic loss (Bethony et al., 2006, Hotez et 
al., 2009) and sometimes, but uncommonly, causing death (van Riet et al., 2007).  
 
1.6 Immunity and immune evasion in schistosomiasis 
As also reviewed by (Pearce and MacDonald, 2002), adults in endemic areas show 
lower levels of re-infection following treatment, and this is not entirely explained by 
lower water contact in adults than in children as it is also seen in fishing communities 
with high adult water contact (Kabatereine et al., 1999). This resistance to reinfection of 
humans post puberty correlates with elevated schistosome specific IgE and with 
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eosinophilia and it is suggested that these immune components may kill skin stage 
schistosomula in resistant humans as they do in vitro. Irrespective of the mechanism this 
strong age-dependent resistance has a significant limiting effect on the disease. There is 
also some evidence of Th2-mediated immunity to STH (Jackson et al., 2004) but there 
is little evidence of immunity developing to hookworm infections which continue to 
build up in adulthood.  
Schistosomes and STHs have mechanisms to help evade the human host immune 
system allowing them to initiate chronic infection and persist for many years, up to 30 
years in the case of schistosome and 10 years for hookworms (Kamal and El Sayed 
Khalifa, 2006) although they use different strategies. Schistosomes absorb alpha (α) -2 
macroglobulin, red blood cell and blood group determinants of the human host (van 
Riet et al., 2007) and thus may disguise their recognition by host’s immune response. 
There is also constant membrane repair and turnover. A tough, weakly antigenic outer 
cuticle together with molecular mimicry are mechanisms used by STHs to establish 
persistent human infections (van Riet et al., 2007). During the acute phases of 
schistosomiasis and STH infection the host immune response is usually characterized by 
a T helper (h) 1 response (Maizels and Yazdanbakhsh, 2003) with production of 
interferon gamma (IFN γ) and Interleukin (IL)- 2. But as the diseases progress toward 
chronic stages, there is a switch to a  induction of potent Th2 responses with abundant 
production of IL-4, IL-5, IL-10 and IL-13 which in turns activates B-lymphocytes to 
produce immunoglobulin (IgE), development of eosinophilia and mast cell responses 
(van Riet et al., 2007, Kamal and El Sayed Khalifa, 2006). 
 
1.7 Effects of worm infections on concomitant immune responses 
The skewing of Th1 to Th2 responses observed during the course of schistosomiasis and 
STH infection can influence ongoing immune responses in the host and so  modify 
clinical presentation of concomitant diseases (Harris et al., 2009) or hamper efficacy of 
vaccination targeted against bacterial infections and viral diseases (van Riet et al., 
2007). This Th2 response is also associated with induction of immunomodulatory and 
immunoregulatory mechanisms which can lead to hyporesponsiveness and anergy 
(Kamal and El Sayed Khalifa, 2006). As a consequence, it has been postulated that 
helminth infections could interfere with efficacy of vaccines due to switching of Th1 to 
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Th2 responses and that this could be reversed by anthelminthic treatment (van Riet et 
al., 2007, Cooper et al., 2000). Thus, Cooper et al., (2000) have demonstrated 
remarkably increased levels of vibriocidal antibodies and sero-conversion post 
vaccination with the oral, live attenuated cholera vaccine CVD 103-HgR in 
albendazole-treated individuals bearing STH than in the untreated control group. 
Similarly individuals co-infected with cholera and STH infection mounted poor 
mucosal immune responses to the sub-unit B cholera toxin (CTB) (Harris et al., 2009). 
The impairment of vaccine efficacy observed in STH or schistosomiasis infected 
individuals is not limited to oral vaccines. Studies show individuals infected with 
schistosomiasis had reduced IFN-γ responses to tetanus toxoid (TT) as compared to 
controls following tetanus vaccination (van Riet et al., 2007). In another study, it has 
been shown that individuals with helminth infection failed to elicit immune response to 
tuberculin purified derivative (PPD) when subjected to Mycobacterium tuberculosis or 
vaccinated with Bacille Calmette-Guẻrin (BCG) (Borkow and Bentwich, 2004).  
It has been suggested that schistosomiasis and STH infection influence susceptibility to 
other microorganisms such as malaria, tuberculosis (TB) and HIV/AIDS (van Riet et al., 
2007). However, the published data is inconsistent. For example in relation to malaria 
(Nacher et al., 2000) reported that people infected with A. lumbricoides were protected 
against cerebral malaria but other workers indicated that A. lumbricoides infection was 
associated with development of severe malaria (Le Hesran et al., 2004). Moreover, 
(Shapiro et al., 2005) found no association of helminth infection and development of 
malaria. Likewise, some studies have reported negative interactions between 
schistosomiasis and control of HIV-1 (Secor, 2006). Helminths are also able to affect 
responses in autoimmune diseases. T. trichiura, in particular, has been reported to be 
beneficial in modulating inflammatory bowel disease (Broadhurst et al., 2012, 
Broadhurst et al., 2010) 
 
1.8 Control of STH and schistosomiasis 
Like the other parasitic diseases of humans, there is, as yet, no effective vaccine against 
STH infection and schistosomiasis (Liu and Weller, 1996, Fenwick et al., 2006b) 
despite intensive effort in developing those vaccines in experimental animals. The 
hookworm vaccine candidate recombinant secreted protein 2 (Na-ASP-2) has produced 
9 
 
partial protection in experimental animals (Xiao et al., 2008, Bethony et al., 2008) but 
phase 1 human trials using recombinant Na ASP-2 in alum were terminated because of 
allergic reactions in sensitized people. A number of vaccine candidates for 
schistosomiasis have also shown promise in experimental animals but no vaccines are 
available yet. Thus effective control measures for all of these parasites require  
integration of various approaches i.e. improved sanitation, personal hygiene, 
accessibility to safe water supplies and, currently most importantly, chemotherapy with 
PZQ for schistosomiasis and Benzimidazoles (BZ) for STHs (Gabrielli et al., 2011, 
WHO, 2006, Utzinger et al., 2003), behavioural changes (Fenwick et al., 2006b, 
Sturrock, 2001) and health education. Combination of safe water supply, improved 
sanitation and chemotherapy can reduce A. lumbricoides infection markedly more 
effectively than water supply and sanitation alone (Esrey et al., 1991). Similarly 
chemotherapy in conjunction with provision of safe water had a higher impact on 
reduction of prevalence of schistosomiasis than safe water provision alone (Esrey et al., 
1991). In reality, for many reasons, a number of these approaches are difficult to 
achieve in many developing countries (Sturrock, 2001) where about 90% of 
schistosomiasis exists. It has been noted that sanitation alone is a slow method which 
requires a wide coverage (Warren, 1981). Furthermore, health education has a minimal 
benefit in preventing contamination or exposure if provision of safe water supply and 
proper ways of disposing excreta are not available (Sturrock, 2001).  
Controlling snails through environmental modification and application of molluscicide, 
notably niclosamide, has proved very effective in some areas but the use of niclosamide 
has raised concerns over the environmental effect (Smits, 2009). Therefore 
chemotherapy has become the mainstay of controlling STH infection and 
schistosomiasis because of 1) low cost/donation of the drugs and safety records and 2) 
the rapid results which can be obtained (Fenwick and Webster, 2006). It has been 
shown that the cost of treating a single school-child with albendazole ranges from US$ 
0.063-0.105 and the distribution costs were between US$ 0.04- 0.08 in different districts 
in Uganda (Kabatereine et al., 2005). Similar costs for drug distribution were also 
reported in Ghana, Tanzania (Kabatereine et al., 2005) and Myanmar (Montresor et al., 
2004). Mebendazole and albendazole belonging to the benzimidazole class are cheap, 
safe and well tolerated drugs with broad-spectrum activity, that the World Health 
Organisation (WHO) has advocated for use in the control of morbidity of STH infection 
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among the high risk population where the problem is endemic (WHO, 2006). The drugs 
are frequently targeted to children in schools (school-based treatment [SBT]) and to 
women and preschool children attending health clinics. However, the strategies for drug 
provision vary with prevalence (WHO, 2006). The drugs can also be distributed by 
community mass drug administration1 (MDA) at a single dose of 400 mg or 500 mg for 
albendazole and mebendazole respectively (Geary et al., 2009, WHO, 2006) . Similarly, 
since its discovery in 1970s, Praziquantel (PZQ) has become the mainstay for the 
treatment as well as control of morbidity due to schistosomiasis and therefore WHO and 
other United Nation agencies have suggested it for that purpose (WHO, 2006). The drug 
is given as a single dose of 40 mg/kg body weight (WHO, 2006). There is now 
overwhelming evidence on the safety of  PZQ in pregnancy due to the fact that many 
pregnant and lactating women have been treated with PZQ in mass campaigns without 
developing adverse events (Fenwick and Webster, 2006). In addition, in a recent study 
conducted in Zanzibar to assess the safety of co-administration of triple therapy, 
albendazole, praziquantel and ivermectin in MDA, no major untoward effects were 
observed (Mohammed et al., 2008). Based on this report, the three drugs can be 
simultaneously administered in areas where lymphatic filariasis (LF), schistosomiasis 
and STH infection co-exist. In endemic areas with no previous treatment, the triple 
therapy co-administration is subject to further investigation. However, effectiveness of 
MDA largely depends on the coverage (Smits, 2009). In China, MDAs using PZQ 
treatment integrated with other control measures managed to reduce schistosomiasis 
infection by 52.2% over ten years (1992-2001) (Xianyi et al., 2005a). Similarly a 
tremendous reduction of schistosomiasis, from 6.2% to 0.3%, was demonstrated in 
Morocco following provision of PZQ combined with health education and snails 
control, for a period of 14yrs (Laamrani et al., 2000b).  
 
1.9 Resistance to mebendazole/albendazole 
BZs have been extensively used for the treatment of parasitic diseases of animals since 
their discovery in 1960s. Later the drugs were also proven to be highly effective against 
                                                 
1
 Mass drug administration (MDA) or sometimes knowns as community wide treatment (CWT) is a term 
used to denote distribution of drug(s) to all eligible members in a community irrespective of infection 
status. 
11 
 
a variety of human parasitic infections such as gastrointestinal nematodes, cestodes, 
tissue nematodes and intestinal protozoa (Morgan et al., 1993, Robinson et al., 2004, 
Prichard, 2007). Functionally, the drugs are claimed to inhibit polymerisation of beta 
(β)-tubulin, a component of cytoskeletal structure, or affect neuromuscular function of 
the parasites (Liu and Weller, 1996) resulting in disruption of the parasite homeostasis 
and eventually parasite death. Thus, parasite populations with altered β-tubulin structure 
are potentially resistant to BZs drugs. So far, a single nucleotide polymorphism (SNP) – 
phenylalanine to tyrosine or histidine substitution, at the codon position 167 or 200, of 
the isotype-1 β-tubulin gene of helminths has been associated with the development of 
resistance of nematodes of veterinary importance to BZs drugs (Schwenkenbecher et al., 
2007, Robinson et al., 2004). A prolonged and frequent use of monotherapy for the 
treatment of infectious diseases triggers selective pressure to micro-organisms and 
hence leads to the development of drugs resistance. Improper use and rapid metabolism 
of drugs are among factors considered to associate with selection for drug resistance 
(Sangster and Gill, 1999). To date, BZ resistance is well documented in animal 
helminthiasis in many parts around the World (Sangster and Gill, 1999, Chandrawathani 
et al., 1999) and has raised a great concern for the economy of the countries. Although, 
several factors may play a role in the selection of resistance in animal helminthiasis it is 
generally suggested that parasites with short life cycles are prone to contract resistance 
earlier (Sangster and Gill, 1999). As a lesson from animal infections, the emergence of 
BZ resistance in human STH infections should not be a surprising occurrence and the 
increase in targeted and mass treatments will increase selection pressures for resistance. 
In Pemba, Zanzibar, targeted and mass BZ treatments for STHs have been applied over 
a number of years and this led to investigation of the drug sensitivity of hookworms to 
these drugs. It was shown that hookworms from Pemba showed somewhat lower 
sensitivity than a strain from Mafia island where periodic treatment was not practiced 
(Albonico et al., 2005) but there was no evidence of the mutations typically associated 
with benzimidazole selection in animal helminths (Albonico et al., 2004c, Diawara et 
al., 2009). However, the fact that neither albendazole nor mebendazole are completely 
effective in curing hookworm and T. trichiura infections raises the risk of selection of 
resistance (Geary et al., 2009, Albonico et al., 1994). These concerns highlight the 
importance of monitoring drug efficacy in ongoing treatment campaigns (Albonico et 
al., 2004a).  
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1.10 Resistance to Praziquantel 
It is about 40yrs since the discovery of praziquantel, the drug which has potent killing 
action against a number of trematodes and cestodes. Since then, praziquantel has been 
the only drug widely used for the treatment of schistosomiasis at the individual level 
and also for the control of morbidity in high risk populations. Despite its widespread 
use, the exact killing mechanism of this drug is poorly elucidated (Kasinathan et al., 
2010). Nevertheless, it is thought that the drug kills susceptible parasites by disruption 
of the tegument as well as imposing muscular contraction probably through interference 
with calcium ion (Ca2+) homeostasis (Greenberg, 2005, Kasinathan et al., 2010). This 
mechanism has been postulated from the fact that muscular contraction and tegument 
disruption are not apparent in the absence of Ca2+ (Greenberg, 2005). It has also been 
proposed that changes in membrane phospholipids and membrane fluidity may play a 
role in PZQ action (Greenberg, 2005). Moreover, the production of anti-schistosomal 
antibodies elicited during the course of the infection accelerate the killing effect of 
praziquantel as the disrupted membrane makes schistosome antigen accessible to 
antibodies (Liu and Weller, 1996). The current over-reliance on a single drug poses a 
threat for the potential development of resistant parasites which would pose a great 
challenge for schistosomiasis control. Some studies that assessed the efficacy of PZQ in 
treatment of schistosomiasis have raised fears about the possibilities of the emergency 
of drug resistance among schistosome populations. For instance, in Egypt, it was 
demonstrated that 2.4% of the individuals infected with S. mansoni were not cured 
following administration of three doses (40 mg/kg [twice] and 60 mg/kg [once]) of PZQ 
(Ismail et al., 1996). Similarly, in Senegal, a remarkably low cure rate (CR) (18%) was 
detected following administration of 40 mg/kg of PZQ (Gryseels et al., 2001b). 
However, it was later concluded that the low cure rates were due to the presence of 
immature worms and subsequent studies, using S. mansoni isolates collected from 
Senegal, did not demonstrate the emergence of praziquantel resistance (Gryseels et al., 
2001a). However, strains of schistosomes isolated from some such cases in Senegal and 
Egypt showed lower susceptibility to PZQ experimentally as do strains selected by sub-
optimal PZQ exposure during mouse passage (Cioli et al., 2004). Nevertheless there is 
no convincing evidence yet of development and selection of genetically-based 
resistance following repeated rounds of treatment (Guidi et al., 2010, Botros et al., 
13 
 
2005, Black et al., 2009). Nevertheless, the increasing number of countries applying 
repeated annual treatment programmes, increased frequency and coverage of treatment 
(e.g. the new National Control Programme in Pemba involves biannual treatments 
through implementation of whole community- based MDA rather than school-based 
programmes (Fenwick et al., 2009) and the proposal to extend treatment to younger 
(>2year old) children (Sousa-Figueiredo et al., 2010c) will apply selection pressure to a 
larger proportion of the gene pool and may facilitate emergence of resistance. 
Therefore, a strong monitoring system for PZQ efficacy is needed in control 
programmes based on preventive chemotherapy so that any signs of emergence of 
resistance in the schistosome population can be detected at an early stage.  
 
1.11 Control efforts for schistosomiasis and STH in Zanzibar: historical 
perspectives 
In 1986 the Zanzibar Schistosomiasis Control Programme was initiated and 
implemented periodic selective chemotherapy (i.e. treatment of individuals diagnosed as 
infected) to successfully control morbidity due to schistosomiasis (Savioli and Mott, 
1989, Savioli et al., 1990). In the early 1990s this control initiative with PZQ was 
progressively integrated with other major disease control strategies including STH with 
BZ and lymphatic filariasis (LF) with ivermectin as part of the National Control 
programmes (Mohammed et al., 2006). However, due to shortage of drugs, the 
chemotherapy campaigns between 1999 and 2004 were less consistent. Starting in 2001 
the Global Programme for Elimination of Lymphatic Filariasis (GPELF) carried out 6 
rounds of MDA with provision of ivermectin and albendazole. This strategy was 
successfully implemented with good drug coverage (>80%) and led the prevalence of 
microfilariaemia dropping to <1%, a threshold for considering discontinuation of MDA 
treatment campaigns for LF. From 2004 to 2006 the Schistosomiasis Control Initiative 
(SCI) supported the MDA with PZQ on a community basis using the delivery system 
utilised by the GPELF, and in 2006 the strategy became SBT. 
Since December 2006, when the last MDA campaigns was carried out with triple 
therapy regimen (Mohammed et al., 2008) no community–based treatment has been 
delivered (Figure 6). Since then no documented control effort has been implemented 
against schistosomiasis or STHs. Consequently, it was planned that from 2010 the 
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distribution of PZQ and ABZ would be reintroduced and again targeted to school-
children.. This package was in synergy and coordination with distribution of 
antimalaria, bed nets, vitamin A, immunizations and other health interventions and 
planned to be delivered through the reinforcement of the current network of peripheral 
health centres in order to constitute an innovative and efficient system for delivery of 
preventive chemotherapy packages. 
This phase of NTD control in Zanzibar was envisaged to be maintained year on year 
and to progress towards control of STH as a public health problem and towards 
elimination of schistosomiasis. As there had been only sporadic evaluation of the impact 
of the various previous interventions, the work proposed for this PhD programme has 
been partially designed to carefully evaluate the impact of control or elimination efforts 
in Pemba. In 2010 baseline surveys were undertaken and follow-ups carried out in 2011 
after the single annual SBT with a further follow-up planned for 2012 again following 
the 2011 school based treatments. However, in 2010 the Ministry of Health (MoH) 
Zanzibar revised the strategy for control of STH and schistosomiasis for Zanzibar, 
recommending increasing the frequency of drug delivery (from single annual to 
biannual). Furthermore, in 2010, Zanzibar was selected by SCORE (Schistosomiasis 
Consortium for Operational Research and Evaluation) for trialling additional 
interventions, mollusciciding and behavioural change for progressing towards 
elimination of schistosomiasis. An alliance was formed including various partners (e.g. 
WHO Headquarters, WHO AFRO, Ivo de Carneri Foundation- (IdCF), SCI, Swiss 
Tropical and Public Health Institute (STPHI), Natural History Museum (NHM), 
London, and Zanzibar Ministries) and called the Zanzibar Elimination of 
Schistosomiasis Transmission (ZEST) to be implemented in 2012. The aim of ZEST 
was to assess the impact of three parallel control intervention strategies in Pemba:- (i) 
The National Control Programme (NCP) alone based on PZQ treatment and health 
education, ii) NCP plus mollusciciding and iii) NCP plus behavioural modification. 
Fifteen Shehias out of a total of 45 were randomised to each arm. The studies planned 
for this PhD programme were extended in light of these developments. They were 
designed:- to inform the establishment and conduct of ZEST; to evaluate, compare and 
contrast the impacts of the various different intervention strategies on prevalence and 
intensity of schistosomiasis and STH; to evaluate the delivery of the MDA and any 
changes in PZQ efficacy over the course of the intensive intervention period; to assess 
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the Bulinus snail populations and their infection status. The earlier parasitological 
monitoring during the SBTs of 2010-2012 would provide baseline data to compare with 
the impact of the more intensive control measures. It was hypothesised that combining 
schistosomiasis interventions (Snail control plus MDA or Behavioural changes plus 
MDA) would produce substantial impact in reducing transmission and consequently 
lead to elimination. 
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1.12 Aims and objectives 
Aims and Objectives of the experimental chapters: 
Chapter 3 
Aim 1: To assess the impact of reintroduction of single annual, School-based treatment 
(SBT) with Praziquantel (PZQ) in Pemba for control of urogenital schistosomiasis  
Objectives:   
[a] To recruit a cohort of 24 schools across different areas of Pemba in order to 
undertake a survey of infection levels in Standard (Std)-1 and Std-3 children 
[b] To determine the prevalence and intensity of S. haematobium infection in the 
Std-1 (new school entry) children by urine filtration at baseline. 
[c] To determine microhaematuria using Heamastix 
[d] To determine the prevalence and intensity of S. haematobium infection and 
prevalence of haematuria in Std-1 and St-3 children during 2 annual rounds of 
PZQ treatment 
Aim 2: To assess the implementation of MDA±snail control or human behavioural 
modification on urogenital schistosomiasis.  
Objectives:  
[a] To recruit a cohort of 45 schools across the whole of Pemba in order to 
undertake a baseline survey of infection levels in Std -3 and Std -4 children. 
[b] To randomly allocate 15 of the 45 schools to each of three different 
intervention arms: (MDA alone, MDA + Snail control, MDA + behavioural 
modification) 
[c] To compare the prevalence and intensity of S. haematobium infection in the 
different intervention arms over 3years 
 
Chapter 4   
Aim1: To assess the impact of reintroduction of single annual, SBT using Albendazole 
(ALB) in Pemba for control of soil transmitted helminthiasis (STHs:-Ascaris 
lumbricoides, Trichuris trichiura and hookworm) 
Objectives:  
[a] To determine the prevalence and intensity of the STHs in Std-1 children in 
the cohort of 24 schools. 
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[b] To determine haemoglobin concentration in the Std-1 children by Hemocue 
[c] To determine the prevalence and intensity of infection and haemoglobin 
concentration during 2 annual rounds of ALB treatment 
Aim 2: To assess the impact of reintroduction of mass drug administration (MDA) with 
ALB in Pemba for control of STHs. 
 Objectives: 
[a] To determine the prevalence and intensity of the common STHs in Std-1 
children in the cohort of 24 schools 
[b] To determine level of haemoglobin concentration in the Std-1 children by 
Hemocue 
[c] To determine the prevalence and intensity of S. haematobium infection and 
haemoglobin concentration after implementation of two years of biannual MDA 
with ALB. 
 
Chapter 5 
Aim: To assess drug coverage during the MDA and factors associated with its 
compliance 
Objectives:  
[a] To assess drug (ALB and PZQ) distribution coverage among the 
communities 
[b] To determine the level of ALB and PZQ compliance among the community 
members  
[c] To assess knowledge and attitudes of community members in relation to 
compliance to ALB and PZQ treatment 
 
Chapter 6 
Aim: To investigate S. haematobium infection in children <6yrs 
Objectives: 
 [a] To assess the prevalence and intensity of S. haematobium infection in pre-
school aged children <6yrs  
 [b] To assess risk factors associated with transmission of S. haematobium 
infection in pre-school aged children through questionnaire to mothers/guardians 
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Chapter 7 
Aim: To investigate transmission dynamics of S. haematobium in Pemba 
Objectives: 
[a] To evaluate the snail populations in S. haematobium transmission sites 
[b] To assess physical and chemical characteristics of the snail habitats 
[c] To assess presence of S. haematobium in the snails 
[d] To characterize the snail intermediate hosts responsible for transmission of S. 
haematobium infection  
 
Chapter 8 
Aim: To determine efficacy and safety of praziquantel and its impact on S. 
haematobium genetic diversity  
Objectives: 
[a] Using the cohort of 24 schools, to collect miracidia during the surveys pre- 
and post- PZQ SBT and to store them in FTA™ cards for molecular analysis 
[b] To assess efficacy and safety of praziquantel for the treatment of urogenital 
schistosomiasis in school-aged children during SBT 
[c] To establish the efficacy of PZQ after the SCORE elimination programme by 
follow-up diagnosis at 4 weeks or 7 weeks after the 2013 treatments 
[d] Using the miracidial DNA, to assess genetic diversity of S. haematobium 
pre-and post- treatment 
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 Chapter 2 Materials and Methods 
2.1 Study site and population  
Pemba is the smaller of the two main islands of Zanzibar off the east cost of mainland 
Tanzania. The Island had an estimated population at 362,166 inhabitants with a growth 
rate of about 3.1% (census 2002) with 80% living in small villages and making their 
living from subsistence agriculture, fishing, tourism (which is becoming more important 
due to the fall of the clove price in the World market) and cultivation of cloves and 
seaweeds for export. Administratively, Pemba is divided into two regions with four 
districts (two districts per region). Within each district there are several shehias2. The 
average rainfall in Zanzibar is 1500 mm. The big rains (“Masika”) occur between April 
and June and the small rains (“Vuli”) between November and December. The hottest 
weather occurs from December to the end of March. During this time usually there is 
little rainfall and thus most ponds and streams become dry or have insufficient water for 
domestic (washing of utensils, clothes) and recreational (swimming, bathing) use. In 
Zanzibar water infrastructures are widespread even in remote areas but safe water 
supply is not fully available (Mshindo–personal communication).  
In Pemba, STH infection and urogenital schistosomiasis are currently among the major 
public health problems. Bulinus globosus snails are intermediate hosts for S. 
haematobium in this area (Stothard et al., 2002). In Zanzibar there has been intensive 
control of malaria using combination of interventions (Indoor Residual Spray [IRS], 
Long-Lasting Insecticide Nets [LLIN] and Artesunate–Amodiaquine) which resulted to 
a remarkable decrease in malaria cases such that it is not now considered a public health 
problem.  
 
2.2 Collection and examination of urine samples 
Urine samples were collected in mid-morning from children. Each child was given a 
plastic container and asked to provide about 20ml of urine. The samples were 
                                                 
2
 shehia is the lowest level of local administration which is led by a Sheha -who is appointed by the 
District commissioner.  
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transported immediately to the Public Health Laboratory-Ivo de Carneri (PHL-IdC) for 
processing and examination. Each sample was thoroughly mixed and 10ml was 
transferred in a 10ml syringe. The sample was passed through a filter holder housing a 
polycarbonate filter membrane (Vesteraard Frandsen, Denmark). The filter was then 
placed on a clean grease-free microscope slide and one drop of normal saline was added 
to avoid drying. The slide was examined using a compound microscope with a low 
power (x10) objective. The number of eggs was counted and reported per 10ml. Those 
samples with egg count ≤49/10ml of urine were considered as light infection and the 
ones with egg count ≥50/10ml of urine were considered as heavy infection (WHO, 
1983, Ahmed et al., 2012).  
 
2.3 Assessment of macro and micro-haematuria  
For macro-haematuria, the appearance of each urine sample was compared to the colour 
chart developed by the WHO (see Appendix 2.1). The urine colour was scored as 1 
(clear urine sample) through 6 (bloody urine sample) depending on the colour perceived 
by the observer. 
Micro-haematuria was assessed by using Hemastix® (Siemens Healthcare Diagnostics 
Inc, USA). The procedure was carried out as indicated by the manufacturer’s 
instruction. Briefly, the haemastix strip was immersed into the urine sample, 
immediately removed and compared with the colour chart indicated on the bottle within 
60 seconds. In some studies the results were recorded as positive or negative (any 
sample recorded as a trace response through to positive +++ was considered as 
positive). In other studies the graded score was recorded (nil, trace, +, ++, +++) 
 
2.4 Assessment of Praziquantel efficacy 
After urine samples had been collected, each child was given praziquantel tablets 
(40mg/kg) regardless of his/her infection status as part of the schistosomiasis control 
programme campaigns using height pole or as sometimes known as dose pole). 
Thereafter, all children who were found positive with schistosomiasis at baseline were 
followed up at the 4th and 7th week post treatment. During each visit, all children who 
were still found positive with schistosomiasis were asked to provide another urine 
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sample which was assessed for the presence of S. haematobium eggs as described 
above. At the end of the assessment, any infected children were re-treated with 
praziquantel (40mg /kg). 
In addition, miracidia were collected from Schistosoma eggs recovered before and after 
treatment, for DNA sequencing and PCR analysis. S. haematobium eggs were filtered 
through a pitchford™ filter, consisting of two meshes: the inner mesh of 200 µm 
allowed eggs to pass through but collected any larger debris and the outer mesh of 40 
µm collected the eggs. The filter was then washed and left in water at room temperature 
in sunlight for ~4-5 hours. The presence of miracidia was assessed using a dissecting 
microscope (CETI, Twin Z, UK). Individual miracidia were captured with ~3µl of 
mineral water (drop) and transferred onto Whatman FTA® cards (Whatman™, GE 
Healthcare, UK). The cards were allowed to air dry and stored at room temperature until 
ready for use.  
 
2.5 Collection and examination of stool samples 
Each child was provided with a stool collection container (without preservative) and 
asked to bring a stool sample of at least two grams the next morning. The samples were 
collected at the same time as for urine samples. The samples were then sent to the 
Public Health Laboratory-Ivo de Carneri (PHL-IdC) for processing and examination. 
The samples were assessed for the presence of intestinal nematode eggs using the Kato-
Katz method as recommended by the World Health Organization (WHO, 1994). The 
41.7mg templates were used for preparation of stool smears. Slides were examined 
within 30 minutes of the slide preparation to avoid clearing of hookworm eggs. 
Intensity results were expressed as eggs per gram faeces by multiplying with a factor of 
24. 
2.6 Assessment of haemoglobin level 
For each child, a capillary blood sample was obtained by finger prick using a standard 
disposable capillary lancet. The first drop of blood to appear was wiped off; the second 
was collected into a special microcuvette holder and analysed immediately by 
HemoCue (HemoCue, Denmark) in accordance with the manufacturer's instructions. 
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Determination of Hb level was performed within 2 to 3 minutes with the same 
HemoCue hemoglobinometer that was calibrated daily. 
 
2.7 Administration of questionnaire for the infant infection rate study 
The mothers of enrolled children were asked to participate in the interview to assess 
their knowledge, attitude and practice towards schistosomiasis. This was done using a 
structured questionnaire (Appendix 6.1). 
 
2.8 Preservation of snails for molecular studies 
All snails (whether shed or unshed) were placed in 20-100ml tubes containing water 
collected from their original sites. The container was placed at 4oC for 20 minutes. After 
this incubation period, the snails were blotted dry and individually placed in 20ml tubes 
containing absolute ethanol. The tubes were placed at room temperature until ready for 
transport to Natural History Museum (NHM) for further analysis. 
 
2.9 Extraction of DNA from FTA cards 
An individual FTA card was placed on a clean cutting mat and the 0.2mm discs that 
contained the miracidia DNA were removed using a Harris-Micro-Punch (VWR, UK) 
and placed individually into 0.2ml Eppendorf tubes. The punch and the pad were 
cleaned with absolute ethanol between each sample. The individual punches were 
washed in 200µl of FTA purification reagent and incubated at room temperature (RT) 
for 5 minutes when the purification reagent was removed and the process repeated for a 
total of 3 times. Then 200µl of TE buffer was added to each punch and incubated for 5 
minutes. After this incubation period the Tris-Ethylene Diamine Tetra Acetic acid 
(EDTA) (TE) buffer was removed and the TE wash repeated. The TE buffer was 
removed and the tube was left open and placed in a PCR machine at 56oC for 1hr to 
completely dry the disc.  
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2.10 Amplification of the Cox-1 gene from miracidia for bar-coding 
The amplification of the Cox-1 gene was carried out using PCR beads (IllustraTM 
puRETaq Ready-To-Go PCR beads (GE Healthcare, UK). The bead was directly added 
to the dried punch and then 1µl (10 pmol) of both the forward primer 
(Schisto_Cox1_5’) and the reverse primer (Schisto_Cox1_3’) added along with 23µl of 
DNAse free water. (The primer sequences used 5´-TCT TTR3 GAT CAT AAG CG-
3´for forward primer and 5´-TAA TGC ATM4 GGA AAA AAA CA-3´ for reverse 
primer). For the positive control 2µl of the DNA extract (DNA extract of S. 
haematobium worms from Zanzibar from the NHM SCAN collection), 1 µl of each 
forward and reverse primers and 21µl of DNAse free water were added to the bead. For 
the negative control 2µl of DNA extract and 23 µl were added to the bead. The mixture 
was briefly centrifuged then loaded into a Thermal cycler (Gene Amp, PCR system 
9700 Applied Biosystems, UK). The PCR reaction was carried out by initial 
denaturation at 94oC for 5minutes - one cycle, then denatured at 95oC for 15 seconds, 
annealed at 40oC for 30 seconds and extended at 72oC for 45 seconds, this cycle being 
repeated 40 times followed by final extension and holding at 72oC for 7 minutes. 4ul of 
the PCR amplicons were run on 0.8% gel red agarose gels together with Hyperladder 
IV. The PCR amplicons were visualized using an ultra-violet (UV) transilluminator. 
Positive amplicons were identified and the size of the amplicon was checked (expected 
~1000 base pair [bp]). 
 
2.11 Purification of the PCR product, sequencing and analysis of Cox-1 gene from 
miracidia 
Only amplicons from positive reactions were purified and sequenced. Efforts were made 
to ensure that DNA sequences were obtained from a similar number of miracidia from 
each child. However, for each child (n=5), a minimum of 8 miracidia were obtained. 
Overall, a total of 89 miracidia (44 collected pre-treatment and 45 post-treatment) from 
which the cox-1 gene had been amplified were included in the analysis. Four ml of each 
amplicon was visualised on a 0.8% gel-red agarose gel and positive PCRs products 
were purified using the QIAquick PCR purification Kit (Qiagen Ltd, UK) and then 
                                                 
3
 R represents any nucleotide (A, T, G or C) 
4
 M also represents any nucleotide just like R above 
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sequenced on an 3730XL 96 capillary automated sequencer (Applied Biosystems, UK) 
in both directions using 1.6pmol dilutions of the original PCR primers and an Applied 
Biosystems Big Dye Kit (version 1.1).  
For the purpose of construction of phylogenic tree, all sequences for the different (Cox1 
and nad-1 [nicotinamide adenine dinucleotide-1]) datasets were assembled and 
manually edited using Sequencher v.4.6 (http://genecodes.com) to remove any 
ambiguities between forward and reverse strands. Data from the two mitochondrial 
genes (cox-1 and nad-1) was used to analyse any differences in the phylogenic signal 
from the two mitochondrial regions. For each sample consensus sequences were aligned 
in Sequencher and polymorphic positions observed between individuals were checked 
and confirmed by visualisation of the original sequence chromatograms. The identity 
(species and gene) of the sequence was also confirmed using the Basic Local Alignment 
Search Tool (NCBI-Blast). Data analysis was carried out as explained by (Webster et 
al., 2012a). Briefly the assessments of the genealogical relationship amongst different 
mitochondrial gene region sequences were aligned in MacClade 4.05. The spanning 
network was created in the program TCS as described (Templeton et al., 1992) 
(http://darwin.uvigo.es/software/tcs.html). The evolutionary relationships between the 
haplotypes were inferred using Neighbour-Joining Minimum Evolution and Maximum 
Parsimony method using the Kimura 2-parameter model (K2P) in Mega V5. Analyses 
were subjected to 1000 bootstraps to evaluate the consistency of the branches of the 
trees. The topologies were rooted by the closely related species S. bovis.  
 
2.12 Selection and identification of transmission sites and collections of snails 
Potential S. haematobium transmission sites were selected for the assessment of Bulinus 
populations. The selection of these sites was based on the prevalence of S. haematobium 
infection in school children in the 24 schools study during the survey in January 2010 
(chapter 3; survey_1 cohort 24). Additionally, the accessibility of the site was 
considered. This survey of water bodies in the study area was made possible through the 
cooperation of local community members. Each site was visited once a month for the 
period of one year from October 2010 to September 2011. The nature of water body i.e. 
pond or stream, and type of vegetation present was also recorded. Two experienced 
malacology technicians helped search for snails over a distance of 15 meters from the 
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initial contact point, for a maximum of 15 minutes. Bulinus snails were collected using 
metal scoops (Figure 2.1) or picked up using forceps, where possible, and taken to PHL-
IdC for processing and assessment of cercarial shedding as described below. In July 
2011, with the assistance of, Linzy Elton, an MSc project student from the LSHTM, 
additional sites from 15 shehias, allocated for snail control under the SCORE 
programme, were visited. In those 15 shehias an intensive search of water bodies was 
carried out and Bulinus spp. snails collected as described above. Similarly, chemical 
characteristics of water from the sites were assessed as described below. 
 
Figure 4: Photograph of the author searching for snails in one of the visited sites.  
The arrow head indicates a dish immersed in water to allow easy washing. 
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Figure 5: Map of Pemba Island showing snail sampled shehias and other interventions 
planned for SCORE.  
2.13 Chemical characterisation of water from snail transmission sites 
A small amount of water (just enough to ensure the electrode can be submerged) from 
the source was collected in a container and a dual water meter (HACH sension5, USA) 
electrode was immersed and the parameters of interest (salinity, total dissolved salt 
Mkoani 
district 
Chake 
district 
Wete 
district 
Micheweni 
district 
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(TDS), temperature and conductivity) were recorded. A separate electrode was used to 
measure pH. 
  
2.14 Assessment of cercarial shedding from field collected snails 
Collected snails from the field were taken to the PHL-IdC to observe cercarial shedding. 
Whenever possible, shedding was carried out on the same day as the snail collection. 
Otherwise, the snails were kept in a bowl containing water from their source with dried 
cabbage leaves to feed them. To induce shedding, individual snails were placed into 24-
well culture plates containing 2ml of bottled drinking water (Figure 2.3). The plates 
were then exposed to sunlight and the cercarial shedding was assessed after every hour. 
This was performed by looking in each well using a dissecting microscope (SZ-ST, 
Olympus, Japan) and cercarial production was recorded. When snails did not shed 
cercariae on the first attempt they were kept in a bowl containing water from the source 
and the shedding process was repeated for a maximum of three consecutive days. Any 
snail shedding cercariae was removed and stored as described below. Also, some of the 
cercariae were collected and stored on FTA card (Whatman™, GE Healthcare, UK) for 
DNA isolation and determination of S. haematobium genetic variability. This was 
carried out at the NHM, London. 
 
2.15 Detection of patent and prepatent S. haematobium in snails: dissection of snail 
tissue and DNA extraction  
Due to limited resources available only a small proportion of the snails collected were 
processed for this experiment. However, all wild caught snails shedding cercariae were 
included. 
Individual snails were dissected using a dissecting microscope (LEICA MZ6). The snail 
tissues were briefly re-hydrated in millique water for about 5-10 minutes and stored at -
20oC until ready to use. 
For DNA extraction, snail tissue was chopped up using a scalpel and placed in a 1.5 ml 
Eppendorf tube. The scalpel and slide were wiped with absolute ethanol between each 
28 
 
sample. The DNA extraction was done using a DNeasy Blood and Tissues kit (Qiagen) 
as described in the protocol. Briefly, this was done as follows: 
To each sample, 3605 µl of ATL (tissue lysis buffer) buffer and 40 µl of proteinase K 
were added and the mixture was incubated at 56oC overnight on a rocking platform for 
digestion. After this incubation period, the mixture was vortexed and 400 µl of AL 
(lysis buffer) buffer/ absolute ethanol was added and mixed by vortex. The tubes were 
centrifuged at 3000 RPM for 1 minute. For each sample, 500 µl of the lysate was 
removed and placed into a separate well of the 96 DNeasy plate. The plate was sealed 
with air pore tape and centrifuged at 6000 RPM for 10 minutes. The tape was removed 
and 500 µl of ethanol-AW1 buffer was added to each sample. Then the plate was sealed 
with air pore tape and centrifuged at 6000 RPM for 5 minutes. Thereafter tape was 
removed and 500 µl of ethanol-AW2 buffer was added to each sample. Then the plate 
was centrifuged at 6000 RPM for 15 minutes. For DNA elution, the plate was 
transferred into a new rack without affecting the orientation and 200 µl of Tri-Acetate 
EDTA (TAE [AE]) buffer was added to each sample. The plate was sealed with air pore 
tape and incubated at room temperature for 1 minute. After this incubation period the 
plate was centrifuged at 6000 RPM for 2 minutes. DNA samples were stored at -20oC 
until when they were ready for use. The quantity of DNA extracted was measured in a 
NanoDrop™ (ND-1000) spectrophotometer at 260 nm wave length. 
 
2. 16 Detection of patent and prepatent S. haematobium in snails: amplification of 
the Dra-1 gene from snail tissue 
The genomic DNA samples were removed from the freezer and left at room temperature 
for a minimum of 30 minutes, for thawing. The stock solutions were diluted or 
suspended using sterile millique water (Fisher Scientific). The master mix solution was 
prepared by mixing 2.5µl of PCR buffer (containing 20mM magnesium chloride 
[MgCl2]), 2.0 µl each for (2.5µM) forward and reverse primer, 2.0 µl (2.5µM) dNTPs, 
0.25µl of DreamTaq™ Green Taq DNA polymerase (Fermentas, Life Sciences) and 
15.25µl of distilled water were added. The primer sequences used were 5´GAT CTC 
                                                 
5
 In some cases the volumes of ATL buffer, Proteinase K, AL buffer and Ethanol were doubled due to the 
size of the snail tissues 
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ACC TAT CAG ACG AAAC3´ and 5´TCA CAA CGA TAC GAC CAAC3´ 
(Hamburger et al., 2004) for forward and reverse primer, respectively (Sigma Aldrich). 
The PCR reaction was set by mixing 24µl of master mix solution and 1µl of the 
genomic DNA sample. The reaction was carried out on a Thermal cycler (Gene Amp, 
PCR system 9700 Applied Biosystems, UK). The PCR reaction was carried out by 
initial denaturation at 95oC for 5 minutes, then denatured at 95oC for 1 minute, annealed 
at 60oC for 1 minute and extended at 72oC for 30 seconds, the cycles being repeated for 
35 times with final extension and holding at 72oC for 10 minutes. The PCR product was 
loaded into a 1.5% agarose gel in 1X TAE buffer and run at 100V for 20-25 minutes 
together with ladder – HyperLadder IV (Bioline). The gel was stained with gel-red dye. 
The DNA bands were visualized using an ultra violet (UV) trans-illuminator. The size 
of the DNA expected was 121bp. 
 
2.17 Amplification of the cox-1 (Asmit-1 gene): detection of Bulinus species 
The total genomic DNA samples extracted previously were used for amplification of the 
cox-1 gene. The samples were removed from the freezer and left at room temperature 
for a minimum of 30 minutes, for thawing. The master mix was made based on 
Illustra™ pureTaq Ready-To-Go PCR Beads (GE Healthcare, UK) procedure. Briefly 
for each reaction, 1µl (10pmol) each of forward and reverse primers, 22µl of DNase 
free water, 1µl DNA sample (pre-diluted 1:10) and 1 PCR bead were added. At the 
volume of 25µl, the bead yielded a final concentration of 200 µM of each dNTP, 10 
mM Tris-HCL, 50 mM KCl and 1.5 mM of MgCl2. The primer sequences used 5´TTT 
TTT GGG CAT CCT GAG GTT TAT3´for forward primer (Asmit1) and 5´TAA AGA 
AAG AAC ATA ATG AAA ATG3´ for reverse primer (Asmit2) (Kane et al., 2013). 
The reaction was carried out on a Thermal cycler (Gene Amp, PCR system 9700 
Applied Biosystems, UK). The PCR reaction was carried out by initial denaturation at 
94oC for 5 minutes -one cycle, then denatured at 94oC for 15 seconds, annealed at 40oC 
for 30 seconds and extended at 72oC for 45 seconds, the cycles being repeated for 45 
times with final extension and holding at 72oC for 7 minutes. The PCR product was 
loaded into a 1.5% agarose gel in 1X TAE buffer and run at 100V for 20-25 minutes 
together with positive control and DNA markers. The gel was stained with gel-red dye. 
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The DNA bands were visualized using ultra violet (UV) transilluminator. The size of 
the DNA expected was 300 bp. 
 
2.18 Purification of the PCR products: Qiagen PCR Purification (single columns) 
Since the PCR product that has been obtained following amplification of genomic DNA 
may contain other products it was necessary to purify the product before sequencing as 
those products might interfere with sequencing. The QIAquick purification (Qiagen, 
UK) method was used and carried out as follows: 
One hundred and five microlitre (105µl) of PBI buffer was added to each of the PCR 
products. The mixture was transferred into a QIAquick spin column, placed in a 2ml 
collection tube and centrifuged for 1min at 13000rpm. Following this brief 
centrifugation, the flow through was discarded and the column returned into the same 
tube. The tube was washed and 750ml of PE Buffer was added and centrifuged for 1 min 
at 13000rpm. The flow through was discarded. The column was returned to the 
collection tube and centrifuged for 1 min at 13000 rpm (to remove any residual 
ethanol). The column was placed in 1.5m Eppendorf tube for DNA elution. 30ml of 
elution (EB) buffer was added and left to incubate for one minute at room temperature. 
The column was centrifuged for 1 min at 13000rpm. The purified DNA product was 
transferred into the new tube and stored at -20oC until used for sequencing. 
 
2.19 Sequencing of Cox-1 gene from snails 
Due to limited resources available it was not possible to process all the samples but 
effort was made to ensure a sub-sample from each selected site was sequenced. This 
allowed assessing distribution of snails from various sites and their potential role in 
transmitting schistosomiasis. Thirteen samples were randomly selected from the pool of 
74 snails in which the cox-1 gene had been demonstrated but which had not produced 
cercariae in the field. In addition almost all samples that had shed cercariae were 
included in the analysis. For each reaction mixture, 3µl of buffer, 3µl of sterile distilled 
water, 1µl of Big dye, 1µl of each forward and reverse primer (1.6pmol) and 2µl 
purified PCR product were added. This was carried out using fluorescent dye terminator 
(Applied Biosystems, UK) as described previously by other workers (Stothard and 
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Rollinson, 1997b, Kane et al., 2008). The chromatograms produced were manually 
edited and used to perform BLAST search using National Centre for Biotechnology 
Information against GenBank.  
 
2.20 Organisation of the MDA and Assessment of drug coverage  
2.20.1 Selection of shehia 
Administratively Zanzibar is divided into regions, districts and shehias. A shehia, being 
the lowest administrative unit, consists of one or several villages depending on some 
special situations. In Pemba there are 2 regions, 4 districts and 122 shehias -which are 
not equally distributed among the districts. For the purpose of drug distribution, special 
units (prisons, military camps) are regarded as one shehia -which is included in this 
number. So for the drug coverage studies, all shehias were included and the drugs were 
administered as described below.  
2.20.2 Selection and recruitment of community drug distributors (CDDs) 
During the implementation of GPELF, a combination of CDDs6, health workers and 
school teachers, across Pemba Island were involved in the distribution of drugs in the 
communities. This composition of the CDDs was intended to be maintained in the 
subsequent MDA. However, with the passage of time and due to limited financial 
resources, the number of school teachers involved in later MDAs declined and was 
replaced by secondary school leavers unemployed in formal sectors. In each shehia, the 
Sheha (local leader in a shehia) was asked to provide the names of secondary school 
leavers who could be involved in the drug distribution. So in the later MDAs the CDDs 
were mostly health workers and secondary school leavers. 
 
2.20.3 Drug delivery 
Before implementation of each MDA, CDDs were trained by health professionals in 
drug delivery and record keeping. Prior to drug delivery the CDDs made a visit to each 
                                                 
6
 Community drug distributors is a general term used to indicate diverse group of individuals (health 
professionals and non-professionals) who are responsible for drugs distribution in their respective 
communities. 
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household within their communities to determine the number of household members. 
Drugs were delivered house-to-house to all eligible people mentioned above and were 
administered using the modified dose pole (Sousa-Figueiredo et al., 2010a) in the case 
of PZQ. In addition one tablet of ALB (400 mg) was administered to each eligible 
individual. The CDDs recorded the numbers of individual treated, the amount of drugs 
given and the reasons for not taking the drugs. Each CDD was assigned ~50 households. 
Ideally CDDs were required to observe treatment but in some occasions this was 
impossible. 
 
2.20.4 Assessment of compliance and of side effect 
Selection of shehias for participation in the assessment of compliance has been 
described above. However, due to difficulties in accessing the so called special units 
they were excluded in the randomisation process for participation in the compliance 
assessment. The remaining shehias were randomly selected to get a total of 15 shehias 
to participate. For the purpose of this exercise only subjects aged ≥10yrs were selected 
to participate in the study as they were perceived to be able to answer interview 
questions and also recall the amount of drugs given. One week post MDA 
administration a structured questionnaire (annex 5.1) was completed with each eligible 
participant. Only individuals who were given the drugs were allowed to participate in 
the survey. The participants were assessed on their knowledge about schistosomiasis, 
and the number of tablets given and taken was recorded. In addition the participants 
were asked if they experienced any side effect following consumption of the drugs. For 
the compliance assessment, any participant who did not take the drugs at all or took less 
than the actual number provided was considered as non-compliant.  
 
2.21 Data management and analysis 
All data were entered in EpiInfo version 3.4.3 and later exported to Microsoft Excel for 
cleaning. Cleaned data were then transferred in STATA 10.0 (College Station, Texas, 
USA) for analysis. Arithmetic means were used to categorize the infection intensity for 
STH infections, A. lumbricoides, hookworms and T. trichiura according to the 
thresholds set by the WHO (Montresor et al., 1998) and revised by (Albonico et al., 
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2003). S. haematobium ova counts were quantified and classified as light infection (<50 
ova/10 ml) or heavy infection (≥50 ova/10 ml) according to WHO standards (Ahmed et 
al., 2012, WHO, 1983). The Chi Square test (χ2) was used to assess association of 
categorical data and the probability of ≤0.05 was considered as significant. McNamara 
χ
2
 was used to determine the association of paired data. For comparison between data 
from multiple schools e.g. prevalence between one year and another or between 
different classes in the school, multivariate analysis was applied using the Mantel-
Haenszel test. The Mantel-Haenszel test was also used to assess the trend of infection 
over the years. The proportion test (z-test) was used to compare the differences between 
two proportions in two time points (Kirkwood and Sterne, 2003). Haemoglobin level 
(anaemia) was classified according WHO (WHO, 2015, WHO, 2001) haemoglobin 
concentration of ≥11.5 g/dl was considered as normal (i.e. non-anaemic), 7.1-10.4 g/dl 
was regarded as moderate anaemia and ≤7.0 g/dl was considered as severe anaemia. 
Efficacy of PZQ was judged by assessing cure rate (CR) and egg reduction rate. The 
latter was calculated as follows: 
Egg reduction rate was calculated using the formula:  
 !!
=
"#$%&'(%$)*'("+*(,,*)-.+%*"%*/"0(1$+( 2 "#$%&'(%$)*'("+*(,,*)-.+%*"%*3-11-4.5
"#$%&'(%$)*'("+*(,,*)-.+%*"%*/"0(1$+(
6*788* 
The general estimation of the prevalence of (STH) any worm was calculated using the 
formula:  
9* :;<
= >" ? % ? &@ 2 >"*6*% ? "*6*& ? %*6*&@ ? >"*6*%*6*&@
7A8B
 
Where:  
a = proportion of Ascaris infection; t = proportion of Trichuris infection and h= 
proportion of hookworm infection (WHO, 2011b). 
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Chapter 3 Impact of control interventions on S. haematobium 
infections in Pemba 
3.1 Introduction 
Attempts to control schistosomiasis in Pemba started in 1986 (Savioli and Mott, 1989) 
with the ultimate objective of reducing schistosomiasis-related morbidities through 
focusing on health care delivery systems and specifically on case detection and 
treatment. This effort led to a remarkable reduction in the prevalence of both visual and 
micro-haematuria (Savioli et al., 1989a). Furthermore, this effort promoted subsequent 
schistosomiasis control programs in the area although these have been intermittent and 
varied in approach to control the disease. 
The various interventions applied are summarised in Figure 6 which is based on earlier 
analysis carried out in collaboration with Dr Marco Albonico and in consultation with 
the helminth control program manager in Pemba, Dr Khalfan Mohammed and with Mr. 
Kassim Shimely. It represents a review of the literature on activities and studies carried 
out in Pemba since the establishment of schistosomiasis control initiatives and the later 
integration of Soil Transmitted Helminth (STH) and Lymphatic Filariasis (LF) control 
strategies. Figure 6 makes reference to the integrated helminth control programmes 
carried out and the various anthelminthics employed i.e. the Zanzibar Helminth Control 
Programme (ZHCP) which was responsible for controlling morbidity of schistosomiasis 
and STH infections; and the Global Programme for Elimination of Lymphatic Filariasis 
(GPELF) aimed at eliminating lymphatic filariasis due to Wuchereria bancrofti. Along 
the top of the Figure are the values for prevalence of S. haematobium recorded in 
publications/records. During the early years of schistosomiasis control, the impact of the 
control measures had relied on the use of haemastix on urine for monitoring infection as 
suggested by microhaematuria, rather than on parasitology. The control of STH was 
steadily merged into the existing schistosomiasis programme and subsequently 
integrated with LF so that different drugs/drug combinations were administered during 
the course of implementation of the control strategies. Initially PZQ was used alone to 
control schistosomiasis and later combined with mebendazole (MBZ) (500mg) or 
albendazole (ALB) (400mg) to control STH. The control of transmission of LF 
employed a combination of ivermectin (IVM) and ALB. Following revival of the 
schistosomiasis control in 2004, PZQ was distributed in communities by MDA and later 
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in schools by SBT. At the late stage (in 2006) of the transmission control of LF, IVM 
combined with PZQ and ALB was distributed by ration (MDA), as part of an 
operational community-based trial to assess the side effects following administration of 
those three drugs together (Mohammed et al., 2008). In this MDA each individual in the 
communities aged ≥5ys, excluding those with chronic diseases or conditions 
(hypertension or diabetes), pregnant women and lactating mothers at first week, was 
given that drug combination. The drugs were distributed by house to house visit through 
community drug distributors (CDDs) from their respective shehias.  
As shown in Figure 6 the intensive annual selective treatment7 targeted at school-
children (1986-1988) in which school-children aged between 5-19yrs were diagnosed 
and those found positive were treated, led to a marked decline in prevalence of 
haematuria from the baseline of 54.1% to around 13% (Savioli and Mott, 1989). After 
this there was a period (1989-1998) of school-based treatments8 (SBT), twice a year but 
later, due to the high cost and limited availability of praziquantel, only once a year and 
restricted to high prevalence schools was delivered between the years 1994-2002. After 
this period the prevalence had risen to 31% and following subsequent sporadic 
provision of SBT prevalence had rebounded by 2004 to 63% among the school-children 
and 37% in the community (Mr Haji, Unpublished data). Then in 2004-2006 
reintroduction of intense treatment through CWT-MDA supported by the 
Schistosomiasis Control Initiative (SCI) again led to marked reductions in prevalence 
which in 2007 had fallen to 18% based both on haemastix testing and egg detection. 
After this there was minimal consistent intervention or monitoring until the initiation of 
this study and the implementation of the National Plan for Pemba in 2010 which 
initially involved annual SBT with ALB and PZQ. 
In 2001, the WHO passed resolution WHA 54.19 which urges schistosomiasis endemic 
countries to have essential drugs for schistosomiasis and to reach to at least 75% of 
school-children and those at risk (WHO, 2006). The resolution emphasized the use of 
chemotherapy to control schistosomiasis morbidity. Additionally, following lessons 
learnt from other schistosomiasis endemic countries such as China and Morocco, which 
                                                 
7
 Selective treatment is a term used to indicate treatment only of those individuals found to be infected 
following diagnosis. 
8
 School based treatment (SBT): treatment targeted to school aged children and delivered through the 
schools. 
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have successfully eliminated the disease (Engels et al., 2002) it was thought feasible for 
other countries to eliminate schistosomiasis. Thus, the WHO has endorsed resolution 
WHA 65.21 which encourages schistosomiasis-endemic countries to change their 
control strategies and focus on elimination (www.who.int/schistosomiasis/strategy/en/)
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Figure 6: Review of Schistosomiasis control in Pemba 
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1993 
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Praziquantel (PZQ) 1 2 3 4 
 
6 7 
 
9 10 
Mebendazole (MBZ) 
 
3 
 
8 
ALB + Ivermectin 
(IVM) 
 
 
 
 
5 
 
7 
 
Albendazole (ALB) 
 
6 
 
9 10 
                    
 
1 Selective chemotherapy to children and adults - test and treat campaign, twice a year 
2 School targeted treatment, twice a year 
 
3 
ZHCP: Initiated 
PZQ for school targeted treatment, only in high prevalence schools 
MBZ for school targeted treatment, twice a year 
 
 
4 Irregular distribution 
5 
GPELF: Community MDA (> 5 years of age), once a  year . In 2006 PZQ was also included in the package and the 
three drugs were delivered together in the communities in MDA. 
 6 
ZHCP ,> 5 years of age, once a year  
2004 - 2005, Community MDA in Pemba (supported by SCI - Schistosomiasis Control Initiative) 
2006, School based treatment in both Islands  
 
7 Integrated Triple Drug Administration, Community MDA, only once 
 
8 Preschool targeted treatment (12 - 59 months), twice a year, supported by UNICEF 
 
9 School based treatment, once a year: (The treatment was partially implemented), no PZQ distributed 
 
10 
School based treatment (SBT), once a year (during the National Baseline Survey). SBT was followed by MDA from 
2012 to 2018 
a(Guidi et al., 
2010) 
b(Savioli and 
Mott, 1989) 
c(Albonico et al., 
1997) 
dHaji–
unpublished SCI 
data 
 
All based on 
school-children 
 
54.1b 31.0c 63.0
d 16.0d 19.0d 18.0d 26.4 b 12.8b S.haem:micro-    
haematuria % 
S.haem: parasitology  18.9
a 
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In 2010 annual SBT was re-introduced with the intention of it being run continuously 
and the work in this chapter was initiated to monitor and assess the impact of this more 
consistent approach. However, in 2012 the Zanzibar National Neglected Tropical 
Diseases (NTDs) control program (ZNCP) decided to push for elimination of urogenital 
schistosomiasis, in an initiative called Zanzibar Elimination of Schistosomiasis 
Transmission (ZEST9) and so it was deemed necessary to change the treatment 
approach to introduce more frequent and widespread treatments. Furthermore, the 
Schistosomiasis Consortium for Operational Research and Evaluation (SCORE6) 
initiative chose Zanzibar (Unguja and Pemba) as one of the locations to assess the 
impact of alternative supplementary control measures on schistosomiasis. So the work 
in this chapter which started looking at the SBT programme applied in 2010 became 
concerned with establishing and then comparing and monitoring these new approaches 
in Pemba. For the SCORE initiative 45 local administrative units (shehias) in each 
Island (Unguja and Pemba) were sub-divided into three interventions arms and assigned 
either to receive MDA alone, MDA plus snail control or MDA plus behavioural 
changes intervention. 
 The timeline for these more intensive interventions is shown in Figure 7.  
                                                 
9
 ZEST is an alliance of different institutions and international organisations (Natural History Museum, 
Ministry of Health- Zanzibar, WHO and SCORE, SCI) with common interest of eliminating schistosomiasis 
in Zanzibar.  
SCORE is housed at the University of Georgia, United States of America and is funded by the Bill and 
Melinda Gates Foundation. http://www.score.uga.edu  
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     Figure 7: Timeline indicating implementation of different SCORE interventions for controlling schistosomiasis in Zanzibar 
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As detailed below (section 3.3.1.2), at the outset of ZEST in 2012 the overall baseline 
prevalence in Pemba was 10.1% and the programme started by introducing biannual 
MDA of praziquantel to all eligible individuals aged ≥3yrs in 2012, the initial treatment 
round being in April and the second one in November of 2012. This MDA treatment 
campaign was delivered through house-to-house approach. However, the subsequent 
parasitological survey carried out one year later revealed a minimal reduction of the 
disease prevalence (8.2%). Thus during the SCORE annual general meeting to evaluate 
the project progress it was proposed that the existing drug delivery strategy may not 
have been implemented effectively to reach the desired coverage rate. So it was decided 
to change the drug delivery approach with school-aged children being treated at school 
and adults and preschool children (aged 3-5yrs) being treated in the community by 
house to house drug administration. This regimen (referred to as “SBT/MDA”) was first 
implemented in November, 2013.  
The surveys summarized in Figure 10 (below) started with establishing the baseline 
prevalence at the beginning of this project work in 2010 and subsequently assessed the 
impact of the successive control strategies. School-based treatment was reintroduced in 
Pemba in 2010. The impact of these SBTs was assessed by three surveys during 2010 – 
2012 which are described below. In 2012 MDA was implemented twice yearly 
supplemented in defined areas with either mollusciciding or behavioural change 
initiatives, supported by the SCORE programme. The data described serves to compare 
these approaches. In the surveys parasitological diagnosis based on microscopic 
examination of filtered urine was carried out alongside use of haemastix for blood in the 
urine which had been used traditionally for prevalence assessments in Pemba (see 
Figure 6). The analysis described in this chapter deals principally with the use of the 
parasitological data to define impact of control on prevalence. 
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 Figure 8:  Timeline for STH and schistosomiasis surveys and treatment strategic approach 
       
    
  
 
             
              
* Urine eggs and haemastix for schistosomiasis. Stool eggs for STH.   
** Included 17 out of the 24 Schools cohort; # MDA: community-based, house to house treatment to> 3yrs.  
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3.2 Results 
 
3.3. Outline of the various surveys 
N.B. Surveys_1, 2 and 5 are described first since they deal with the pre-MDA period 
when only SBT had been applied. 
 
3.3.1 Survey_1 of baseline prevalence and intensity of S. haematobium infections in 
schoolchildren in Jan 2010 
 
3.3.1.1 Study population: 
During January 2010 a survey was carried out in 24 primary schools in Pemba Island (6 
primary schools in each of the four districts), referred to as “Cohort 24”. The schools 
were selected to cover both urban vs. rural locations although the whole Pemba may be 
regarded as rural (Stoltzfus et al., 2000). 
A total of 1185 standard-1 (Std-1) school-children were enrolled in the study. The 
children had a mean age of 7.3yr (± SD 0.7). Figure 9 shows the profile of the children 
enrolled. Of the children enrolled, 610 (51.5%) were girls and 575 (48.5%) were boys.  
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Figure 9: Outline of the districts and Cohort 24 schools surveyed for schistosomiasis 
and soil transmitted helminthiasis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NB =Ng’ombeni, MG= Mizingani, MK= Mkanyageni, NW=Ngwachani, CB=Chambani, 
MT=Mtambile, MI=Michakaini, WE=Wesha, ZI, Ziwani, UW= Uwandani, PU= Pujini, 
CM=Chanjamjawiri, PK=Piki, BM=Bagamoyo, KY=Kiuyu Minungwini, MZ=Mzambarauni, 
KZ=Kizimbani, KG=Kangagani, SV=Sumba Viamboni, KN=Kinowe, KA= Konde Msingi A, 
KB= Konde Msingi B, TU=Tumbe, WG=Wingwi 
 
3.3.2 Survey _2 in Jan 2011 after one annual SB treatment 
 
3.3.2.1 Study population  
This survey of Cohort 24 schools was to determine any effects of this single annual 
school-based treatment on helminth infection rates in the new Std-1 cohort recruited a 
year later. In addition, Std-3 children were evaluated since this was the age group, along 
Enrolle Enrolled  Enrolled  Enrolled  
SCH and STH 
survey in Pemba 
Mkoani District Chake-chake 
District 
Wete District Micheweni 
District 
Six schools: 
NB, MG, MK, 
NW, CB, MB 
Six schools: 
MI, WE, ZI, 
UW, PU, CM 
Six schools: 
PK, BM, KY, 
MZ, KZ, KG 
Six schools: 
SV, KN, KA, 
TU, KB, WG 
N= 300 N= 301 N= 284 N= 300 
Boys 
= 147 
Girls 
= 153 
Boys 
= 139 
Girls 
= 162 
Boys 
= 144 
Girls 
= 155 
Boys 
= 145 
Girls 
= 140 
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with Std-4, selected for monitoring during the proposed future National Plan and 
SCORE activities. Parallel sampling of infection in the Std-3 children also allowed 
comparison of their levels of infection after having been treated in 2010 with that in the 
previously untreated Std-1 children. A total of 2382 children were enrolled. Of these, 
2372 (99.6%) produced enough urine sample for processing. 
 
3.3.3 Survey _5 in Jan 2012 after two annual SB treatments 
 
3.3.3.1 Study population 
Prior to the implementation of the SCORE initiatives themselves, a new baseline survey 
to assess the prevalence of schistosomiasis across Pemba Island was conducted between 
January–March, 2012. Forty five primary schools (“Score Cohort 45”) were selected 
and 15 of these allocated to the snail control arm, 15 to the behavioural change arm and 
15 to the MDA alone arm. The list of the 45 schools is shown in appendix 3.1. Of these, 
17 were from the Cohort 24 schools used in the previous surveys (2010-2011) during 
the implementation of single annual school-based treatment. For some of the analysis 
described later these 17 schools will be considered separately under “Cohort 24/17”as 
they allowed comparison of the trend of schistosomiasis in Pemba following the 
different control strategies. Table 1 shows the allocation of schools between the Cohort 
24, the Score Cohort 45 and the three different arms of the SCORE intervention. 
A total of 7977 school children were enrolled in Survey_5 of which 7834 (98.2%) had 
complete records of urine samples. Of these 3497 (44.6%), 2243 (28.6%), 2094 (26.7%) 
were in Std-1, Std-3 and Std-4 respectively. Overall the children had a mean age of 
9.4yrs (± SD 1.9), Std-1 children having a mean age of 7.7yrs (± SD 0.9), Std-3 children 
had a mean age of 10.2yrs (± SD 1.1) and Std-4 had a mean age of 11.4yrs (± SD 1.0). 
In all standards the number of girls was slightly higher than that of boys (52.8%, 51.9% 
and 55% for Std-1, Std-3 and Std-4 respectively). 
 
3.3.4 Survey _4 (Cohort 24 schools) 
This survey was carried out in 2013 to assess the trends of schistosomiasis (and also 
STH) in the Std-1 children from the Cohort 24 schools that had been surveyed annually 
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since 2010 and so allowed comparison of the effects of the SBT with the ZEST/SCORE 
MDA and MDA supplemented interventions. This was necessary because the SCORE 
surveys (survey_6 and survey_7) only sampled Std-3 and Std-4 children.  
Survey_4 was carried out between January-March, 2013 and involved a total of 2309 
Std-1 school-children (52% girls and 48% boys). The children had a mean age of 7.3yrs 
(± SD 0.7).  
 
3.3.5 Survey_6  
This was carried out along with Survey_4 to evaluate the impact of SCORE 
interventions in Std-3 and Std-4 children following one year of ZEST/SCORE 
implementation.  
In this survey a total of 5632 children were enrolled of whom 4862 (83.1%) gave 
consent and also provided urine samples. Of these 54.6% were girls. The children had a 
mean age of 10.6yrs (± SD 0.95).  
 
3.3.6 Survey_7  
This was carried out as a routine programme monitoring to assess the effectiveness of 
the ongoing ZEST/SCORE strategies after 2years of their implementation. In this 
survey a total of 5684 school children were enrolled. Among those 51.0% were girls. 
The children had a mean age of 10.6yrs (± SD 1.1). 
 
46 
 
 Table 1: Relationship between the “Cohort 24” schools and the “Score cohort 45” 
schools involved in each of the surveys.  
 Survey_ 1 Survey_ 2 Survey_ 5 
SCORE 
ARM 
Survey_ 4 Survey_ 6 
Survey_ 
7 
24 
school 
cohort 
24* 24 
7 (N.D.)#  7*   
17 
Behaviour 6 6 6 
Snail 6 6 6 
MDA 5* 5* 5* 
45 
school 
cohort 
  28 
Behaviour 
N.D.# 
9 9 
Snail 9 9 
MDA 10 10 
School 
Standard 
sampled 
1 1 &3 1,3,4  1 3&4 3&4 
 
 * Underlined numbers show the schools from the original 24 which were just subject to 
the chemotherapy interventions. 
# ND – not done in this survey 
Shaded area – the 45 schools included in the SCORE study (which includes 17 from the 
original 24 school cohort). 
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3.4 Monitoring of School Based Treatment (SBT) control implemented 2010 
-2012 (Cohort 24).  
3.4.1 Assessment of prevalence 
3.4.1.1 Baseline prevalence Jan 2010 (Survey_1) 
Overall, S. haematobium infections as defined by single urine filtration were found in 
112 (9.5%) (95% CI = 7.8-11.1) children. Of these, 44 (39.3%) were girls. Further 
analysis showed a significant association of infection with sex (χ2 = 7.4; df = 1; p = 
0.007), boys being more frequently infected. 
The prevalence in each of the 24 schools in the four districts of Pemba is shown in 
Figure 10 and the mean for the schools in each of the 4 districts in Figure 11. 
There was marked variation in schistosomiasis prevalence in schools both within and 
between the 4 districts ranging from 0-30% for individual schools, The mean 
prevalences for schools in the 4 districts (Figure 11) were significantly different (χ2 = 
32; df = 3; p = 0.0001 for the districts). The differences in prevalence both within and 
between districts are likely to be due to ecological differences between the areas 
(districts). For example Mkoani district has more hills and valleys with abundant water 
bodies which increase the potential transmission of schistosomiasis, while Micheweni 
district is more flat and sandy with relatively fewer water bodies. The presence of hills 
and valleys extends from Mkoani district to the northern west of Pemba Island. Similar 
factors are likely to underlie the differences seen within districts e.g. Ng’ombeni (2% 
prevalence) and Chambani (30% prevalence), are both in Mkoani district, but there are 
more water bodies in Chambani than in Ng’ombeni. 
4
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Figure 11: Overall (mean) prevalence of schistosomiasis among districts in Pemba in     
2010 
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Figure 11 Mean prevalence (+S.D.) for schools in each of the four districts in 2010 
 
3.4.1.2 Comparison of prevalence in the Cohort 24 schools in Jan 2010 (Survey_1), 
Jan 2011 (Survey_2) and Jan 2012 (survey_5).  
 
The prevalences in the 24 schools (surveys_1 and 2) and the subset of 17 from the 
original 24 (survey_5) are aligned for comparison in Figure 12. NB Data from the Std- 
4 children in survey_5 is not shown here since this age group were not sampled in 
earlier rounds.  
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Figure 12: Comparison of prevalence of schistosomiasis in Cohort 24 schools (2010-
2012) 
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Figure 12. Prevalence in the individual schools in 2010-2012.  
Arrows show the schools of Cohort 24 not included in Survey_5. 
 
For a clearer comparison of the prevalence by year the data for the Std-1 children in the 
individual Cohort 24/17schools studied in all three surveys is also represented in Figure 
13. 
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Figure 13: Prevalence of schistosomiasis by year for each of the Cohort 24/17 schools. 
Figure 13: Prevalence in years 2010, 2011 and 2012 for the Std-1 Children in the Cohort 24/17 
schools. 
From Figures 12 and 13, it is clear that the pattern of infection levels across the schools 
was essentially similar in 2010, 2011 and 2012 e.g. Chambani and Uwandani Schools 
consistently had the highest level of infection as compared to other schools.  
Somewhat unexpectedly, as more clearly seen in Figure 14, the overall mean 
prevalences, for the Std-1 children in the 17 schools, of 19.6% (95% CI = 16.9-22.3) 
and 17.6% (95% CI = 15.6-19.6) in 2011 and 2012 respectively, were noticeably higher 
than that recorded in the same age group in 2010 (10.7% [95%CI = 8.6-12.8]) (z = 5.1; 
p = 0.0001 for the levels observed between 2010 and 2011]). The slight decrease in 
mean prevalence between 2011 and 2012 was not significant (z = 1.2; p = 0.2). Mantel-
Haenszel analysis was also used to assess the significance of this difference in 
prevalence. Mantel-Haenszel analysis is able to assess the overall odds ratio (OR) for 
the change in prevalence between two time points e.g. 2010 and 2011 by integration of 
52 
 
the individual odds ratios for the prevalence change in each of the 24 schools 
individually. Applying Mantel-Haenszel analysis to the changes in prevalence between 
2010 and 2011 showed there was a highly significant OR for prevalence being higher 
across the schools in 2011 (MHOR = 2.3 [95%CI = 1.81-3.04]; p = 0.0001), (see 
appendix 3.5A). Similarly, applying Mantel-Haenszel analysis to all individual schools 
to estimate the trend of infection over the three year (2010-2012) period, there was a 
significant OR for infection increase (MHOR = 1.2 [95% CI = 1.1 -1.3], p = 0.003).  
Figure 14: Mean prevalence for the Cohort 24/17 sampled 2010-2012 
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Figure 14: Mean (± SD) percentage prevalence for the Standard 1 children in the 17 schools 
tested in each of years 2010, 2011 and 2012. Error bars = standard deviation. 
 
The higher overall prevalence in 2011 compared with 2010 was reflected in higher 
prevalences in 19 out of the 24 schools and across the different districts. Of the Std-1 
children, there were significantly more boys infected than girls in 2010 (overall 
prevalences 58.2 vs. 41.8% respectively; χ
2 = 3.5; p = 0.06) and also in 2011 (61.8 vs. 
38.2% for boys and girls respectively; χ
2 = 15.3; p = 0.0001) but not in 2012 (47.7% for 
boys vs. 52.3% for girls; χ2 = 0.4; p = 0.4). It is generally observed, in settings like 
Pemba, that boys usually engage more in risk behaviours for transmission of 
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schistosomiasis than girls which in turn increase the potential of acquiring the infection. 
So the finding of higher prevalence of schistosomiasis in girls in 2012, albeit non-
significant, was unexpected. However, this pattern was not observed for Std-3 children 
tested in 2011 and 2012. On both of these occasions: boys were more infected than girls 
(69.4% vs. 30.6% for boys and girls respectively in 2011; χ
2 = 19.3; p = 0.0001) and 
66.7% for boys vs. 33.3 for girls in 2012; χ
2 = 16.5; p = 0.0001) in 2012. 
The inclusion of Std-3 children in the surveys in 2011 (to conform to the newly planned 
ZEST/SCORE programme) allowed a comparison of the prevalence in Std-1 and St-3 
children. Std-1 children had not been previously treated and so their level of infection 
represents cumulative infection over preschool years. In contrast the Std-3 children 
sampled in 2011 had been treated via SBT once in 2010 and those sampled in 2012 
would have been treated twice (annually in 2010 and 2011). So differences between the 
Std-1 and Std-3 levels of infection is likely to reflect the impact of elimination of the 
preschool worm burden but may also be affected by changing exposure levels or 
development of immunity. In 2011, 359 (15.1% [95%CI = 13.7- 16.6%]) of the children 
were infected, with Std-1 children showing a significantly higher prevalence (18.6% 
[95%CI = 16.6-21.0], 226 infected) than Std-3 (11.3% [95%CI = 9.5-13.2], 133 
infected) (χ2 = 26; p = 0.0001). Furthermore, the prevalence in individual schools 
(Figure 15.) showed marked variation between the schools for both Std-1 and Std-3 
children with many schools showing prevalences ≥20% for Std-1 classes. Interestingly 
the pattern of infection was somewhat similar within the schools for the two classes. In 
2012, after two rounds of annual SBT, the situation was similar with a higher 
prevalence of infection in Std-1 (17.6% [95%CI = 15.6-19.6%]) than Std-3 (11.6% 
[95%CI = 9.6-13.6%]; χ2 = 15. 8; p = 0.0001). Applying Mantel-Haenszel analysis to all 
the individual schools showed a highly significant odds ratio for prevalence being lower 
in Std-3 children (MHOR = 0.56 [95%CI = 0.44-0.2%], p = 0.0001).  
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Figure 15: Comparison of prevalence of schistosomiasis in Std-1 and Std-3 in 2011 
(Survey_2: Cohort 24 school) in Pemba 
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3.2.1.3. Comparison of overall prevalence by district 2010-2012.  
 
The data for mean prevalence by district for 2010-2012 is shown in Figure 16. As can 
be seen, the above mentioned increase in overall prevalence between 2010 and 2011 
was seen in all four of the districts with the regional patterns of prevalence being similar 
between 2010 and 2011. In 2012 the pattern was somewhat different. Overall, the data 
indicate a progressive increase in prevalence in Micheweni and Wete, the levels of 
infection being significantly 
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Figure 16: Mean prevalence of schistosomiasis by district 2010-2012 
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Figure 16 Mean (+SD) prevalence of schistosomiasis in Pemban districts in 2010-2012 
increased over the years from 2% (95%CI = 0.6-3.9) and 12.1% (95%CI = 6.9-17.3) 
respectively at the baseline (2010) to reach 16.2% (95%CI =12.0-20.3% [z -5.1; p = 
0.00001]) and 25.4% (95%CI = 20.0-30.8% [z -3.2; p = 0.002]) respectively in 2012. 
The prevalence of 16.2% observed at Micheweni district was surprisingly high as 
compared to the baseline 2%. The reason for this marked increase of schistosomiasis 
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infection was not apparent as there had been no any environmental changes that would 
favour transmission.    
Overall this data provides no evidence that the one or two rounds of annual SBT had 
any impact on prevalence of schistosomiasis. Indeed prevalence was seen to increase 
significantly in 2010-2011 the reasons for which are unknown. The difference in 
prevalence demonstrated between Std-1 and Std-3 is likely to reflect the impact of 
elimination of the preschool worm burden but may also be affected by changing 
exposure levels or development of immunity 
 
3.4.2. Assessment of intensity 
3.4.2.1. Comparison of arithmetic mean Intensities by School (2010-2012) 
This analysis involved only Cohort 24/17 schools for which there was complete data. 
The overall mean intensities in the different individual schools and standards and the 
means across all children are shown in Figures 3.2.8 and 3.2.9. As described above, at 
baseline, only Std-1 children were sampled and their overall mean intensity ± standard 
deviation was 9.1± 65 eggs/10 ml of urine. Some schools especially Pujini had 
somewhat higher mean intensities i.e. (53.8 ±204.7). Although the patterns varied, the 
overall pattern indicates stable or increasing intensities in the majority of schools.  
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Figure 17:  Intensity of infection 2010-2012 
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Figure 17 Arithmetic mean Intensity (SD) of infection 2010-2012. Top graph Std-1 and bottom 
Std-3 
 
Arithmetic mean egg intensities derived from the individual child egg counts from all 
schools are shown in Figure 18. (Standard error bars are shown in this graph due to the 
large variance in egg counts). These were progressively increased as compared to 
baseline for both Std-1 and St-3. The mean intensities ± S.D. were 9.069 ± 65.0, 13.21 
±57.8, 28.31 ±161.6 in 2010, 2011 and 2012, respectively in Std-1 and 6.259 ±39.3 and 
17.05 ±135.4 in 2011 and 2012 respectively, for Std-3. Since the egg count data was not 
normally distributed the non-parametric Mann-Whitney statistical test was used. This 
showed a significant difference for the Std-1 children between the Survey _1 and 
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Survey _5 values (p = 0.0001). However, the values for both Std-1 and Std-3 children in 
2011 compared with 2012 were not significantly different. 
Figure 18: Arithmetic mean intensity 2010-2012 
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Figure 18 Arithmetic mean intensity (+SE) 2010-2012 based on the mean values from all 
individual children in all Cohort 24/17 schools. Top graph Std 1, bottom graph Std 3. 
 
3.4.2.2. Comparison of Intensity by WHO designation (heavy [≥ 50 eggs/10ml 
urine] and light [≤49 eggs/10ml urine](Cohorts 24 and 24/17: Survey_1, 2 and 5) 
This analysis concerned the data from Cohort 24 and its sub-set of 17 schools collected 
from 2010 to 2012 from Std-1 children prior to, and at the start, of the shift of treatment 
approach from annually SBT to SBT/MDA. The sampling of Std-1 children in 2012 in 
the ZEST/SCORE program allowed further comparison of the trends of both prevalence 
and intensity.  
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At baseline, (survey_1, 2010) the intensity of infection in Cohort 24 was 7.4 eggs/ 10ml 
of urine ± 56.0. Among the infected children, 76 (67.9%) had light infections and 36 
(32.1%) heavy infections, which were more common in boys (26 [38.2%]) than girls 
(10 [22%]) although this was not statistically significant (χ2 = 2.94; df 1; p = 0.086). The 
children classified with light schistosomiasis infection had an arithmetic mean egg 
count of 15.2 (± SD 10.8) /10ml of urine with a range of 2-44/10ml of urine while those 
with heavy infection had a mean count of 210.4 ± SD 248.6/10ml of urine and a range 
of 50-994/10ml of urine.  
For survey_2 (2011), Std-1 children in Cohort 24 had a mean intensity of 12.3 
eggs/10ml of urine ± 53.7. Of the infected children (n=226), 153 (67.7%) had light 
intensity and 73 (32.3%) had heavy intensity. However, the proportions of boys 
(27.97%) and girls (27.6%) with heavy intensities were very similar. The children 
identified with light infection had an arithmetic mean egg count of 11.7 (± SD 12.2) 
/10ml of urine with a range of 1-49eggs/10ml of urine whilst those with heavy intensity 
had an arithmetic mean count of 177.68 (± SD 133.87) /10ml of urine with a range of 
50-653 eggs/10ml of urine. So comparison between the two years (2010-2011), for 
cohort 24 schools only, clearly showed that the overall mean egg count was significantly 
higher (t = -2.18; p = 0.02) in 2011 but the proportions of light or heavy intensities were 
similar between the years (proportion of light intensities: 67.9% v.s 67.7% for 2010 and 
2011 respectively).  
Considering Std-1 children in Cohort 24/17 schools between 2010 -2012 (surveys_1, _2 
and _5), 62 (68.1%) had light infection at baseline compared with 115 (69.7%) in 
survey_2 and 138 (53.9%) in survey_5. Further analysis revealed that lightly infected 
children had overall mean intensities of 15.2 ± 11.1 eggs/10ml at baseline, 11.9 ± 12.2 
in survey_2 and 14.3 ± 12.7 in survey_5 whilst those with heavy infections had mean 
intensities of 233.3 ± 271 eggs/10ml, 195.4 ± 144.2 in survey _2 and 333.3 ± 472 in 
survey _5. The differences in these intensities between successive years were not 
statistically significant. As in the Cohort 24 data, a somewhat higher percentage of the 
infections were deemed heavy in boys compared with girls (Table 2) in each survey.  
 
 
60 
 
Table 2: Proportion of infected Std-1 children in relation to sex with heavy infections 
from 2010-2012 for cohort 24/17        
Sex 
     Boys    Girls  
   
2010    37.7    23.7  
2011    33.3    25.4  
2012    48.6    44.0  
 
3.4.3. Schistosomiasis and anaemia (Cohort 24, survey_1 and survey_4) 
It was intended at the start of this project to assess the impact of the newly reintroduced 
SBT on the haemoglobin (Hb) concentration in school-children. Therefore, this was 
assessed in the baseline survey of Cohort 24 in 2010 (survey_1) but the monitoring 
scheme for the ZEST/SCORE programme did not involve Hb assessment and so this 
assessment was not continued. However, to provide some insight into any impact on 
anaemia of the interventions, Hb was assessed in the 2013 survey_4 of Cohort 24 
schools. This was after two annual rounds of SBT and the two rounds of MDA in 2012 
for the ZEST/SCORE interventions.  
Among the children enrolled at baseline, the mean haemoglobin concentration was 11.3 
± 1.7 g/dl. Of the 1185 children, 514 (43.8%), 665 (56.1%) and 6 (0.5%) respectively 
had normal (≥ 11.5 g/dl), moderately reduced (7.01-11.4g/dl), and severely reduced (≤ 7 
g/dl) haemoglobin levels and so the overall prevalence of anaemia was 56.6%. 
Generally, the prevalence of anaemia (moderate or severe) was not significantly 
associated with S. haematobium infection status (58.0% in infected and 56.5% in non-
infected children (χ
2 = 0.1; p = 0.75). Moreover, schistosomiasis was not statistically 
associated with severity of anaemia (Fisher exact test: 0.6). However, most of the 
children with anaemia, 232 (34.6%), were from Mkoani district which had the highest 
prevalences of both schistosomiasis and STH. 
Further analysis of anaemia in relation to sex revealed that the proportions of girls and 
boys with or without anaemia that were either infected with schistosomiasis or not were 
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comparable. For instance, 56.6% of the boys and 56.4% of the girls who were not 
infected with schistosomiasis had anaemia and 55.9% and 61.4% respectively of boys 
and girls infected with schistosomiasis had anaemia.  
At the subsequent survey_4, the mean Hb for the children was 11.9±1.8 g/dl and the 
prevalence of anaemia was 38.2% (95%CI = 36.2-40.2) which was significantly (z = 
7.2; p = 0.0001) lower compared to baseline (56.6% [95%CI = 53.8-59.4]). Of these 
anaemic children, only 5 (0.6%) had severe anaemia (Hb ≤ 7.0 g/dl); thus most of the 
children had moderate anaemia 866 (99.4%). Of the S. haematobium infected children, 
68 (42.8%), had anaemia but as at baseline the anaemia was not statistically associated 
with schistosomiasis (χ2 = 1.5; p = 0.21). Furthermore, schistosomiasis was not 
statistically associated with severity of anaemia (Fisher exact test: 1.0). 
With regards to anaemia in relation to schistosomiasis in the different sexes, it was 
found that the proportion of girls (47.1%) who were infected with schistosomiasis and 
who were anaemic was slightly higher than that of boys (39.6%) but this was non-
significant (χ
2 = 0.9; p = 0.34). The proportions of girls (35.7%) who were not infected 
with schistosomiasis but were anaemic was lower than that of boys (40.1%) and this 
was statistically significant (χ2 = 4.1; p = 0.04).  
Comparison of anaemia relative to schistosomiasis infection at baseline between 2010 
and 2013 showed that at baseline the mean Hb in egg positive children was lower (11.2 
g/dl [95%CI = 10.9-11.3]) than that observed three years later (11.7 g/dl [95%CI = 11.5 
-11.9]) following implementation of SBT and MDA. The increase in Hb concentration 
was statistical significantly (t-test = -2.6; p = 0.01). Similarly, the proportion of S. 
haematobium infected children who were anaemic at baseline (58.0% [95%CI= 48.9-
67.1]) was also significantly (z = 2.46; p = 0.01) reduced to 42.8% (95%CI = 35.1-50.5) 
in 2013.  
.  
3.5 Monitoring of the impact of introduction of the ZNCP and SCORE 
interventions 
The SCORE programme introduced in 2012 consisted of a comparison of (i) more 
intensive (biannual) PZQ administration to all ≥3yrs old (MDA) (ii) MDA plus 
additional snail control (SC) or (iii) MDA plus behavioural modification (BM). These 
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methods were introduced into 45 defined areas, 15 of each randomized for each 
intervention strategy.  
By the end of the study period covered in this thesis there had been 6 rounds of MDA 
and 2 follow-up surveys of prevalence and intensity (Surveys_ 6 and _7) for this 45 
school cohort (see Figures 3.2 and 3.3) which is referred to as “Score cohort 45”. Of 
these 45 there were 5 schools which were included in the original 24 schools sampled 
during the SBT period (2010-2012) (surveys_1, 2 and 5) which were included in the 
MDA (only) arm of MDA/SCORE and so subject to the more intensive MDA after 
MDA/SCORE introduction. To assess impact of the switch from SBT to MDA data for 
these 5 schools (“Score cohort 5”) is analysed separately. In addition, all of the original 
24 schools were also sampled during the SBT (2010-12, surveys_1 and _2) and once 
after the first year of MDA (survey_4). This data is analysed under “Cohort 24”). 
 
3.5.1 Analysis of “Score cohort 45” - PREVALENCE 
3.5.1.1 Baseline prevalence for the ZNCP/SCORE control initiative Jan 2012 
(Survey_5) 
The baseline ZNCP/SCORE data involved sampling of Std-1, 3 and 4 children (n = 
3556, 2290 and 2131 for Stds-1, 3 and 4 respectively). N.B. the inclusion of the Std-1 
children in Survey_5 was to provide another data point for the earlier SBT evaluation 
(described above) and Std-1 children were not included in the subsequent 
ZNCP/SCORE monitoring. So data for Std-1 children are only included in Figure 19. 
Overall, schistosomiasis was found in 793 (10.1% [95% CI= 9.4-10.8]) of the children. 
Figure 19 shows the distribution of schistosomiasis among the 45 schools. The 
prevalence of schistosomiasis varied markedly between the schools (0-32.5%) but only 
4 schools: Daya, Madungu, Makombeni and Ng’ombeni had no cases of infection. 
3.5.1.2 Overall impact of SCORE interventions on the whole “Score cohort 45”.  
Figure 24 shows the combined prevalence data from the three arms for all 45 schools 
tested at baseline (Survey _5) and at subsequent follow-ups in 2013 and 2014 (Surveys 
_6 and 7 respectively). The data is presented as the mean prevalence for the 45 schools. 
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For both Std-3 and Std-4 the patterns were generally similar showing little difference 
between 2012 and 2013 indicating that the two MDAs in April and November of 2012 
had no discernible effect on prevalence in 2013. This led to the change in strategy with 
the introduction of SBT/MDA in 2013 as described above (see Figure 8). As seen in 
Figure 24 there was a more marked drop in prevalence between 2013 and 2014. For 
Std-3 the values for each successive year were 7.91 % (95%CI = 5.29-10.53); 6.92 % 
(95%CI = 4.65-9.2); 5.34% (3.20-7.48). This equates to 32.5% reduction 2012-2014. 
For Std-4 the values were 8.57% (95%CI = 5.90-11.23); 8.38% (95%CI= 5.02-11.74); 
5.27% (95%CI=3.41-7.14) giving a 38.5% reduction 2012-2014. The combined 
prevalence of infection for Std-3 and Std-4 children were 8.24% (95%CI=6.41-10.07); 
7.66% (95%CI = 5.66-9.66); 5.31% (95%CI = 3.92-6.70) giving a reduction 2012-2014 
of 35.6%. Applying Mantel-Haenszel analysis to estimate the trend for the odds of 
infection (2012-2014), revealed significant declining odds ratios over the years for both 
Std-3 (MHOR = 0.82 [95%CI = 0.73-0.92]; p =0.001), Std- 4 (MHOR = 0.78 [95%CI = 
0.71-0.87; p = 0.0001]) and for the combined data for Std-3 and Std-4 (MHOR = 0.8 
[95%CI = 0.74-0.87]; (p = 0.0001]). 
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Figure 19:   Baseline prevalence of schistosomiasis in each of the 45 schools in 2012 
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Figure 19. Baseline prevalence for the 45 schools in the ZNCP/SCORE interventions (Survey_5). 
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Figure 20:  Mean prevalences of schistosomiasis from all 45 schools 
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Figure 20 Mean ± S.D. of prevalences in all 45 schools by standard in 2012, 2013 and 2014.  
 
 
3.5.1.3 Impact of the three different SCORE initiatives on prevalence in each of the 
45 schools 
As seen in Figures 21 and 22, the prevalence of infection in Std-3 and Std-4 relative to 
interventions varied between and within the schools over the years (3yrs period). Over 
the two year period a similar trend of declining prevalence in the majority of schools 
was seen in both the Std-3 and Std-4 groups for the three different interventions. The 
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Std-3 data showed: for MDA:- a decline in 47% of schools and an increase in 33%; for 
Behaviour modification (BM):- a decline in 60% and an increase in 27%; for SNAIL 
control:- a decline in 60% and an increase in 27%. The Std-4 data showed: for MDA:- a 
decline in 73% and an increase in 13%; for BM:- a decline of 80% and in increase in 
0%; for SNAIL control:- a decline in 67% and an increase in 27%. Of the schools with 
prevalence of >10%, 24 (83%) showed a decline and 17% and increase. For some 
schools marked declines in prevalence were noted e.g. in Kwale (34.2→1.7% [Std-3]; 
34.2→1.2% [Std-4]) although in other areas prevalences increased to >10% e.g. in 
Kinowe (5.1→14.3% [Std-3 and Std-4]). Analysis of the possible reasons for, and 
persistence of, such marked and varied changes in the different areas will be of great 
interest. 
 
Considering the impact of the BM intervention which required individual behaviour 
modification there was no obvious marked difference in the trend for prevalence in 
2012-2014 in the (older) Std-4 children compared with the Std-3 children i.e. there was 
no suggestion that the older children responded more effectively than the younger ones. 
 
 It should also be pointed out that when the prevalence changed between 2012 and 2014 
the corresponding values for 2013 did not consistently show an intermediate value so 
monitoring over successive years will be essential to determine if the trend is stable. 
 
In the analysis below the mean prevalence values for the schools in each arm are 
considered allowing statistical analysis of the trends suggested above.  
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Figure 21: Prevalences for the 45 schools according to intervention strategy – Standard 3 
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Figure 22: Prevalences for the 45 schools according to intervention strategy – Standard 4 
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3.5.1.4 Impact of the individual SCORE interventions on mean prevalences for the 
15 schools in each of the intervention arms  
The mean prevalences from the 15 schools in each intervention arm of SCORE are 
shown in Figure 23. The mean prevalences at baseline for the schools randomized into 
the three intervention arms differed for Std3, Sd4 and the combined Std-3 and Std-4 
values (which represent the combined prevalences for both Standards from each school 
and not the mean prevalences for the two Standards).  
 
Std-3 cohort 
The Std-3 children placed in the MDA arm had a baseline (2012) prevalence of 4.33% 
(95%CI =2.9-5.7) that was slightly increased to 4.61% (95% CI= 3.0-6.1) in 2013, 
although, the difference was non-significant (z = -0.28, p = 0.7; MH-OR 1.23 [95%CI = 
0.76-1.99; p = 0.39]). For 2014, the prevalence was unchanged (4.60% [95%CI = 3.2-
6.0]). The Mantel-Haenszel score test for trend of infection for Std-3 children in MDA 
arm when controlled by intervention and standard showed an equal odds ratio (MH-OR 
1.0 [95%CI = 0.8-1.3]) i.e. the MDA had no significant effect on prevalence in this 3yr 
period (2012-14). 
 
For the Behavioural Change intervention, the baseline (2012) prevalence of infection for 
the Std-3 children was 7.75% [95%CI = 5.82-9.67]. In the succeeding year (2013) this 
reduced to 5.74% (95%CI = 3.96-7.51) a difference which was not significant by z test 
(z = 1.49, p = 0.13) but the Mantel-Haenszel test was significant at the <5% level (MH-
OR 0.56 [95%CI = 0.35-0.88; p = 0.01]). The trend for reduction of prevalence was also 
apparent in 2014 (4.16% [95%CI = 2.77-5.54]) but this was not significantly lower by 
either test (z = 1.39, p = 0.16; MH-OR 0.84 [95% = 0.50-1.40; p = 0.51]). The Mantel-
Haenszel score test for trend of infection (2012-2014) when controlled by intervention 
and standard revealed a significantly lower odds ratio (MH-OR 0.68 [95%CI = 0.54-
0.84; p = 0.0006].  
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Figure 23: Mean prevalences of schistosomiasis 2012-2014 for the 15 schools in each of the SCORE interventions 
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For the Snail Control arm, the Std-3 children had the highest baseline prevalence 
(11.62% [95%CI = 9.46-14.17]) relative to the other interventions. This prevalence was 
not significantly reduced in the succeeding year (10.62% [95%CI = 8.23-13.04]; z = 
0.57, p=0.56; MH-OR 0.75 [95%CI = 0.52-1.06; p=0.11]). Prevalence declined a little 
more by 2014 (7.95% [95%CI = 6.1-9.7], although, the decline was not significant by z-
score (z = 1.78; p = 0.07), or Mantel-Haenszel analysis (MH-OR 0.84 [95%CI = 0.58-
1.21; p = 0.35]). However, the Mantel-Haenszel score test for trend of infection over the 
3yr period (2012-14) revealed a lower odds ratio that was significant (MH-OR 0.79 
[95%CI = 0.67-0.93; p= 0.007])  
 
Std-4 cohort 
At baseline (2012), the Std-4 children allocated to the MDA arm had a prevalence of 
infection of 5.79% (95%CI= 4.1-7.75) that was reduced to 4.46% (95%CI = 3.16-5.75) 
in the succeeding year (2013) but this was not significantly lower (z = 1.24, p = 0.2; 
MH-OR 0.67 [95%CI = 0.43-1.05; p = 0.08]). By 2014 prevalence was again lower at 
3.92% (95%CI = 2.63-5.20) the reduction again being non-significant (z = 0.57, p = 
0.56; MH-OR 0.99 [95%CI = 0.62-1.58]). Moreover, the MH score test for trend of 
infection for the Std-4 children allocated in the MDA group over the 3yr period (2012-
14), when controlled with intervention and standard, revealed lower, but not 
significantly lower, odds ratio (MH-OR 0.81 [95%CI = 0.64-1.02; p = 0.08]). 
 
For the Behavioural Change intervention, the Std-4 children had a baseline (2012) 
prevalence of infection of 9.74% (95%CI = 7.53-11.94). This prevalence was non-
significantly reduced by 2013 to 8.32% (95%CI = 6.52-10.1) (z = 0.98; p = 0.32; MH-
OR 0.98 [95%CI = 0.71-1.36; p = 0.91]). However, in 2014 the prevalence of infection 
was reduced to 4.96% (95%CI= 3.5-6.41), a significant difference by both statistical 
analyses (z = 2.8, p = 0.004; MH-OR 0.48 [95%CI = 0.33-0.70; p = 0.0001]). The 
Mantel-Haenszel score test for trend of infection for the period 2012-14 when controlled 
by intervention and standard also showed a significantly reduced odds ratio (MH-OR 
0.71 [95%CI = 0.59-.0.85; p = 0.0002]. 
 
The Std-4 children in the Snail Control group had a high baseline prevalence (10.13% 
[95%CI = 7.83-12.42]) of infection which was, in fact slightly increased the following 
year (2013) (12.86% [95%CI = 10.75-14.96]; z = -1.69; p = 0.09; MH-OR 1.47 [95%CI 
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= 1.08-2.0; p = 0.01]). In the subsequent year (2014), the prevalence of infection was 
reduced to 6.91% (95%CI = 5.2-8.61) which, compared to the prevalence observed in 
2013, was significantly lower (z= 4.2, p = 0.0001; MH-OR 0.44 [95%CI = 0.32-0.60; p = 
0.00001]). Also the Mantel-Haenszel score test for trend of infection showed a 
significantly reduced odds ratio (MH-OR 0.81 [95%CI = 0.69-0.96; p = 0.01]) when 
controlled for intervention and standard for the period 2012-2014. See appendix 3.4A 
 
Combined Std-3&4 cohort  
For the Std-3&4 group, the baseline (2012) prevalence in the MDA arm 5.06% ([95%CI 
= 3.96-6.17]) was only slightly and non-significantly reduced to 4.54% [95%CI = 3.54-
5.53;] (z = 0.7, p = 0.5; MH-OR 0.89 [95%CI = 0.64-1.23; p = 0.49] in 2013 and to 
4.26% [95%CI = 3.3-5.2] (z = 0.3, p = 0.4; MH-OR 0.95 [95%CI = 0.68-1.31; p = 0.76]) 
in 2014. Furthermore, the score test for trend for the overall period 2012-2014 was also 
not significant (MH-OR 0.92 [95%CI = 0.78-1.08; p = 0.33]). 
 
For the Behavioural Change intervention, the baseline prevalence for the Std-3&4 group 
was 8.75% (95%CI = 7.28-10.21) which was reduced to 6.99% (95%CI =5.72-8.25) in 
2013. This change was non-significant (z = 1.3; p = 0.2; MH-OR 0.85 [95%CI = 0.65-
1.10; p = 0.22]). In the subsequent year (2014) the prevalence was further reduced to 
4.56% (95%CI =3.55-5.56) and this reduction in the prevalence was significant (z = 
2.96, p=0.003; MH-OR 0.56 [95%CI = 0.42-0.76; p = 0.0001]). Overall the prevalence 
was 48% lower and the score test for trend of infection for the combined data was also 
significant (MH-OR 0.7 [95%CI = 0.61-0.81; p = 0.00001]) for a period of three years 
(2012-2014). 
 
For the snail control arm, at baseline (2012), the prevalence was 10.88% [95%CI = 
9.24-12.51] which subsequently increased to 12.14 (95%CI = 10.54-13.73) in 2013. 
However, the increase was non-significant (z = -1.07, p = 0.28; MH-OR 1.13 [95%CI = 
0.91-1.42; p = 0.25]). Nevertheless, for 2014, the prevalence was significantly reduced 
(7.43% [95%CI = 6.20-8.65]; z = 4.60; p = 0.0001 (MH-OR 0.56 [95%CI = 0.44-0.71; p 
= 0.00001]). Moreover, the score test for trend of infection over the period 2012-14 
showed significantly reduced odds ratio (MH-OR 0.8 [95%CI = 0.71-0.90; p = 0.0003]). 
See appendix 3.4B 
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Overall, the data indicates that the MDA alone had little impact on prevalence following 
either the 2012/2013 or the enhanced 2013/2014 interventions. However, it appeared 
that the Behaviour (plus MDA) interventions led to progressive reductions following 
each of the annual interventions. With the Snail control (plus MDA) interventions there 
was no sign of impact 2012-2013 but a more marked decline between 2013-2014.  
 
3.5.2 Analysis of “Score cohort 45” - INTENSITY 
3.5.2.1 Overall impact of the SCORE intervention on intensity  
The simple arithmetic mean intensity is shown in Figure 24. The data shows the trend in 
mean egg count to be downwards over the study period. However, because the 
distribution of egg counts was highly skewed due to the high percentage of zero values 
in all of the data sets no statistical analysis is appropriate.  
 
3.5.2.2 Intensity according to WHO classification. 
When the S. haematobium infection intensity was classified into light (<50 eggs/10 ml 
of urine) and heavy (≥50 eggs/10 ml of urine), as defined by the World Health 
Organization (WHO), the percentages of heavy infections across all children for both 
Std-3 and Std-4 were 2.71, 1.83 and 1.71 for surveys 5, 6 and 7 respectively. But 
considering only those infected, the proportions of heavy infections were 32.4% at 
baseline, 22.3% for survey_6 carried out a year later and 31.4% for survey_7 carried out 
two years after baseline. Furthermore, looking at the proportions of heavy infection for 
Std-3 and Std-4 separately, these were comparable between the Stds and between the 
years.  
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Figure 24: Arithmetic mean intensity for children in all intervention arms 
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Figure 24 Graph shows arithmetic mean (±SE) intensity (eggs/10ml urine) 
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3.5.2.3 Overall impact of the SCORE intervention on intensity: data from the three 
individual arms for Std-3 and Std-4 children for the individual 45 schools 
 
The mean intensities for the individual schools for Std-3 and Std-4 children across the 
three years are shown in Figures 25 and 26 respectively. The mean values were very 
low and the standard deviations high. Also the trends in mean intensities across the 
three years were variable amongst the schools and in some cases divergent between St-3 
and Std-4 groups within the same school (e.g. for Konde A the intensity dropped in 
2013 for Std-4 but not for Std-3 and for Pujini the intensity increased progressively in 
the Std-3 cohort but decreased in the Std-4). Regarding the diversity across schools, 
some showed consistently higher values in all years e.g. Ukutini, Uwandani, Chambani 
and Kangagani, others showed consistently low values e.g. Chanjamjawiri, Kangani, 
Kiwani, Tumbe. In other schools the intensities rose or fell in individual years. Overall 
though there was no obvious consistent trend seen for either a rise or fall in intensity. 
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Figure 25: Mean (±SD) intensity of infection from the Std-3 children for the individual 45 schools 
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3.5.2.4 Impact of the individual SCORE interventions on mean intensity in 
SCORE Cohort 45. 
The arithmetic mean values for all pupils by standard in each of the intervention arms 
are shown in Figure 27. It shows the mean intensities for the individual schools for Std -
3 and 4 children. Because of the high percentage of zero values in all of the data sets no 
statistical analysis is appropriate. Overall, at baseline, for Std-3 children, the mean 
intensity was almost two-fold higher (15.2 ± 115) in schools allocated to the Snail 
control arm but was comparable between MDA (7.7 ± 111) and Behavioural change 
(7.1 ± 58) intervention arms.  
 
For the MDA arm both Std-3 and St-4 showed an overall drop in intensity between 
2012 and 2013 and remained reduced at the 2014 survey. For the Behavioural change 
arm a very similar pattern of lower intensity after baseline was also seen. For the Snail 
control arm intensity also dropped over the three years despite an inconsistency in Std-4 
initially showing an increase in 2013. Thus in general the mean intensities for children 
allocated to each of the intervention groups was progressively reduced as compared to 
baseline over a period of 2yrs and there was no evidence of major differences in the 
declines in the different interventions.  
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Figure 27: Intensity by standard and by SCORE intervention in Score Cohort 45. 
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Figure 27 Mean (±SE) number of eggs/10ml of urine from individual children 
  
3.5.2.5 Intensity by intervention strategy according to WHO classification. 
Considering intensity characterised as light (egg count <50/10ml of urine) or heavy (egg 
count ≥50/10ml of urine) in those infected, a higher percentage of light infections was 
consistently found (Table 3) with no markedly different trends between the different 
intervention arms.  
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Table 3: Percentages of children with light/heavy infections in the different 
interventions over 2012-14 
  
Year     Intervention  
      Behaviour                 MDA        Snail control 
   Light     Heavy  Light       Heavy   Light            Heavy 
 2012  (61.5)      (38.5)           (67.1)       (32.9)   (72.9)            (27.1) 
 2013  (83.7)     (16.3) (82.9)       (17.1)   (72.1)  (27.9) 
 2014  (61.8)     (38.2) (72.4)       (27.6)    (70.3) (29.7) 
  
Numbers in parenthesis are percentages 
 
3.5.3 Assessment of the impact of MDA/SCORE using data from “Cohort 24” (surveys 
1, 2 and 4):- PREVALENCE 
Standard-1 children in the original 24 school cohort were tested at baseline in 2010, 
after one year of SBT with PZQ and again in 2013 after the two rounds of MDA in 
2012. They provide a different data set from the above Score Cohort 45 (Stds 3 and 4) 
to look for any effects of the change in intervention policy. 
 
3.5.3.1 Mean prevalence “Cohort 24”. 
The mean prevalence, before and after the introduction of MDA/SCORE, is shown in 
Figure 28. For comparison purposes data for the full 24 school cohort is shown in the 
top graph and its sub-set of 12 schools which only received chemotherapy (i.e. those 
schools which were allocated to MDA in the SCORE intervention) in the bottom graph. 
For Cohort 24 schools, at baseline, the prevalence of infection was (9.45% [95%CI = 
7.78-11.11]) which increased significantly (z = -6.6; p = 0.0001); (MH-OR = 2.34; 
[95%CI = 1.81-3.04]; p = 0.00001) in survey_2 (18.85% [95%CI = 16.6-21.06]). 
However, the prevalence was significantly below baseline in survey_4 (2013) (7.2% 
[95% CI = 6.12-8.27] (z = 2.30; p = 0.02) following administration of two rounds each 
of SBT and MDA. Indeed, the score test for trend revealed significantly lower odds 
ratio (MH-OR = 0.87 [95% CI = 0.82-0.93]; p = 0.00001) over the period of 3yrs 
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Similarly, for the sub-set of 12 schools, the baseline prevalence was 6.67% (95%CI = 
4.63-8.69) which was significantly increased to 15.97% (95%CI = 14.95-18.91); (z = -
5.04; p = 0.00001) in survey_2. This prevalence (15.97% in 2011) was significantly (z = 
6.85; p = 0.00001) reduced to 5.77% (95%CI = 4.37-7.16) in subsequent survey_4, 
although this prevalence was similar to that demonstrated at baseline. Furthermore, for 
the cohort of /12 schools, the score test for trend revealed significantly lower odds ratio 
(MH-OR = 0.86 [95% CI = 0.77-0.973]; p = 0.00001) over a period of 3yrs. So, 
generally, in both cohort 24 schools and its sub-set of 12 schools, the baseline 
prevalences were significantly increased in survey_2 but significantly reduced 
subsequently, though in some occasion, the reduction was somewhat similar with 
baseline.  
Figure 28: Mean prevalence across the 24 school cohort 
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Figure 28 Mean prevalence of all schools in (i) the 24 school cohort (top graph) and (ii) the 12 
schools which were only subject to the two different chemotherapy regimens i.e. the annual 
school based interventions in 2010 and 2011 and the bi-yearly MDA in 2012. 
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3.5.3.2 Mean prevalence “Cohort 24” by area 
As shown in figure 29, at baseline (survey_1 2010), the mean prevalence of infection 
was highest in Mkoani district (14.67% [95% CI = 10.6-18.7]) and lowest in Micheweni 
(1.67% [95% = 0.2-3.1]). In the subsequent survey carried out a year later (survey_2 
2011) following administration of one round of SBT the prevalence was quite markedly 
increased in all districts although the pattern of prevalences remained essentially similar 
to the baseline. Notably, in Micheweni district the infection increased to almost seven-
fold (from 1.67% to 11.46%) (z = -4.87; p = 0.00001) as compared to the year before. 
The reason for the particular increase of infection was not apparent. The area is flat and 
sandy with relatively few transmission sites (water bodies) and there was no reported 
unexpectedly high rainfall which could result in formation of temporary water bodies or 
other ecological change that could facilitate transmission of the infection. In survey_4 
2013 carried one year later after introduction of twice/yearly MDA, the mean 
prevalences in all districts were noticeably reduced and were more comparable between 
districts than at baseline.  
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Figure 29: Prevalence of schistosomiasis pre and post MDA/SCORE by area 
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Figure 29 Mean prevalence (±SD) of Standard 1 children in “Cohort 24” by area. 
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3.5.3.3 Individual school prevalence 
Figure 30 shows the prevalence data for each of the 24 schools over this period. As 
shown in Figure 8 and Appendix 3.1 some of these 24 schools were included in the 
different arms of SCORE but all would have been given chemotherapy. It can be seen 
that, overall, prevalence varied between and within the schools over time, some of the 
schools at baseline showing low and even zero prevalence while others had prevalences 
close to 30%. Although some schools showed consistently high prevalence over the 
study period e.g. Pujini, Chambani, Piki, Uwandani, S/viamboni and K/minungwini 
others showed consistently low prevalences e.g. Michakaini and Tumbe. In almost all of 
the schools, prevalence recorded at baseline was somewhat increased in survey_2 and 
then decreased in survey_4 and so, applying Mantel-Haenszel analysis to assess the 
trend of odds of infection over the years when controlled by schools, there was a 
significant odds ratio (OR-MH = 0.83 (95%CI = 0.77-0.89; p = 0.00001) (Appendix 3.2)
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Figure 30: Individual school prevalences for Std-1 children in the 24 schools (2010-2014) 
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3.5.4 Assessment of the impact of MDA/SCORE using data from “Cohort 24” (surveys 
1, 2 and 4):- INTENSITY   
3.5.4.1. Intensities for the individual schools 2010-2013 
The data on intensities for the individual schools is shown in Figure 31. No consistent 
trend is seen across the schools. In the majority (16/24) of schools mean intensity was 
reduced somewhat between 2011-13 although in most of the schools showing the 
highest intensities there was little change across the study period e.g. Pujini, Uwadani, 
Chambani, Mizingani. 
 
3.5.4.2. Intensity by intervention strategy according to WHO classification. 
As mentioned previously some of the Cohort 24 schools were included in the 45 schools 
involved in the ZEST/SCORE project and so they were allocated into different 
interventions strategies but also some of the schools were not included. Thus since 
MDA was administered across all schools despite whether they were involved or not in 
the ZEST/SCCORE project, for the purpose of this analysis, the schools not involved in 
the ZEST/SCORE project were allocated in the MDA intervention data.  
Considering intensities as light (egg count <50/10ml of urine) or heavy (egg count 
≥50/10ml of urine) (Table 4) clearly showed that overall many of the infected children 
had light intensity across the different interventions over the years but there was some 
variation with time in different intervention groups. For the Behavioural change group 
the proportion of heavy intensity infections was progressively increased while for the 
MDA alone heavy infections declined 
 
Table 4: Proportion of intensities in Std-1 children in cohort 24 schools from 2010-2013 
relative to different intervention strategies  
Year          Intervention strategy  
       Behaviour               MDA          Snail control 
     Light     Heavy  Light    Heavy      Light  Heavy 
  2010 (66.7)      (33.3)            (61.5)   (38.5)         (80.6) (19.4) 
  2011 (61.1)     (38.9) (64.6)   (35.4)         (81.0) (19.0) 
  2013 (48.8)     (51.2) (74.2)   (25.8)         (82.1) (17.9) 
  
Numbers in parenthesis are percentages
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Figure 31: Intensity for each of the “Cohort 24” schools 2010-2013 
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Figure 31 Arithmetic mean egg counts (eggs/10ml urine) from Std_1 children in each of the 24 schools following SBT in 2010 and 2011 and MDA (±other 
SCORE interventions) in 2012. 
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3.5.5 Impact of the introduction of the MDA compared with SBT on prevalence and 
intensity in “SCORE Cohort 5” surveys 1, 2, 5, 6 and 7) 
Within “Cohort 45” there were 5 schools which were included in the original “Cohort 
24” schools sampled during the SB treatment period (2010-2012) (surveys 1, 2 and 5) 
and which were also included in the MDA only arm of MDA/SCORE and so subject to 
the more intensive MDA after MDA/SCORE introduction. These give the opportunity 
to compare the infection levels following the successive SBT and MDA interventions. 
Standard-1 children were sampled in surveys_1 (baseline), 2, 5 (after successive annual 
SBT) and 4 (post one round of MDA) and Standard 3 children were sampled in surveys 
2 (baseline), 5 (after one round of SBT), 6 and 7 (after one and two annual rounds of 
MDA, respectively). 
 
3.5.5.1 Assessment of prevalence  
The prevalence data for the 5 individual schools from 2010-2014 is shown in Figure 32. 
No consistent changes in prevalence over the period of the interventions are obvious for 
the individual schools with the exception of the data for the Std-3 children from 
Chanjamjawiri which suggested a persistently reduced prevalence following baseline. 
However, this was not reflected in the Std-1 data for the same school. Although the 
prevalence values vary over time for all of the schools, there is no consistent trend for 
values to be lower following the initial SBT interventions or following the subsequent 
MDA. Across the period as a whole, Mantel-Haenszel analysis to assess the trend of 
odds of infection over the years did not show a significant odds ratio (MH-OR 0.92 [95% 
CI = 0.77-1.11; p = 0.38]) (see appendix 3.3A). However, for Std-3 children, the 
Mantel-Haenszel test for trend of odds of infection over the years did produce a 
significantly lower odds ratio (MH-OR 0.79 [95% CI= 0.64-0.97]; p = 0.02) (see 
appendix 3.3B). 
 
Overall there was no evidence from these 5 schools that the switch from SBT to MDA 
led to a reduction in prevalence over the period of study.  
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Figure 32: Prevalence of schistosomiasis during SBT and then MDA in each of 
the “Cohort 5" schools. 
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Figure 32 Prevalence in each of the “Cohort 5” schools. 
 
3.5.5.2. Assessment of Intensity 
Figure 33.shows the mean school intensities for the Cohort 5 schools. As with the 
prevalence there was an indication of slightly lower intensity following baseline for the 
Std-3 from Chanjamjawiri but as with prevalence this was not seen with the Std-1 
children from this school. Overall there was no consistent pattern of change across the 
schools and, in general egg counts were broadly similar at the end of the intervention 
periods as at baseline e.g. for both Std-1 and Std-3 in Uwandani. Overall, as with the 
prevalence data, there was little evidence from these 5 schools that the implementation 
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of SBT or the switch from SBT to MDA led to reductions in intensity over the period of 
study. 
 
Figure 33: Comparison of Intensity for Cohort 5 during SBT and MDA 
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Figure 33 Mean ± SD egg counts for the SCORE Cohort 5 schools for Standard 1 and Standard 
3 children 
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3.6 Discussion  
Chemotherapy based control for schistosomiasis using PZQ is the fundamental 
approach advocated by the WHO and is adopted by most countries where these 
infections are prevalent. Generally, the chemotherapy is either targeted to school-
children or community based MDA. Such interventions are often regarded as aiming to 
control morbidity rather than significantly reducing transmission. Both approaches have 
been used in Pemba but the relative impact of these on transmission has not been 
formally compared and this was one of the aims at the start of this study in 2010 since 
SBT was to be reintroduced then after a period of three years without routine treatments 
and also there was a proposal to implement a new National Control Programme in 2012 
involving more intensive treatment i.e. MDA twice yearly. In fact the baseline survey in 
2010 reported here showed a prevalence of S. haematobium of only 9.5% and so 
Zanzibar was considered and selected for inclusion in the newly proposed SCORE 
programme aimed at evaluating the use of other control methods (snail control and 
education) in addition to chemotherapy to progressively reduce transmission with a 
view to elimination in selected countries with schistosome prevalences of ≤10%. So the 
original study was expanded to evaluation of the different arms of this intervention. The 
study was envisaged to include various aspects of the monitoring of the implementation 
and impact of these control measures including human infection and disease, snail 
populations/infection levels, coverage and compliance, and drug efficacy.  
 
3.6.1 Impact of chemotherapy  
Schistosomiasis is a major public health problem across tropical and sub-tropical 
countries including Zanzibar. Current figures show that over 207 million people 
worldwide have schistosomiasis and many more are at risk of infection (Webster et al., 
2009). In endemic countries, children aged between 5-15yrs are the most infected 
population because of their tendency of frequent contact with fresh water that in turns 
increase exposure to the infection. Furthermore, there is evidence of development of 
resistance to reinfection from mid-teenage years (Pinot de Moira et al., 2010, De Moira 
et al., 2010). For this reason, most countries engaged in the control of this devastating 
disease focus on MDA targeted at school-aged children with provision of praziquantel 
(40 mg/kg). Furthermore, school-children are easily accessible (Brooker et al., 2004). 
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The frequency of drug provision whether annual or biannual remains the choice of 
individual countries although the WHO proposed guidelines for the frequency of drug 
distribution and measures to be taken depending on the prevalence of the infection and 
methodology used (WHO, 2006). Such chemotherapy-based control has been reported 
to be successful in reducing disease morbidity (Savioli et al., 2004a), prevalence (Ming-
Gang, 2005) and reversing pathology (Kabatereine et al., 2007, Brooker et al., 2004). 
Using mathematical modelling, it has been postulated that focusing control of 
schistosomiasis through school-aged children may interrupt and possibly eliminate 
transmission (Muchiri et al., 1996). The present study started with evaluating the impact 
of single annual treatment for the control of schistosomiasis in school children in Pemba 
based on parasitological data. To our knowledge this is the first formal study of this 
approach to be carried out in this setting.  
 
3.6.2 Baseline characteristics and the effects of single annual SBT 
The initial baseline monitoring in 2010 involved sampling of the Std-1 children who 
had not been mass treated previously and who therefore gave an indication of 
transmission in the community. By follow up in 2011 any impact of the single annual 
SBT on this transmission could be evaluated. In addition in 2011, by comparing the Std-
1 and Std-3 children (who had had a single school based treatment one year previously) 
the impact of this on infection a year afterwards could be evaluated and compared. 
The prevalence observed at baseline was 9.5%, the majority (67.9%) having light 
infections. This was surprising since, although the intensive (annual, community based) 
MDA, involving triple therapy with provision of ALB, ivermectin and PZQ in 2004-
2006 had reduced the prevalence from 63% to 18% by 2007 (Guidi et al., 2010), there 
had not been any systematic drug treatment between 2006-2010 and it might have been 
expected that prevalence would have rebounded from the 2007 level. A similar trend of 
remarkable reduction (76.3%) [54.1% in 1986 to 12.8% in 1988] in haematuria was 
demonstrated in the earlier attempts to control the disease by selective chemotherapy in 
the late 1980s (Savioli and Mott, 1989). The observation of 9.5% prevalence was 
encouraging but the real cause for this apparently persistent low level infection since 
2006 in the absence of efficient intervention such as snail control, intensive 
chemotherapy or effective behavioural change is unclear. Multiple possible factors 
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might have contributed to this reduction: increasing availability of safe water supplies in 
some villages where the investigated children come from; relatively reliable power 
supplies; increasing awareness of schistosomiasis and accessibility of PZQ leading to 
change of health seeking behaviour; or realization of the health impact of the disease. 
Also artesunate derivatives for the treatment of uncomplicated malaria were introduced 
and intensively used since late 2003 (Froberg et al., 2012) and have been shown to have 
a potent killing effect on schistosomes albeit at higher dose levels than usually used for 
malaria (Utzinger et al., 2001).. 
However, despite the low prevalence in 2011, the prevalence determined at follow-up in 
the same Std-1 age group the following year after a single annual SBT showed the 
prevalence of schistosomiasis to be 18.9%. Similarly the number of the children with 
either light or heavy schistosomiasis was higher than that of the 2010 baseline even 
after stratification by class. For example, 73 (73%) of the Std-1 children had severe 
infection in 2011 as compared to 36 at baseline (32.1%). The reasons for this apparent 
rebound is unclear as there had been no change in health systems or climate e.g. 
increased rainfall that could have resulted in increased transmission sites. The fact that 
the 2011 estimate of 18.9% was similar to the previous most recent estimate of 18.9% in 
2007 (Guidi et al., 2010) might be considered to raise questions about the reliability of 
the 9.5% value obtained in 2010. However, the sample sizes were large in both studies 
(n= 1531 in 2007; n= 2372 in 2011) and the same personnel and techniques were 
involved in the surveys headed by Shaali. Furthermore, the baseline for the SCORE 
study (see below) in 2012 showed comparable prevalences to that seen in the 2010 
baseline for Std-1 children.  
Despite the anomaly of the prevalence actually being higher in 2011 than in 2010 it is 
clear that the SBT did not result in lower prevalences in the Std-1 children attending 
school for the first time in 2011. It should be emphasised however, that the only 
potential impact the SBT in 2010 could have had would be to reduce environmental 
contamination of the 2011 Std-1 cohort in the year before they started school. It is 
perhaps unsurprising that this did not reduce worm burdens which would have 
accumulated in the 2011 Std-1 intake over their preschool years. There was however, 
some evidence that the SBT had a prolonged effect on the 2010-treated children 
themselves in that the prevalence in the Std-3 children in 2011 who would have also 
been treated in 2010 were significantly lower than that in the previously untreated Std1 
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children (11.4% cf 18.5%). However, the percentage difference was markedly lower 
than had been seen in earlier longitudinal studies whether monitoring haematuria or 
prevalence e.g. Savioli, Dixon et al. 1989 working in the same epidemiological setting 
(Savioli et al., 1989b) observed a remarkable reduction in both micro- and macro-
haematuria, indicators of urinary schistosomiasis, following one year of selective 
chemotherapeutic (praziquantel) intervention (15.8→0.9% for macro-haematuria and 
54.1→12.8% for micro-haematuria). It is also evident that as in recent years there has 
been some improvement in terms of availability of piped water supply, electricity, 
secio-economic aspects of individuals and school attendance which in some ways have 
contributed to the reduction of the prevalence of schistosomiasis compared to 1988 
when the earlier studies were carried out. However, a similar observation was also 
reported in Kenya (Magnussen et al., 1997). Higher reductions were also reported by 
others (Toure et al., 2008, Koukounari et al., 2007, Tohon et al., 2008) who 
demonstrated 89.6% (from 59.6% to 6.2%), 89.2% (from 53.9% to 5.8%) and 49.6% 
(75.4% to 38%) decreases in prevalence after one year of praziquantel administration, 
respectively.  
Infection intensity is the principal indicator in evaluating the effectiveness of 
schistosomiasis control programs based on chemotherapy (Brooker et al., 2004) since 
intensity is a measure of morbidity and a more sensitive indicator of worm reductions. 
In our study we observed progressive increases in overall mean intensity for the Std-1 
children over the years (2010-2012) and also for the Std-3 during the period of 2011-
2012, although, in both occasions, the majority of the infected children had light 
intensities. This was in contrast to what was observed in the above published 
longitudinal studies which showed significant decrease in the intensity of infection after 
few years of the program implementation (Koukounari et al., 2007, Toure et al., 2008). 
The Std-3 (older) children had lower overall mean intensity in each time period (2011-
2012) which may be due to related to the fact that the Std-3 children had been 
previously treated at least twice in 2010 and 2011 during the SBT. Studies have shown 
that older age is associated with lower intensity (Etard et al., 1995) which could be 
explained by acquired immunity. 
So overall the two years of SBT had no apparent beneficial effects on prevalence or 
intensity. However, the apparently modest impact of PZQ seen in the Std-3 children was 
not due to poor PZQ efficacy in Pemba as discussed below. 
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3.6.3. The effect of integrated control measures on prevalence of infection  
From 2012 onwards (at least until this present study was completed), the NCP changed 
its approach and extended it to evaluate the possibility of elimination of schistosomiasis 
through implementation of integrated control measures. This involved introducing 
MDA twice a year, alone or in combination with Behavioural changes intervention or 
Snail control in defined areas.  
In the Behavioural modification intervention, the “community co-designed process, 
based upon human-centred design” approach was implemented (Person et al., 2016). In 
this approach, community members identified their own problems and participated in 
designing related interventions which included school-based education and training, 
safe play activities, installation of community-designed washing platforms and 
installation of community-designed urinals (for both boys and girls). However, the 
urinals were found to be culturally unacceptable, complicated by various local factors 
and hence were not utilized so this strategy was abandoned by the community members. 
In all of the above-mentioned strategies, the main focus was directed to school-aged 
children. 
The Snail control activities consisted of identification of fresh water bodies (in the 
intervention areas) and intensive snail searching followed by application of 
molluscicide, niclosamide (70% wettable powder (WP)). It was initially planned to 
apply niclosamide twice/year to coincide with PZQ distribution in communities (Knopp 
et al., 2012) but for some reasons that was impossible. It was realized that the Snail 
control team could spend little time in the field such that it could be difficult to achieve 
the desired outcomes and so it was decided to increase niclosamide application period to 
a total of ~8 months/year- which started from August-March each year.  
For operational purposes, searching for snails as well as application of niclosamide were 
halted during the heavy rain seasons between April-July and resumed from August to 
March each year. Moreover, the application of niclosamide was focused i.e. was only 
applied in contact areas (areas with human activities) within the water bodies (Knopp et 
al., 2012). The focal application of niclosamide usually happen in large water bodies 
and this strategy has been found as one of the major challenge in snail control (Fenwick 
et al., 2006a). 
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The overall new baseline prevalence for this expanded study was based on evaluation of 
Std-1, 3 and 4 children and found to be 10.1%, the Std-1 children having a somewhat 
higher prevalence (12.4%) than Std-3 (7.9%) or Std-4 (8.8%) alone or the combined 
data between Std-3 and 4 (8.3%) which is consistent with the older children having had 
previous SBT. During the subsequent follow-up a year later, the Std-1 children were not 
sampled but the overall prevalence for the Std-3 and 4 was almost similar (8.2% 
[95%CI = 7.5-9.0]) with that of baseline. This disappointing finding led to changing the 
PZQ treatment strategies - (i) SBT to all school-aged children at school (ii) community-
based MDA to pre-school-aged children and also adults (iii) provision of the SBT and 
MDA twice/year. This treatment approach in combination with other intervention 
strategies yielded a more marked reduction in the prevalence in subsequent years as 
detailed further below.  
 In the follow-up survey carried two years later after the baseline and a year after the 
move to twice-yearly SBT and MDA, the overall prevalence in Std-3&4 across all arms 
was significantly reduced to 5.31% (95%CI = 3.92-6.70) following implementation of 
integrated control measures for schistosomiasis (MHOR = 0.8 [95%CI = 0.74-0.87]; (p = 
0.0001]). However, the three different interventions showed quite marked differences in 
impact. The MDA alone only reduced the prevalence by 16% compared to baseline and 
this difference was not statistically significant. 
Unlike the MDA alone, the combination of MDA with behavioural change and snail 
control appeared to enhance prevalence reduction (Fig 3.3.5). In the case of the 
behavioural modification arm, prevalence was reduced following the first year of 
intervention and further reduced after the second year giving an overall reduction or 
48% over the two years. In contrast, for the snail control cohort, prevalence actually 
increased between baseline and the first year of intervention before subsequently 
declining in the following year. Overall prevalence for snail control was 32% lower 
over the two years. Whether these patterns reflect real differences in the speed of impact 
of the different approaches is unknown. The snail control and behavioural change 
interventions were initially implemented from Mid-August, 2012 just a few months 
before undertaking the first follow-up survey in 2013 giving little time for either to have 
a significant impact on prevalence. However, the results over the two years indicate the 
greater effectiveness of the integrated approach for schistosomiasis control. The validity 
of this conclusion will be tested following the ongoing control and evaluation as part of 
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SCORE. This further work will also determine if the decline is maintained and establish 
the rate of decline which is crucial in establishing whether such interventions could lead 
to elimination in such a setting as Pemba.  
Although the results to date in this comparison of control interventions indicate that 
MDA alone was less effective than when combined with Behavioural modification or 
Snail control, it must be noted that the randomization of schools to the three 
interventions resulted in many of the shehia/schools allocated to MDA having lower 
baseline prevalence of infection compared to schools allocated in Snail control or 
Behavioural change intervention arms. 
Despite the lack of impact of MDA alone in the present study it has been proposed that 
MDA could lead to interruption of transmission (Basanez et al., 2012, Wang et al., 
2012b, Fenwick and Jourdan, 2016). However, for such MDA based control  to produce 
better outcomes a longer implementation time may well be required, perhaps at least 
6yrs (Wang et al., 2012b),  
As part of the current study we were able to analyse the effect of more prolonged 
repeated chemotherapy in a small subset of 5 schools (Cohort 5) (Section 3.3.5) that 
were only subjected to chemotherapy, initially to SBT and then MDA from 2010-14 (8 
rounds cumulatively: SBT [2] and [6] MDA). This data also failed to show any 
consistent trend in prevalence reduction. This failure in effectively interrupting 
schistosomiasis transmission by chemotherapy-based control raises concerns over its 
impact (Ross et al., 2015b). Concerns over possible lack of drug efficacy/emergence of 
resistance seem unlikely since we have assessed the efficacy of PZQ in two different 
time points (2011 and 2013) and all surveys have revealed high cure rates (CR [ 
94.4%]) and egg reduction rates (ERR [76.1%]. In addition, an earlier study in the same 
setting (Guidi et al., 2010) did not indicate reduced PZQ efficacy. Other potential 
factors could be resistance of people in changing their behaviour or attitudes towards 
engaging in more risky activities or host determinant factors of the local people there 
and deterioration of public health services. Studies have shown that differences in the 
rate of transmission, pre-treatment infection intensity, rate of exposure and other host 
factors such as immunological (IgG level, especially IgG 1, 2 and 4; IgA, IgE and IgM) 
and demographic are significantly associated with schistosomiasis reinfection in a 
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population despite provision of regular treatment (Mbanefo et al., 2014, McManus and 
Bartley, 2004, Figueiredo et al., 2012, Jiz et al., 2009, Acosta et al., 2002).  
The effectiveness of the combination of mollusciciding and treatment with PZQ in 
terms of controlling schistosomiasis has been long appreciated (Sturrock, 1995, 
McCullough et al., 1980) and reported to be more effective than using them individually 
(Mangal et al., 2008). In this present study, snail control plus MDA resulted in a drop in 
prevalence in the Std-3 plus Std-4 cohort of 31.7% (from 10.88.2%-7.43%) in two years 
from 2012-2014. By comparison, in China it was shown that schistosomiasis integrated 
control measures using mollusciciding with niclosamide, chemotherapy (PZQ), 
education and environmental modification substantially reduced infection from 1.7% to 
0.4% in 8yrs (2005-12) (Chen et al., 2014). Similarly, in Morocco, the disease was 
eliminated through implementation of these strategies (Barkia et al., 2014, Laamrani et 
al., 2000a).  
The current results suggest that the behavioural modification plus MDA had the best 
outcome. Despite this apparent success there are no direct explanations in relation to 
that achievement especially considering the timeframe to which the intervention was 
implemented. As indicated earlier, the behavioural modification strategy was effectively 
initiated in late 2012 giving just a short period of implementation of the strategy. 
Moreover some of the components of the strategy for example the installation of 
washing platform were progressively introduced as found feasible but also were 
inconsistently carried out. Notwithstanding this, behavioural modification is an integral 
component of the schistosomiasis control and if widely disseminated in communities 
could eventual lead to interruption of disease transmission (Fenwick et al., 2006a, 
Aagaard-Hansen et al., 2009, Useh and Ejezie, 1999). Indeed, several the countries 
(China, Morocco) which have reported successful elimination of schistosomiasis in 
certain areas have implemented behavioural change strategies (Xianyi et al., 2005b, 
Laamrani et al., 2000a). 
With regards to intensity of infection as an indicator of the success of intervention 
measures, the initial phase of single annual SBT (2010-2012) was characterised by an 
increase in intensity as measured simply by arithmetic mean intensity or by the 
frequency of high intensity infections in Std-1 children. So this reflected the increase in 
prevalence also recorded during this time.  
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Regarding the more intensive interventions of the SCORE period, the simple arithmetic 
mean scores did not mirror the prevalence trends so well with the intensity for the MDA 
and Behaviour arms showing greater percentage declines than seen for prevalence. The 
trend for the Snail control arm was more similar for both. However, these trends in 
arithmetic mean values were not reflected in the percentage of “heavy” infections (egg 
count ≥50/10ml of urine) which were essentially the same at baseline in 2012 and in 
2014 for all three of the intervention arms (Table 4). Similarly, for the original “Cohort 
24” schools, 12 of which continued with MDA alone during the SCORE period, there 
was no consistent trend in reduction of the proportion of “heavy” infections (Table 3). 
As has been mentioned with regard to the trends in prevalence reductions the 
significance of these variations should become clearer with analysis of the subsequent 
monitoring of the SCORE intervention period.  
To our understanding this present study is the first to attempt to evaluate 
comprehensively the impact on both prevalence and intensity of integrated interventions 
for schistosomiasis control in this setting. Many of the earlier studies that attempted 
implementing integrated schistosomiasis control focused only on prevalence (Chen et 
al., 2014, Katz, 1998, Amarir et al., 2011) and in some cases, the control measures were 
not implemented concurrently as carried out in Saint Lucia (Jordan, 1985). In fact in 
Saint Lucia, the implementation of schistosomiasis control measures were undertaken 
stepwise, initially involved snail control followed by increased distribution of safe water 
supply and selective chemotherapy. Nonetheless we could hypothesise that the 
concurrent implementation of integrated, synergistic, control measures for 
schistosomiasis in Pemba could lead to decreases of both prevalence as well as intensity 
as proposed by (Coura, 1995). 
 
3.6.4. The impact of schistosomiasis control measures on anaemia 
Infections with schistosomes has adverse effect on the health of children; anaemia being 
one of the major problems associated with this infection (Abd Ellah et al., 2015, Casmo 
et al., 2014). There are several hypotheses concerning the mechanisms that might be 
linked to the development of anaemia in children infected with schistosomiasis 
including inflammation, iron deficiency (due to direct ingestion of blood or regular 
blood loss resulting from rupturing small blood vessels), splenic iron retention and 
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autohaemolysis (Butler et al., 2012, Friedman et al., 2005b, Tolentino and Friedman, 
2007, Friedman et al., 2005a, Mahmoud and Woodruff, 1972). Demonstration of 
improvement in terms of increasing haemoglobin concentration in children living in 
areas where this infection is prevalent is considered as a positive impact or a success 
indicator of control programs. The present study assessed the level of haemoglobin 
concentration in school-children as an impact of schistosomiasis control following 4 
years of chemotherapy-based intervention. Unfortunately, most of the earlier studies 
conducted in this setting have focused on the relationship of anaemia and STH infection 
but not with schistosomiasis (Kung'u et al., 2009) and this report would serve as 
baseline data for the upcoming control initiatives. Measurement of anaemia was carried 
out in 2010 in the St-1 children in the Cohort 24 schools and then again in 2013. During 
this time control in the corresponding communities would have involved the initial SBT 
followed by one or other of the MDA, Behavioural modification or Snail control 
measures.  
The data showed that at baseline, the mean haemoglobin concentration in Std-1 children 
was 11.3 g/dl with overall prevalence of anaemia being 56.6%; and only a small 
proportion (0.9%) had severe anaemia (Hb ≤ 7.0 g/dl). Following implementation of 
schistosomiasis control measures, the mean Hb concentration of the children in the 
population significantly increased to 11.9g/dl. Similarly, the proportions of children 
with anaemia (38.2%) or severe anaemia (0.6%) were significantly reduced. Our 
baseline mean haemoglobin concentration observed in the present study is similar to 
that obtained by (Koukounari et al., 2007) and (Tohon et al., 2008) one year after initial 
treatment implementation. The apparent improvement in Hb status mentioned above 
does not show an obvious relationship with the trends in prevalence (Figure 26) and 
intensity (Figure 30) over the same period although it a significant association of 
anaemia development with schistosomiasis intensity has been reported by others (King 
et al., 2005). This may indicate the complexity of development of anaemia with many 
factors necessary for its progression. Our data shows that most the anaemic children 
were from Mkoani district where the prevalence of schistosomiasis was higher than 
other districts. Unfortunately, resource constraints meant that it was not possible to 
monitor Hb levels in the other surveys reported in this project. 
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Chapter 4 Impact of Control Interventions on Soil 
Transmitted Helminth Infections 
4.1 Introduction 
The STH programme started in 1994 based on preventive chemotherapy. Since the 
beginning of the STH control programme, the benzimidazole derivates, ABZ and MBZ, 
had been regularly used to control the morbidity of STH in Pemba (Figure 34). 
However, the interventions were carried out using different approaches ranging from 
selective chemotherapy to community-based MDA. Furthermore, high prevalences 
(90%+) were demonstrated before interventions started (1986-1988) and although use 
of chemotherapy had been sporadic after that the prevalence remained comparably high 
throughout the 1990s. However, the use of MDA with albendazole as part of the GPELF 
and SCI programmes in 2000- 2006 led to lower prevalences (~60%) being recorded 
which, nevertheless, rebounded as soon as the MDAs stopped and school-based 
interventions were re-instated.  
In parallel with the surveys for schistosomiasis described in Chapter 3 (for cohort 24) 
faecal samples were collected from schoolchildren from 2010 to 2013 for analysis of the 
presence of STH in order to assess the impact of the PC-based control in the school-
based and MDA control initiatives. 
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Figure 34: Review of STH control in Pemba 
                                      
  1986    -      1988 1989       -     1993 1994-1998 1999--2002 2003 2004 2005 2006 2007 2008 2009-2010 
Praziquantel (PZQ) 1 2 3 4   6 7   9 10 
Mebendazole (MBZ)  3  8 
ALB + Ivermectin 
(IVM) 
  
  
  
  
5   7   
Albendazole (ALB)   6  9 10 
                    
 1  Selective chemotherapy to children and adults - test and treat campaign, twice a year 
2 School targeted treatment, twice a year 
 3 
ZHCP: Initiated 
PZQ for school targeted treatment, only in high prevalence schools 
MBZ for school targeted treatment, twice a year 
 
 
4 Irregular distribution 
5 GPELF: Community MDA (> 5 years of age), once a year  
 
6 
ZHCP ,> 5 years of age, once a year  
2004 - 2005, Community MDA in Pemba (supported by SCI - Schistosomiasis Control Initiative) 
2006, School targeted treatment in both Islands  
 7 Integrated Triple Drug Administration, Community MDA, only once 
 8 Preschool targeted treatment (12 - 59 months), twice a year, supported by UNICEF 
 9 School targeted treatment, once a year: (The treatment was partially implemented) 
 10 School targeted treatment, once a year (during the National Baseline Survey) 
a Renganathan et al 
(1995) 
 
 
d Albonico et al 
(1997) 
e Haji –unpublished 
SCI data 
fStoltzfus et al 
(1997) 
 
All based on 
school-children 
STH 95.2
e 86.7a 99.9a 60.3e 59.9e 95.8e 94. 4a >97f,d        
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4.2. Prevalence and intensity of STH infections in Std-1 schoolchildren at baseline 
(2010) 
4.2.1 Prevalence in the different schools and districts  
At baseline (2010) the overall prevalence of any STH was 93.9% (95%CI = 92.6-95.3). 
Prevalences of the three common species of STHs were 87.4% (95%CI = 85.5-89.3), 
50.5% (95%CI = 47.7-53.3) and 46.7% (95%CI = 43.9-49.5), for T. trichiura, 
hookworms and A. lumbricoide, respectively. In all three types of infections, there was 
no statistical difference by gender (Table 5). Regarding the intensities of infection the 
overall arithmetic mean egg counts were: Ascaris 1457 ± 3679  eggs per gram (epg); T. 
trichiura 756 ± 1500) and hookworms 302 ± 1106 epg.  
Table 5: Prevalence of the major soil transmitted helminths, A. lumbricoides, T. 
trichiura and hookworms, among school children in relation to sex in 2010 
 Type of infection   No. infected    Sex 
        Boys (%) Girls (%) 
 A. lumbricoides   553   (47.0)  (53.0) 
 T. trichiura    1036   (49.1)  (50.9) 
 Hookworms    598   (49.8)  (50.2)  
The prevalence of STHs by school is shown in Figure 35. T. trichiura was the most 
prevalent species in all schools reaching 100% in two schools. However, the prevalence 
of A. lumbricoides and hookworm varied between schools. Mkoani district had higher 
prevalences of all three species of helminth infection (Figure 37). 
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                                  Figure 35 : Prevalence of STH in Std-1 schoolchildren among schools in Pemba in 2010 
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Figure 36: Prevalence (+SD) of the STHs among districts in Pemba in 2010 
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4.2.2 Multiple infections with STH 
Many of the 1185 children had multiple STH infections as shown in Figure 37:- 296 
(25%) of the children had triple infection with A. lumbricoides, T. trichiura and 
hookworms; 246 (20.8%) were co-infected with T. trichiura and hookworms; 216 
(18.2%) were co-infected with A. lumbricoides and T. trichiura; 20 (1.7%) were co-
infected with A. lumbricoides and hookworm. Thus, as shown previously, only 72 
(6.1%) were not infected with any of the three worms. The remainder of the children, 36 
(3%) were infected with hookworm alone, 278 (23.5%) were infected with T. trichiura 
alone and 21 (1.8%) were infected with A. lumbricoides alone.  
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Figure 37: Proportion of the children with mixed STH infection 
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4.2.3 Intensity of STH infection 
Analysis of the intensity of helminth infections revealed that among the A. lumbricoides 
infected children, 80.1%, 11.9% and 8.0% had light (mean epg 119 ± 1101), moderate 
(mean epg 6712 ± 1467) and heavy (mean epg 17,208 ± 5368) infections respectively. 
Among the T. trichiura infected children, 79% had light infection (mean epg 364 ± SD 
234), 20% had moderate infection (mean epg 2423 ± 1837) and 0.7% had heavy 
infection (mean epg 13,203 ± 1837). Among hookworm infected children 97% had light 
infection (mean epg 409 ± 403), 1.3% moderate infection (mean epg 3183 ± 447) and 
1.7% had heavy infection (mean epg 9494.4 ± 6503.5). 
 
4.3 Prevalence and intensity of STH infections in schoolchildren at follow-up in 
March 2011  
In January 2010 following the above baseline survey, all primary school children on the 
Island aged from 7-13yrs were treated with albendazole (400 mg) for STH. The follow-
up reported below was to determine the effects on helminth infection rates in the new 
Std-1 cohort a year later. Parallel sampling of infection in the Std-3 children also 
 107 
 
allowed some assessment of the impact of the 2010 SBT on worm burdens. In order to 
allow comparison of the data, Std-1 and Std-3 are considered separately.  
Among the school children enrolled, 2355 (98.9%) produced stool samples although 
hookworm data was not available for 3 children. Of those with complete data, 1180 
(50.1%) were in Std-1 and 1175 (49.9%) were in Std-3. The combined overall 
prevalence for any worm was 89.8% (95%CI = 88.6-91.0) and worm specific 
prevalences were 47.4% (955CI = 45.4-49.4) for A. lumbricoides, 83.3% (95%CI = 
81.8-84.8) for T. trichiura and 46.3% (95%CI = 44.2-48.3) for hookworms.  
 
4.3.1.1 Prevalence in Std-1 children in 2011 
The overall prevalence for the Std-1 children was 90.7% (95%CI = 89.0-92.4) for any 
STH and worm specific prevalences were 83.9% (95%CI = 81.8-86.0) for T. trichiura, 
50.3% (95%CI = 47.5-53.2) for hookworm and 46% (95%CI = 43.2-48.8) for A. 
lumbricoides. The data from the individual schools (for Std-1 children only) are shown 
in Figure 38. It is clear that T. trichiura infection was the predominant infection, 
although A. lumbricoides and hookworm infections differed remarkably across the 
schools. Michakaini School had the lowest prevalences for all three STH. 
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4.3.1.2 Intensity of infection for Std-1children 
Regarding intensity of infection, 70.9%, 16.1% and 13% had light, moderate and heavy 
infection with A. lumbricoides respectively. The overall mean intensity for A. 
lumbricoides was 4794 (± 7417) egp. The children with light A. lumbricoides infection 
had an arithmetic mean egg count of 1491(± 1387) epg whilst those with moderate and 
severe A. lumbricoides infection had arithmetic means of 7190 (± 1447) and 19831 ± 
10873) epg, respectively. Among the children infected with T. trichiura, 739 (74.2%) 
had light infection, 251 (25.2%) had moderate and 6 (0.6%) had severe infection and the 
overall intensity was 891 (± 1496) epg. Those with light, moderate and heavy infection 
had, respectively, arithmetic mean egg counts of 354 (± 253), 2176 (± 1521) and 13248 
(± 3435) epg. Out of the hookworm infected children, 576 (96.64%), 15 (2.52%) and 
5(0.84%) had respectively light, moderate and severe infections and the overall mean 
epg was 543 (± 706). These values for light, moderate and heavy infections were very 
similar to those in 2010 (A. lumbricoides: 80.1%, 11.9% and 8.0%; T. trichiura: 79.2%, 
20.1% and 0.7 %; hookworm: 97%, 1.3% and 1.7%). There were no significant 
differences between the mean intensities of any of the STH infection between 2010 and 
2011. 
 
4.3.2. Effect of treatment on worm burden – comparison of Std-1 and Std-3 
4.3.2.1 Prevalence  
As indicated above, the parallel sampling of Std-3 children allowed assessment of worm 
burden after the Std-3 cohort had received the single round of SBT. Comparison of the 
data on prevalence of STH for individual schools for Std-3 and Std-1 children sampled 
at baseline does not show any remarkable difference (Figure 39). However, the overall 
prevalence for any worm was significantly different between the two classes (z = -4.18; 
p = 0.0001). The prevalences were 93.9% (95%CI = 92.5-95.3) for Std-1and 88.86% 
(95%CI: 87.1-90.7) for Std-3. 
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Figure 39: Comparison of the prevalence of STH infection among Std-1 in 2010 and Std-3 in 2011 
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Indeed, in Std-1 children, who were not treated previously, the overall prevalences were 
90.7% (95%CI = 89.1-92.4) for any STH, 83.9% for T. trichiura, 50.3% for hookworm 
and 46% for A. lumbricoides compared with 88.9% (95%CI = 87.1-90.7) for any STH, 
82.6% for T. trichiura, 42.2% for hookworm and 48.9% for A. lumbricoides for the Std-
3 children. Only the hookworm prevalence was significantly higher in Std-1 children (z 
= 3.9, p = 0.0001). 
 
4.3.2.2 Intensity of STH infection in Std-1 and Std-3 children 
Table 6 compares the intensity of STHs infection between Std-1 and Std-3. Generally, 
the proportion of children with any intensity category between different STHs infection 
was comparable between the two classes. The only differences noted were for 
hookworm and T. trichiura but the actual number of children with severe infection was 
too small (5 for Std-1 and 1 for Std-3 for hookworm infection and 6 for Std-1 and 1 for 
Std-3 for T. trichiura infection) for a meaningful comparison. Nevertheless, the overall 
(arithmetic mean) hookworm epg for the two classes was significantly different (t= 2.5; 
p = 0.01) with mean epg of 273.4 for Std-1 and 220.1 for Std-3. However, the overall 
mean epg for both A. lumbricoides (p = 0.5) and T. trichiura (p = 0.2) were similar 
between the classes (Table 6). 
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Table 6: Comparison of the intensity STHs infection among Std-1 and Std-3 children.  
       Intensity  
     Light   Moderate  Heavy 
Infection type   No. (%)  No. (%)  No.  (%) 
A. lumbricoides 
Std-1    389  (71.4)  84  (15.4)  72  (13.2) 
Std-3    404  (70.6)  86 (15.0)  82 (14.3) 
Hookworm 
Std-1    576 (96.8)  14 (2.4)  5 (0.8) 
Std-3    475 (96.4)  17 (3.5)  1 (0.2) 
T. trichiura 
Std-1    735 (74.3)  248 (25.1)  6 (0.6) 
Std-3    721 (74.2)  250 (25.7)  1 (0.1) 
 
4.3.3 General features of the STH infections in 2011 
4.3.3.1 Comparison of districts 
As seen in Figure 41 taking the Std-1 and Std-3 children together, the prevalence of the 
different STH in the different districts was very similar to that seen for the Std-1 
children in 2010 (Figure 37.)  
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4.3.3.2 Multiple Infections
10
 with STH in 2011 
As in 2010 many of the children had multiple infections. Taking the Std-1 and Std-3 
together 556 (23.6%) had triple infection, 444 (18.9%) were co-infected by T. trichiura 
and hookworms, 462 (19.6%) were co-infected by T. trichiura and A. lumbricoides, 33 
(1.4%) were co-infected by A. lumbricoides and hookworms.  
4.3.3.3 Impact of sex on STH infection levels  
As in 2010 there were no strong associations of sex with prevalence of any of the STHs 
(see Table 4). The percentages in boys/girls were: A. lumbricoides, 47/ 53%; (χ2 =0.9, p 
=0.33); hookworms: 49.8/50.2% (χ2 =0.8, p = 0.36); T. trichiura 49.1/50.9% (χ2 =1.2, p 
=0.3).  
 
Figure 40: Prevalence of STH infections among the districts in Pemba in 2011.  
                   Error bar indicates the standard deviation (SD) of the mean 
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10
 The denominator for the multiple infection was 2352. This is based on the number of children who 
had all records on STH 
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4.4 Prevalence and intensity of STH infections in Std-1 schoolchildren at follow-up 
in March 2012  
4.4.1 Prevalence of STH in 2012  
The present survey was carried out in March 2012, after two years of SBT. This survey 
allowed assessment of any trend of infection over the years. A total of 1074 Std-1 
children were enrolled in the study. The children had a mean age of 7.9 yrs ± 0.8 (95% 
CI = 7.8-7.9). Of these 564 (52.5%) were girls and 510 (47.5%) were boys. Of the 
enrolled children, 1050 (97.8%) produced stool sample. The overall prevalence of any 
STH worm was 91.7% (95%CI = 90.0-93.4) and worm specific prevalence was: 52% 
(95%CI = 48.9-55.0) for A. lumbricoides, 87.8% (95%CI = 85.8-89.8) for T. trichiura 
and 51.2% (95%CI = 48.2-54.3) for hookworm. The analysis of STH infection in 
relation to sex revealed that in all worm species the prevalences were similar in boys 
and girls. 
 
4.4.2 Prevalence of STH in schools and districts (2012) 
The prevalence of STH in schools and district is shown in Figure 41. In general, the 
prevalence of T. trichiura was comparable between schools and hence the districts, 
although, in some schools like Wesha the prevalence reached 100%. Surprisingly 
Michakaini School had very low prevalences of A. lumbricoides and hookworm as 
compared to other schools. There was no data of STH infection for Ngwachani School 
due to the fact that all primary school-children in this school were treated with 
albendazole few days prior undertaking the survey. A. lumbricoides and hookworm 
infections were predominantly found in Micheweni district as compared to other 
districts. 
 
4.4.3 Intensity of STH infection (2012) 
Table 7 shows the intensity of STH infections among the children. Generally, most of 
the children infected had light infections with any of the worms. A substantial number 
of children infected with A. lumbricoides had severe infection. The children with light 
A. lumbricoides infection had an arithmetic mean egg count of 1712 ± 1300 epg; those 
with moderate infection had a count of 7055 ± 1481 epg, whilst the children with severe 
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infection had a count of 22908 ± 13970 epg. The children with light, moderate and 
severe T. trichiura infections had, respectively, arithmetic mean egg counts of 394 ± 
255 epg, 2212 ± 1592 epg and 15620 ± 5986 epg. 
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                                                 Figure 41: Prevalence of STH infections in schools and districts in 2012 
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Table 7: Intensity of STH infections 
        Type of infection          Intensity  
       Light   Moderate    Heavy 
    No. (%)     No. (%)  No. (%) 
   A. lumbricoides  351 (64.3)      75   (13.7)  120 (22) 
 T. trichiura   651 (70.6)  267 (28.6)  7 (0.8) 
 Hookworm  515 (95.7)  17 (3.2)  6 (1.1) 
 
The children with light hookworm infection had an arithmetic mean egg count of 388 ± 
SD 383 epg; those with moderate infection had a count of 2715 ± SD 584 epg while the 
children with severe infection had a count of 8044 ± SD 7035 epg. Regarding the 
intensity of STH relative to sex, comparable intensities were seen between boys and 
girls. 
 
4.4.4 Multiple infections (2012) 
Out of 1049 children who produced stool samples, 322 (30.7%) had triple infection with 
A. lumbricoides, T. trichiura and hookworm. 195 (18.6%) children were co-infected 
with T. trichiura and hookworm or T. trichiura and A. lumbricoides. Only 9 children 
(0.9%) were co-infected with A. lumbricoides and hookworm (figure 43). 
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Figure 42:  Prevalence of multiple STH infections in 2012 
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4.5 Comparison of STH infection in 2010 - 2012 
Following reintroduction of SBT for control of STH infections, single annual treatment 
with ALB (400mg) was administered to school-children aged between 7-13yrs. Later, in 
2012, during the course of implementation of the PC strategy focussed on control and 
possibly elimination of schistosomiasis, the drug administration approach was changed 
from single annual SBT to twice/yearly community wide treatment or MDA. Thus the 
STH surveys reported above were aimed at assessing the impact of single annual SBT 
in terms of reduction of prevalence and intensities. For this comparison only Std-1 data 
collected from 2010-12 were considered.  
Figures 44 and 46 show comparisons of the prevalences and intensities of STH infection 
in school-children from 2010 to 2012. Clearly the data shows that the overall prevalence 
of STH (any worm) has been minimally reduced as a result of provision of two rounds 
of SBT. For the three common STH worms, there were inconsistent reduction and 
increase of the prevalences over the years especially for T. trichiura and hookworm 
infections. For A. lumbricoides, the situation was somewhat different by observing 
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steady increase of the prevalences over the years. However, the increase was non-
significant between the successive years.  
The intensities of infection were generally maintained at a low level (light intensity), 
although the percentage of light infections in fact decreased slightly over the time for A. 
lumbricoides and T. trichiura. For example, a higher proportion (80.1) of children with 
light A. lumbricoides infection was demonstrated in 2010 compared to 64.3% in 2012.  
 
Figure 43: Comparison of the prevalence of any STH infections from baseline (2010-
2012) and after two rounds of administration of ALB 
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Figure 44: Comparison of the prevalence of the three common STH worms from 2010-
2012 after two rounds of administration of ALB 
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Conversely the proportion of children with severe A. lumbricoides infection was 
steadily increased over time reaching to 22% in 2012, almost two-fold higher than at 
baseline (2010). Similarly, a higher percentage of children (79%) with light T. trichiura 
infection was observed in 2010 as compared to 2012 paralleled by an increase in 
moderate infections. Interestingly hookworm intensities were comparable between the 
years. 
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Figure 45: Comparison of the intensities of STH infections in Std-1   children in 2010 
(baseline) to 2012 (after administration of two rounds of ALB) 
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4.6 STH infection in individual schools in 2010 - 2012 
As shown in Figure 42 above, the overall prevalence of any STH worm was comparable 
from 2010-2012. However, STH worms (A. lumbricoides, T. trichiura or hookworm) 
specific prevalences (Figure 43) varied between the years and the schools. As in 2010, 
T. trichiura infection was most predominant reaching 100% in some schools (Wesha) 
but decreasing in other schools e.g. Mizingani. Unfortunately, there were no data in 
Ngwachani School for 2012. This was due to provision of ALB to all primary school-
children just prior to undertaking the survey. Applying the Mantel- Haenszel analysis 
for the score test for the trend of odds of T. trichiura infection showed that there was 
slightly increased odds of T. trichiura infection across the schools (Odd ratio [OR] = 
1.02; 95% CI =0.90-1.15; p = 0.7) The detailed table for this analysis is shown in 
Appendix 4C. A similar trend of increase or decrease of hookworm infection was also 
demonstrated in some schools. But the overall trend of odds of infection increase was 
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not significant (OR = 1.0; 95% CI=0.92-1.1; p = 0.9), (see appendix 4B). A. 
lumbricoides infection also showed a decrease and some schools and increases in 
others. In Tumbe the infection rate increased by over 100% in 2012. Indeed, the score 
test for trend of odds revealed there was a slightly increased odds of A. lumbricoides 
infection across the schools (OR = 1.12; 95% CI=1.02-1.21) and this was significant (p 
= 0.01) (see Appendix 4A). 
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To allow easy comparison figures 35, 38 and 41 above have been replicated. 
 
Figure 46: Comparison of STH infections between schools in 2010-2012 
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 Figure 47: Comparison of the prevalences of STH infections in districts from 2010 - 
2012 
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In comparing the prevalences of STH infections in relation to districts between baseline 
(2010) and 2012, after two rounds of ALB administration (Figure 47), the prevalence of 
T. trichiura was broadly similar across the districts over time with a slightly increased 
trend for odds of infection (OR= 1.02, 95% CI = 0.90-1.15; p = 0.80). The situation was 
very similar for hookworm infection, where the overall trend of odds of infection was 
OR= 1.02, (95% CI = 0.93-1.11; p = 0.67) across the districts. Nevertheless, a marked 
increase of the hookworm infection was detected in some of the districts. For example, 
in Micheweni district the infection steadily increased over time reaching 74.1 % in 
2012, a 61.1% increase. Compared to T. trichiura and hookworms, there was slightly 
higher trend of odds of A. lumbricoides infection across the districts (OR= 1.12, 95% CI 
=1.03-1.21; p = 0.01). Appendix 1d-f illustrates the detailed tables for the above 
analysis. 
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4.7 Prevalence and intensity of STH infections in Std-1 schoolchildren at follow-up 
in March 2013  
4.7.1 General prevalence of STH infection in 2013 
Between January-March 2013, a survey to assess the impact of one year of biannual 
MDA for the control of STH infection was conducted in Pemba. This survey was 
designed to provide data for comparing two strategies or approaches on the frequency of 
drug delivery: (1) single annual treatment in 2010-2012; (2) biannual treatment (April 
2012 and Nov 2012) in terms of reduction of the prevalence and intensity of STH.  
During this survey a total of 2309 Std-1 school children were enrolled. Of these 1201 
(52%) were girls and 1108 (48%) were boys. The children had mean age of 7.3yrs (95% 
CI= 7.25- 7.31) with a range of 6-13yrs.  
Of the enrolled children only 1971 (85.4%) produced stool samples. Overall the 
prevalence of any worm was 85.4% (95%CI = 83.8-86.9) and the worm specific 
prevalences were 34.1% (671) (95%CI = 32.0-36.2) for A. lumbricoides, 32.1% (632) 
(95%CI = 30.0-34.1) for hookworm and 80.8% (1592) (95%CI = 79.0-82.5) for T. 
trichiura. More boys were infected with A. lumbricoides (52.9%) than girls (47.1%) and 
the infection was significantly associated with sex (p = 0.001) but this was not the case 
for hookworm and T. trichiura infection. 
 
4.7.2 Prevalence of STH in schools and districts in 2013 
Figure 49 illustrates the prevalence of STH in schools and districts. This figure shows 
that Tumbe School had higher prevalences of all common STH as compared to other 
schools while Michakaini and Kizimbani schools had the lowest prevalences for any of 
the worm infections. Generally, most of the schools had <40% for A. lumbricoides and 
hookworm infections (Michakaini had 0% of hookworm infection). Micheweni district 
had the highest prevalence for A. lumbricoides, hookworm and T. trichiura infections. 
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4.7.3 Intensity of STH infection in 2013 
Among the A. lumbricoides infected children 482 (71.8%), 55 (8.2%) and 134 (20%) 
had light, moderate and heavy intensity, respectively. The children with light A. 
lumbricoides infection had an arithmetic mean epg of 1321 ± 1000, those with moderate 
infection epg of 6962 ± 1328and those with severe infection epg of 26501 ± 14451. 
Most (95%) of the hookworm infected children had light infections with mean epgof 
416 ± 396; 4% had moderate infections with mean epg of 2540 ± 462 epg; and1% had 
heavy infections with mean epg of 5564 ± 1786. Among those children infected with T. 
trichiura, 64.8% had light infection (mean epg 436 ± 263), 34.4% had moderate 
infection (mean epg 1997 ± 1307) and 0.8% had heavy infection (mean epg of 16735 ± 
6700).  
 
4.7.4 Intensity in relation to sex 
The intensity of the three common STH worms in relation to sex is shown in Table 8. 
This table clearly shows that the intensities of A. lumbricoides and T. trichiura 
infections were comparable between sexes. The trend for hookworm infection was 
somewhat different as the proportion of boys with moderate or severe hookworm 
infection was slightly higher in boys than girls. However, the actual number of children 
with severe hookworm infection was remarkably low. 
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Table 8: Intensity of STH worms in relation to sex in 2013. 
Infection type/intensity      Sex 
     Female    Male 
    No.  (%)   No.  (%) 
A. lumbricoides  
 Light   235  (74.4)   247  (69.6)
 Moderate  21  (6.7)   34  (9.6)
 Heavy   60  (19.9)   74  (20.9)
  
Hookworm: 
Light   303  (96.5)   298  (93.7) 
Moderate  9  (2.9)   16  (5.0) 
Heavy   2  (0.6)   4  (1.3)
  
T. trichiura : 
 Light   523  (64.1)   509  (65.6) 
Moderate  283  (34.7)   264  (34.0)
 Heavy   10  (1.2)   3  (0.4)
  
 
4.7.5 Multiple infections (2013) 
Among the children who produced stool samples, only 288 (14.6%) were not infected 
with any of the common STH whilst 681 (34.6%) of the children were infected with T. 
trichiura alone, 42 (2.1%) had A. lumbricoides alone, 34 (1.7%) had hookworm alone. 
Fifteen (0.7%), 328 (16.6%), 297 (15.1%) of the children were respectively co-infected 
with A. lumbricoides and hookworm, A. lumbricoides and T. trichiura, and hookworm 
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and T. trichiura. Only 286 (14.5%) of the children had triple infection. The observation 
of triple infection with STH worms among the children would not be a surprise thing in 
this setting as it is more common in Zanzibar, though with varying levels (Knopp et al., 
2009). 
4.7.6 Comparison of STH prevalence between 2010 and 2013 
Due to the fact that, wherever schistosomiasis is endemic, STH infections usually also 
prevail, WHO has urged schistosomiasis endemic countries to take advantage of any 
planned PC for schistosomiasis and concurrently control STH infections (Montresor et 
al., 2002). In view of this, following implementation of the elimination of 
schistosomiasis project in Zanzibar there was a shift of strategy from annual school 
based treatment with PZQ and ALB to twice yearly provision of both drugs through 
MDA, and therefore it was important to assess the impact of each of these strategies in 
terms of reduction of infection prevalence and intensity.  
The baseline (2010) prevalence of any worm of 93.9% (95%CI = 92.6-95.3) was 
modestly but significantly reduced to 86.2% (8.2% reduction) (z = 6.7; p = 0.0001) in 
2013 after two rounds each of school-based treatment and MDA (Figure 49). Equally, 
worm specific prevalences for any of the common STH infection were considerably 
reduced. For instance, hookworm was reduced from 50.5% to 32.1% (z = 10.3 p = 
0.0001), A. lumbricoides was reduced from 46.8% to 34.0% (z =7.1, p = 0.0001) and T. 
trichiura infection was reduced from 87.4% to 80.8% (z = 4.5, p = 0.0001) (Figure 50) 
following provision of twice-yearly treatment with ALB in the communities as MDA. 
The trend of decrease of STH infections was also apparent across the individual 
schools. As at baseline, T. trichiura infection was predominant across the schools but 
only one school (Tumbe), during the follow-up in 2013, recorded a comparable 
prevalence (98.9%) noticed in some schools (Mizingani and Ngwachani 100%) in 2010. 
Nevertheless, when applying the Mantel- Haenszel analysis revealed that there was no 
increased odds of T. trichiura infection across the schools (Odds ratio [OR] = 0.6; 95% 
CI =0.49-0.71). 
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Figure 49: Comparison of the prevalence of STH infection between 2010-2013 
following administration of ALB as SBT and MDA. 
 
20
10
20
11
20
12
20
13
0
20
40
60
80
100
120
SBT CWT
SBT= School Based Treatment
CWT= Community Wide Treatment
(MDA)
Year
P
re
v
a
le
n
c
e
 (
%
) 
o
f 
c
o
m
m
o
m
S
T
H
 w
o
rm
s
 
Similarly, overall there was remarkable variation of the prevalence of hookworm 
infection across the schools. Indeed when applying the Mantel- Haenszel analysis 
indicated that there was no increased odds of hookworm infection across the schools 
(OR = 0.44; 95% CI =0.38-0.51). Likewise, there was increase or decrease of A. 
lumbricoides infection across the schools but when applying the Mantel-Haenszel 
analysis shows that there were no odds of infection increase (OR = 0.56; 95% CI =0.49-
0.66).  
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Figure 50: Comparison of worm specific prevalence for the common STH infection 
between 2010 and 2013 
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With regards to STH infections in the districts, the prevalence of A. lumbricoides 
between the districts varied over the years. However, when applying Mantel-Haenszel 
analysis it revealed that there was no significant odds of the infection increasing across 
the districts (OR = 0.57; 95% CI = 0.49-0.67). The similar trend of variation in the 
prevalence of the infections in the districts between the years was also demonstrated for 
T. trichiura and hookworm and overall, for any of these infections, there were no 
increasing odds. The OR for T. trichiura infection was 0.60 (95% CI= 0.49-0.74; p = 
0.0001) and the OR for hookworm was 0.45 (95% CI = 0.39-0.52; p = 0.0001). 
 
4.7.7 Comparison of STH infection intensity between 2010 and 2013 
The intensities of infection for any of the common STH worm remained at low level 
(light intensity) (Figure 51) although there was variation between the years. For 
instance, the percentage of children with moderate intensity for T. trichiura infection 
increased in 2013 (34.4%) as compared to 2010 (20%) and the proportion of children 
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with severe intensity infections with A. lumbricoides increased by almost two-fold 
(from 8-20%). For hookworm infection, the proportions of children with light, moderate 
or severe intensity were comparable between the years. The increased proportion of 
children with severe A. lumbricoides or moderate T. trichiura infections may raise 
concern over the possible emergency of drug resistance.  
Figure 51: Comparison of the STH infection intensity between 2010 and 2013 
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4.8 Assessment of anaemia in relation to STH Infection  
4.8.1 Baseline  
The children that produced stool samples were also assessed for their haemoglobin 
levels. The mean haemoglobin concentration was 11.3 g/dl ± 1.7 (95%CI = 11.21 -
11.41). Overall the prevalence of anaemia was 56.6%. Out of the anemic children only 
1.3% had severe anaemia (Hb ≤ 7.0 g/dl) and so 98.7% had moderate anaemia. The 
proportion of girls (56.7%) and boys (56.5%) with anaemia was comparable. 
The analysis of anaemia in relation to common STH infections is illustrated in Table 9. 
It was clearly shown that a high proportion of children regardless their STH infection 
status, were anaemic. However, A. lumbricoides infection was significantly associated 
with anaemia according to Chi-square analysis. Furthermore, univariate analysis using 
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logistic regression also showed a significantly increased odds of anaemia in children 
infected with A. lumbricoides (OR = 1.28; 95%CI = 1.02-1.61).    
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Table 9: Proportions of children with and without anaemia in relation to STH infections 
in 2010 
Type of STH infection  Anaemic   Not Anaemic    p-value    
     No. (%)  N (%) 
Any STH     
 Infected   630 (56.6)  483 (43.4) 
 Not infected   41 (56.94) 31 (43.06) 0.95 
A. lumbricoides: 
Infected    331 (59.9)  222 (40.1) 
Not infected   340 (53.8)  292 (46.2)  0.04 
Hookworm: 
 Infected   341 (57.0)  257 (43.0) 
 Not infected   330 (56.2)  257 (43.8)  0.8 
T. trichiura: 
 Infected   589 (56.8)  447 (43.2) 
 Not Infected   82 (55.0)  67 (45.0)  0.7
  
4.8.2 Follow-up assessment of anaemia in 2013  
A high proportion (98.8%) of the 2283 enrolled children was assessed for haemoglobin 
(Hb) level. Of the children assessed for the presence of STH infections, 1966 (99.7%) 
also had blood test for Hb level. The children had a mean Hb level of 11.9 g/dl (± 1.4) 
(95% CI =11.8-11.9). Of the children assessed for Hb, 871 (38.2%) were anaemic 
(Hb<11.5g/dl). The proportion of girls with anaemia (49.7%) was comparable to that of 
boys (50.3%) and anaemia was not associated with sex (χ2 = 3.04; p = 0.08). 
Moreover, among those with anaemia, only 5 (0.6%) had severe anaemia and 866 
(99.4%) had moderate anaemia.  
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The proportion of children with anaemia relative to STH infection is shown in Table 10. 
With this data, unlike that for A. lumbricoides in Table5 there was no evidence of a 
statistically significant correlation between status with any of the worm species and 
anaemia. Due to the relatively small number of children with severe anaemia, further 
analysis in relation to STH infections was not possible.  
 
Table 10: Proportions of children with and without anaemia in relation to STH 
infections in 2013 
Type of STH infection  Anaemic   Not Anaemic       p-value 
     No. (%)  N (%) 
Any STH 
 Infected   636  (37.92) 1041 (62.08) 
 Not infected   104 (36.11) 184 (63.89) 0.55 
A. lumbricoides: 
Infected    262 (39.1)  408 (60.9) 
Not infected   478 (36.7)  818 (63.1)  0.3 
Hookworm: 
 Infected   246 (39.1)  384 (60.9) 
 Not infected   494 (37.0)  841 (63.0)  0.3 
T. trichiura: 
 Infected   601 (37.9)  986 (62.1) 
 Not Infected   139 (36.7)  240 (63.3)  0.6 
   
4.8.3 Comparison of anaemia between 2010 and 2013 
The overall prevalence of anaemia was significantly reduced from baseline (56.6%) in 
2010 to 38.2% in 2013 (z =10.3; p = 0.0001) following administration of single annual 
 136 
 
treatment or twice yearly in the community with albendazole and praziquantel in 
schools. Equally, the mean Hb concentration significantly increased from 11.3g/dl to 
11.9g/dl (t= -11.1; p = 0.0001). Nevertheless, the absolute number of children with 
severe anaemia (Hb ≤ 7.0g/dl) was too low at both baseline and follow-up for a 
meaningful comparative analysis. However, as shown in tables 9 and 10 the proportion 
of children with anaemia who were infected or not infected with any STH was 
comparable. 
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4.9 Discussion  
Control of STH based on preventive chemotherapy (PC) using benzimidazole drugs is 
the fundamental approach advocated by the WHO and is adopted by most countries 
where these infections are prevalent. Generally the PC is either targeted to school-
children or to the community as MDA (WHO, 2006). Such interventions are often 
regarded as aiming to control morbidity rather than reducing transmission. Both 
approaches have been used in Pemba but their relative impact on transmission has not 
been formally compared. This was one of the aims at the start of this study in 2010 
since school-based treatment was reintroduced after a period of three years without 
routine treatments and also because of changes in treatment strategies following 
implementation of new National Control Programme in 2012 involved more intensive 
treatment i.e. community MDA twice yearly. Despite that ALB has been reported to 
have low cure rate for the treatment of STH worms especially T. trichiura and A. 
lumbricoide in Zanzibar (Stothard et al., 2009) which is similar setting to the study area 
where this project was carried out. 
The baseline study in 2010 followed repeated PC interventions with MBZ or ALB since 
2000 directed either to school-children or preschool children with occasional MDAs 
(see Figure 34). As seen from Figure 34 there has been limited systematic effort to 
monitor effects of the STH treatments. Evidence showed that the MDAs for filariasis 
and schistosomiasis in Pemba caused temporary reduction in STH prevalence (from 
~95% to ~60%) but with a rapid rebound of infection when MDA stopped. Likewise, in 
Unguja where the epidemiological setting is similar, an overall reduction of 39.6% 
prevalence of STH infection with species- specific prevalence of 46.6%, 21.6% and 
16.9% for T. trichiura, hookworm and A. lumbricoides was demonstrated after several 
years (from 1994 to 2007) of PC intervention (Knopp et al., 2009). The present study 
assessed the current prevalence of STH namely: A. lumbricoides, hookworms and T. 
trichiura infection after several years of implementation of MDA and SBT in Pemba. 
The Std-1 children examined at baseline in Feb 2010 should have been included in the 
ongoing UNICEF community based MBZ provision to pre-school children in 2009. 
Nevertheless, a very high prevalence of STH infection was seen (93.9%) including T. 
trichiura [87.4%] and hookworms [50.5%]), exceeding the WHO threshold (≥ 50%) set 
for continuing PC intervention as one of the main control measures.  
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4.9.1 Effect of single SBT in 2010 
The present study was not longitudinal as the impact of treatment in the children was 
not assessed in a cohort but, rather, by studying the Std-1 groups (children who have not 
been treated previously), we looked for any impact of school-based treatment on 
transmission during the previous year. There was no evidence of this overall, (94% cf 
91% overall prevalence of STH) or within the individual schools. Furthermore, when 
comparing St1 and Std3 children (the latter having been treated in 2010) there were no 
significant differences in prevalence for STH or for any individual worm infections 
except for hookworm (50% in Std1 cf 42% in Std-3). The lack of difference likely 
reflects the fact that the BZ are only moderately effective against the STH and also that 
there is rapid reinfection. The children may be re-infected as early as six months post 
treatment, as has been demonstrated early in the control programme (Albonico et al, 
1995), and so the re-infection rate looks not to have changed despite multiple rounds of 
PC. Furthermore the subsequent follow-up of the Std-1 population following two 
rounds of SBT revealed marginal reduction of the overall prevalence comparing 
baseline in 2010 (93.9%with that a year later (2011) (90.2%and then remaining 
comparable in 2012) (91.7%) (Figure 43). Similarly worm specific prevalences were 
comparable between the years, with T. trichiura being more prominent. Indeed there 
was marked variation of the prevalences of STH infection across the schools and 
districts over the years that may reflect changes in transmission dynamics. At baseline 
Mkoani district had high prevalences for any worm as compared to other districts. 
However subsequent analysis revealed high prevalence of STH in Micheweni district. 
This finding is not surprising as the Micheweni district has a high illiteracy rate and is 
also considered the poorest district, two factors that are linked with high transmission of 
STH. Furthermore, a relatively high proportion of children had multiple infections with 
STH even after implementation of two rounds of SBT. This suggests that single annual 
SBT for STH did not significantly reduce transmission, contrary to what other workers 
believe (Truscott et al., 2014b). However, other studies have reiterated that for the 
MDA treatment to interrupt transmission a high drug coverage has to be ensured in a 
wide age groups in the population  (Anderson et al., 2014). In this setting, the drug 
coverage was as high as 80%. Despite this relatively good coverage, the very high STH 
transmission appears to sustain rapid reinfection (Truscott et al., 2014a). Nevertheless, 
overall, many of the children remained with light intensity for any of the STH worm 
over the entire study period. An earlier study conducted by Stoltzfus and colleagues 
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(Stoltzfus et al., 1997) found minimal reduction in prevalence of hookworms (from 
94.5- 89%) and T. trichiura (from 96.7-92%) even after treating children twice/year 
with mebendazole (500mg) in a one year period. The consistent finding of high 
prevalence of these worms in this population clearly indicates an intense transmission 
and rapid reinfection though the likelihood of emergence of drug resistance cannot be 
excluded. A recent study has shown that treatment of children with albendazole alone 
resulted in significantly lower CR against T. trichiura infection compared with oxantel 
pamoate or other drug combinations (Speich et al., 2014). Indeed, it has been confirmed 
in meta-analysis study that ALB has limited efficacy against T. trichiura infection 
(Keiser and Utzinger, 2008). Likewise previous studies carried out in in the same 
epidemiological setting observed low CR of benzimidazoles for the treatment of STH 
but there was no evidence of occurrence of mutation of the beta (β) tubulin gene at 
codon  200 (Albonico et al., 2004b) that is responsible for BZ resistance in animals.  
The overall objective of the PC strategy is to reduce morbidity with the ultimate goal of 
preventing debilitating disease sequelae of chronic STH infection. Thus, in this context, 
maintaining light intensity of STH might be perceived as a positive impact as the STH 
morbidity is directly correlated to intensity.  
4.9.2 Impact of community-based MDA  
Implementation of the schistosomiasis elimination project was concurrently undertaken 
with morbidity control for STH infection through PC. So changes of approach in drug 
delivery in terms of frequency would have an impact on the integrated control of both 
infections directly. As such, in 2012, there was a change of drug delivery approach from 
single annual SBT to biannual community wide MDA. The follow-up study presented 
here was carried out after two rounds of community MDA. The results suggested that 
the MDA led to a moderate reduction in the overall prevalence (to 86.2%) for any worm 
as well as of worm-specific prevalences for A. lumbricoides (34.0%) and hookworm 
(32.1%). T.trichiura infection, however, remained still as high (80.8%) as demonstrated 
before initiation of regular PC treatment (2010). Generally, a high proportion of the 
children had light intensities for any worm but an increase in the proportion of children 
with moderate and heavy intensities for T. trichiura and A. lumbricoides respectively 
was recorded, as compared to baseline. In addition, a substantial proportion of children 
had multiple infections even after two rounds of MDA. The finding of a significant 
decline of the overall prevalences and sustaining a high proportion of light intensities 
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during the course of project implementation is encouraging although the reductions 
were not as high as that reported for other settings (Supali et al., 2013, Oqueka et al., 
2005). However, Supali and colleagues (Supali et al., 2013) assessed the impact after 
several (six) rounds of implementation of MDA whilst the present survey was after just 
two rounds of MDA. Nevertheless, at the time of our survey, considering cumulative 
treatment rounds offered in our setting, the overall rounds of treatment were comparable 
between the two studies. Despite the overall declining of the prevalence of infection 
over the years, still a reasonable proportion of children had double or triple infections. 
The observation of triple infection with STH worms would not be a surprise thing in our 
setting as it more common in Zanzibar, though with varying levels (Knopp et al., 2009). 
There is overwhelming evidence on the impact of the SBT or MDA in terms of 
reduction of prevalence and intensity of STH but it is unlikely that these treatment 
approaches alone could effectively interrupt transmission in schools or communities. 
Nevertheless, continuation of the provision of antihelminthic drugs in school-aged 
children or adults would still be essential to maintain infection at light intensities and so 
to prevent STH negatively affecting the health of the population. Regarding the efficacy 
of BZ drugs, recent multi-centre trials have shown that both ALB (Vercuysse et al, 
2011) and MBZ (Levecke et al., 2015) efficacies are sustained globally. However, the 
very low efficacy of BZs in Pemba, especially against T. trichiura, may warrant more 
in-depth studies to explore the potential occurrence of drug resistance.  
4.9.2.1 Anaemia 
Infections with STH have adverse effect on the health of children; anaemia being one of 
the major problems associated with these infections especially hookworms (Stoltzfus et 
al., 2000, Kung'u et al., 2009). Several hypotheses or mechanisms are linked to the 
development of anaemia in children infected with these worms. For instance, STH are 
associated with mal-absorption, loss of appetite, chronic blood loss (Gilles et al., 1964) 
or haemorrhage which eventually lead to iron deficiency anaemia. The present study 
assessed the level of haemoglobin in school-children as an impact of helminth control 
following several years of PC. At baseline in 2010 the data showed that mean 
haemoglobin concentration in Std-1 children was 11.3 g/dl with overall prevalence of 
anaemia being 56.6%; and a small proportion (1.3%) had severe anaemia (Hb ≤ 7.0 
g/dl). However, during the subsequent follow-up of the Std-1 children (not the same 
individuals) in 2013 after two rounds each of SBT and MDA, the mean Hb 
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concentration of the children has significantly (t = -11.1; p = 0.0001) increased to 11.9 
g/dl and that, inversely, the proportion of children with anaemia was significantly 
reduced from 56.6 to 38.2% (z = 10. 3; p = 0.0001). Nevertheless our baseline data (on 
anaemia) was somewhat lower than that observed by (Mwandawiro et al., 2013) in 
nearby Kenya in a similar epidemiological setting, albeit based on a smaller sample size 
(the Kenyan study examined only 492 children). Nonetheless, the observation of the 
reduction in the prevalence of anaemia and the gain in Hb concentration is promising 
and may indicate a positive impact of the control measures. However, it would be 
difficult to conclude that this achievement was a direct impact of deworming alone and 
other factors may have contributed, as many diseases and conditions are implicated in 
causing anaemia (Brooker et al., 2008). To assess confounders of anaemia, in this 
present study (at least at baseline) it was determined that malaria parasite prevalence 
and intensity in the children was very low (data not shown) but other possible causes of 
anaemia were not explored in the study. 
There is overwhelming evidence on the relationship of anaemia and STH infection 
(Brooker et al., 2006a). We present here anaemia data as a possible consequence of 
helminth infection and in relation to its control. In this study there was slightly higher 
percentage of children with anaemia who were infected with A. lumbricoides compared 
with those who were not and this difference was statistically significantly and also there 
was increasing odds of anaemia in A. lumbricoides infected children. However, no 
significant difference in prevalence of anaemia was seen for T. trichiura or hookworm 
infected children. Interestingly, the association of anaemia with A. lumbricoides 
infection was only apparent at baseline but not during the subsequent follow-up. At that 
period none of the STH worm infection was associated with anaemia. This may be due 
the fact that most infections were light and development of anaemia has been clearly 
shown to be strongly correlated with intensity of infection (Brooker et al., 2008, 
Stoltzfus et al., 2004). Development of anaemia is also crucially dependent on iron 
intake and so another possible explanation could be that the children are now better 
nourished. So, albeit the development of anaemia is a complex and multifactorial 
process the improvement in haemoglobin concentration in children living in areas where 
STH infections are prevalent could be considered a positive impact and, although not 
specific to STH, an indicator of success of the ZHCP. 
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Chapter 5 Assessment of the coverage, compliance and 
attitude to mass drug administration intervention for the 
control of STH and schistosomiasis 
 
5.1 Introduction 
Schistosomiasis and soil transmitted helminthiasis (STH) caused by Ascaris 
lumbricoides, Trichuris trichiura and hookworms pose a great disease burden in 
tropical and sub-tropical countries resulting in growth retardation during childhood, iron 
deficiency anaemia, malnutrition and poor school performance (Stephenson and 
Holland, 1987, Hotez et al., 2004). On the other hand these infections are associated 
with decreased economic productivity in the adult population (Taylor-Robinson et al., 
2012). 
Periodic administration of anthelminthic drugs to populations at risk can revert most of 
the morbidity and prevent the chronic debilitating consequences related to schistosomes 
and STHs infections if administered correctly and in a timely manner (Richter, 2003, 
Savioli et al., 2004b, Simeon et al., 1995).This strategy has been recently branded as 
“preventive chemotherapy” (PC), often referred to as deworming, and has been 
recommended as the cornerstone of control strategies (Who, 2002, Taylor-Robinson et 
al., 2012, WHO, 2006). So far two common approaches: 1) school-based treatment 
(SBT) 2) community wide treatment (CWT) or mass drug administration (MDA) are 
being employed for preventive chemotherapy (Massa et al., 2009a).  Mathematical 
modelling has shown that treatment of school-aged children significantly reduces 
morbidity and may interrupt schistosomiasis transmission to the level of elimination 
(Carabin et al., 2000). Despite this potential, for these strategies to yield maximum 
impact in helminth control, attention must be paid to optimum coverage and community 
compliance (Massa et al., 2009b, Prichard et al., 2012, Mathieu et al., 2004, Worrell and 
Mathieu, 2012). This postulate comes from the fact that if a proportion of the 
individuals within the community remains untreated they act as reservoir of the 
infection (Nandha et al., 2013). The key question is what level of coverage is necessary 
for effective intervention. In an attempt to eliminate lymphatic filariasis (LF) during the 
era of the Global Program on Elimination of Lymphatic Filariasis (GPELF), an 
estimated 65->80% treatment coverage with 5-6 rounds of MDA was considered 
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sufficient to achieve interruption of transmission and eventually elimination 
(Mohammed et al., 2006, Cantey et al., 2010, Nandha et al., 2013). Since control of 
schistosomiasis and STH uses a similar strategy (preventive chemotherapy) to that of 
LF, at least 75% of treatment coverage for the population at risk (school-age children) is 
the target set by WHO for morbidity control (WHO, 2006). 
The drugs used for preventive chemotherapy against STHs and schistosomiasis are 
administered as a single dose (Albendazole [ALB] - 400mg/ Mebendazole 500 mg and 
Praziquantel [PZQ] 40mg/kg) in order to sustain compliance (adherence) for a 
successful chemotherapy-based control strategy. However, there is limited data related 
to coverage and compliance in the use of ALB or PZQ for MDA campaigns against 
STH infection and schistosomiasis. Studies were, however, carried out to assess MDA 
compliance for the elimination of LF mentioned above. This demonstrated that clients 
not realising the importance of taking the drugs, unfavourable provider’s attitude, 
unacceptability of drug distributors (Nujum et al., 2012), and uncertainty of side effects 
(Sunish et al., 2013) were among the factors associated with non-compliance. In another 
study that assessed factors associated with participation in an MDA campaign against 
lymphatic filariasis it was shown that knowledge on the mode of the disease 
transmission (Mathieu et al., 2004), age and sex (Babu and Kar, 2004) and social 
mobilisation strategy (Nandha et al., 2013) were significantly associated with MDA 
compliance. Coverage is a key performance indicator of PC control programmes and is 
the most important data that is required to demonstrate success of such a Programme 
(WHO, 2010). Mass drug administration has been the common approach utilized in 
chemotherapy-based control for schistosomiasis and STHs infection. This delivery 
mechanism is found to be most cost-effective (Lo et al., 2015, Turner et al., 2016, Leslie 
et al., 2011) and has shown a great impact in terms of reduction of disease morbidity as 
well as interruption of disease transmission (Truscott et al., 2014a). However, there 
remains a paucity of information related to coverage and compliance of PC drugs (PZQ 
and ALB) administered in mass campaigns against schistosomiasis and STH infection. 
Zanzibar embarked on MDA treatment for helminth control since 2001 at the time of 
implementation of GPELF where co-administration of ivermectin (IVM- 200mg/kg) 
and ALB (400mg) was delivered to the eligible population excluding children <5yrs, 
pregnant women, lactating mothers at first week and ailing chronic patients, once a year, 
for a period of 5yrs (Mohammed et al., 2006). Parallel to that, in 2004, morbidity 
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control of schistosomiasis and STHs through the support of the Schistosomiasis Control 
Initiative (SCI) was launched. In the latter programme ALB (400mg) and PZQ 
(40mg/kg) were co-administered in the communities as MDA using the platform 
established for elimination of LF. In 2006 there was shift of approach from community-
based MDA to school-based treatment with the provision of the same regimen to all 
primary school-children aged between 7-15yrs. Since then there had been sporadic 
implementation of diverse helminth control programmes up to 2010. Subsequently, with 
the current ambitious goal of elimination of schistosomiasis - twice yearly co-
administration of ALB and PZQ was implemented and included even younger children 
(≥3yrs) (Knopp et al., 2012). Despite the importance of coverage11 and compliance12, 
these factors had not been assessed previously in PC for schistosomiasis and STH in 
Zanzibar. Therefore, the studies described below were undertaken to provide data on 
these variables during the new ZNCP/SCORE initiatives.” 
 
5.2 Results 
Coverage and compliance was studied during the 2nd round of MDA in the 
ZNCP/SCORE undertaken in November 2012. 
5.2.1. Assessment of coverage 
This was assessed from data collected across the whole of the Pemba. Overall, a total of 
448891 individuals were registered during initial CDD house visits but only 362255 
(80.7%) of them were treated. However the majority, 36490 (42.1%), of the untreated 
individuals were children who, during the allocation of drugs by visiting CDDs, were 
deemed to be ineligible for treatment because they were found to be aged <3yrs or 
below the with shorter height for determining drug dose according to  the estimated 
height indicated on the dose pole The remainder of the untreated individuals had other 
reasons including moving (19716 [22.8%]) from their actual residence (19716 [22.8%]), 
being pregnant (4697 [5.4%]), breastfeeding (3898 [4.5%]) or being chronically ill 
                                                 
11
 Coverage is defined as the percentage of individuals in a given population that received drug or drug 
combination in an intervention area. 
12
 Compliance (sometimes referred to as adherence) is a term used to denote a degree to which a client 
correctly follows advice. In this study it indicates how correctly the individuals followed instructions 
from drug distributors. 
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(2519 [2.9%]) at the time of drug delivery. Others, (22.3%), refused to accept the drugs 
from CDDs. 5.4.2 Geographical coverage. Figure 52 illustrates drug distribution 
coverage across the various Pemban districts. This shows that Chake-chake district had 
the lowest drug coverage as compared to other districts. Similarly, Chake-chake had 
high proportions (69.4%), (39.1%), (46.1%), (41.7%) of those individuals denied the 
drugs from CDDs, moved from their locations, breastfeeding and those that had chronic 
illnesses, respectively (Figure 53). The reasons for the overall lower coverage and 
increased proportion of individuals who did not take the drugs for various reasons at 
Chake-chake district are unclear but increased population movement due to the presence 
of many government offices and businesses along with temporary mobile residences 
may have roles in this.  
  
Figure 52: Level of drug coverage across different districts in Pemba achieved during 
MDA in 2012 
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It is also notable that there was a very low drug refusal rate. The reasons for this were 
not obvious. Drug coverage data for individual shehias is not presented here but will be 
analysed further.  
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Figure 53: Distribution of individuals not taking the drugs provided during MDA in 
Pemba for various reasons in 2012 
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5.3.1 Assessment of Compliance 
Following drug distribution, a post mass drug administration (MDA) survey was 
undertaken in 15 shehias in Pemba to assess possible factors involved in 
compliance/non-compliance and potential adverse events (AE). A total of 1464 
individuals were enrolled in the study. Among these 679 (46.4%) were male and 785 
(53.6%) were female. The individuals had a mean age of 30.4yrs (95%CI: 29.6-31.2) 
with a range of 10-91yrs. Table 11 illustrates the shehias participating in the survey.  
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Table 11: List of shehias involved in the post MDA survey 
  S/No   Shehia name    No .participants 
1   Chokocho    100 
2   Kangagani    100 
3   Kizimbani    101 
4   Kojani     93 
5   Konde     99 
6   Makangale    100 
7   Mgelema    99 
8   Michenzani    99 
9   Mjini Wingwi    100 
10   Mtangani    78 
11   Muambe    97 
12   Shengejuu    102 
13   Shumba mjini    99 
14   Wawi     99 
15   Wesha     98 
     
5.3.2 Drug compliance 
5.3.3.1 Praziquantel compliance 
For this analysis only 1438 (98.2%) of the enrolled individuals are included as there was 
an inconsistency between the number of tablets given and does reported as that taken. 
Of these, 146 (10.2%) were non-compliant to PZQ. These individuals were either did 
not take the drug at all or did not take the prescribed amount of tablets provided to them 
or did not take the drugs according to the WHO guideline. Overall there were 58 (8.8%) 
males and 88 (11.3%) males and females who respectively that were non-compliant to 
PZQ, the difference not being significant. Although, further analysis revealed that there 
was no association of PZQ non-compliance between sex (χ2 = 2.6 df 1; p = 0.1). 
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5.3.3.2 Praziquantel compliance in relation to districts 
Figure 54 indicates the proportions of individuals non-compliant to PZQ in relation to 
the districts. Quite marked differences in compliance for the different areas were seen, 
being high in Mkoani and lower in Chake-chake and Wete. The reasons for this were 
not apparent.  
Figure 54: Proportion of individuals non-compliant to praziquantel drug 
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5.3.3.3 PZQ compliance in relation with age group 
This analysis includes only 1431 (97.7%) of the enrolled individuals as unfortunately 
for some of them age was not recorded. Interestingly the percentage of individuals non-
compliant to PQZ was generally similar between the different age group (Figure 55). 
Although, was slightly lower in the age group between 16-20yrs. 
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Figure 55: Proportion of individuals non-compliant to PZQ in different age group 
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5.3.3.4 Compliance with PZQ relative to knowledge on schistosomiasis and its risk 
behaviours. 
Drug compliance was also assessed in relation to the treated individual’s knowledge 
about schistosomiasis and its associated risk behaviours which was considered might 
influence drug uptake to individuals given the drugs in mass treatment campaigns. Of 
the 1462 respondents, 1067 (73%) were aware of schistosomiasis. However, this did not 
significantly alter compliance (110 [(10.5%]) compared to 35 [9%] non-compliant to 
PZQ. Indeed, it shows that there is no statistical association between schistosomiasis 
awareness and PZQ compliance (χ
2 = 0.74, df 1; p = 0.3).  
Further analysis of PZQ compliance in relation to awareness of previous treatment for 
schistosomiasis revealed that among 1437 responded regarding previous treatment for 
the disease, 881 (61.3%) reported had never having been treated, 540 (37.6%) reported 
having been treated and 16 (1.1%) were unaware i.e. they did not know if they had 
previously received treatment for schistosomiasis. Overall, 63 (7.3%), 80 (15.1%) and 2 
(12.5%) of those reported to be previously untreated, treated and unaware (who did not 
know if treated for schistosomiasis) respectively, were non-compliant to PZQ and this 
was statistically significantly by Chi square (χ2 = 22.1, df 2; p = 0.0001), although, in 
univariate analysis using a logistic regression model, it revealed that there was no 
significant association between PZQ non-compliance and having being treated 
previously (odds ratio [OR] =1.0; 95%CI = 1.0-1.01; p = 0.6).  
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Regarding compliance in relation to previous haematuria, 1446 individuals responded 
on whether they had ever experienced haematuria during their life time. Among those 
1211 (84.8%) reported never having had haematuria, 225 (15.6%) reported having had 
haematuria and 10 (0.7%) were unaware of ever having experienced haematuria. Of 
those who had not experienced haematuria, 113 (9.5%) were non-compliant to PZQ. 
Similarly, among those having experienced haematuria, 29 (13.2%) were non-compliant 
to PZQ. Interestingly, none of the individuals unaware of having haematuria were non-
compliant to PZQ, although the actual number of respondents in this category was very 
low. There was no association between experiencing with haematuria and compliance to 
PZQ (χ
2 = 3.9 df 2; p = 0.1). 
With regards to health status of the individuals prior to MDA medication, of the 1433 
respondents with a compliance record, 1317 (91.9%) had good health and 116 (8.1%) 
were unwell. Among those with good health, 130 (10%) were non-compliant to PZQ. 
Similarly, of those who were unwell, 14 (12.1%) were non-compliant to PZQ. Further 
analysis reveals no significant association between PZQ compliance and health status 
(χ
2= 0.6, df 1; p = 0.5). Additionally, individuals were asked if they had had any of the 
NTD diseases controlled through MDA (STH, schistosomiasis or LF) during their 
lifetime. Of the respondents, 215 (16.6%), 1046 (81%) and 31 (2.4%) reported to have 
any of those diseases, not having the disease or did not know, respectively. This was 
significantly associated with non-compliance according to Chi-square analysis (χ2 = 6.0, 
df 2; p = 0.05). When looking specifically at schistosomiasis, the proportion of PZQ 
non-compliants were 9.9% for those without disease, 14.4% for those had disease and 
19.4% for those did not know. Nevertheless, logistic regression analysis did not 
demonstrate a significant association between having the NTD disease and non-
compliance to PZQ (OR =1, 95%CI for the OR =1.0-1.001; p = 0.1). 
5.3.4.1 Albendazole compliance 
 For logistical reasons similar assessment of drug uptake in relation to knowledge of 
risk factors associated with transmission of STH, and of previous treatment history with 
albendazole was not studied. This analysis only focused with compliance with 
albendazole distributed during the MDA. 
The same number of individuals (1438) included in the analysis of PQZ compliance is 
also used in the analysis of ALB compliance. Of those, only 36 (2.5%) were non-
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compliant to ALB. The percentage of males and female who did not comply was 
comparable (3.0% [males] vs. 2.1% [females]).  Non-compliance to ALB was not 
associated with sex (χ
2 =1.2 df 1; p = 0.2).  
5.3.4.2 Albendazole compliance in relation to districts 
With regards to the analysis of ALB compliance in relation to the districts, it was found 
that Wete district had the highest proportion (6.5%) of non-compliance as compared to 
other districts. The proportions of ALB non-compliance for other districts were 1.7% 
and 1.5% for Chake-chake and Micheweni respectively and 0% for Mkoani district. The 
reasons for this small difference in non-compliance rate across the districts are unclear 
and could be difficult to establish but the most plausible reasons could be greater 
awareness and self-motivation.  
5.3.4.3 ALB compliance in relation to age group 
Figure 56 shows the non-compliance to ALB. The figure indicates that the percentage 
of individuals non-compliant to ALB was broadly comparable between different age 
groups although it was slightly higher in the 21-30yr age group.  
Figure 56: Proportion of individuals non-compliant to ALB in different age groups 
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5.4 Adverse Events 
The analysis of adverse events13 (AE) included 1449 (99.0%) out of 1464 individuals 
enrolled. Among those, 192 (13.3%) reported experiencing AE. The list of different 
AEs shown to participants is illustrated in Table 12.  
Table 12: Number of individuals experiencing different adverse events (side effects) 
during MDA.  
______________________________________________________________________ 
 Signs/Symptoms  No. individuals with AE   (%) 
Dizziness     123    (9.3) 
Sleepy     35    (2.8) 
Abdominal pain   42    (3.4) 
Nausea    66    (5.3) 
Diarrhoea     5    (0.4) 
Sweating     5    (0.4) 
Low back-pain   3    (0.2) 
Headache     56    (4.5)  
Tiredness    43    (3.4) 
Cramp     6    (0.6) 
Vomiting    11    (0.9) 
Blood in faeces   1    (0.1) 
Night fever    2    (0.2) 
Numbers in parentheses are percentages. 
From this table it is clearly observed that there were small proportions of individuals 
who experienced one or more adverse event as a result of consumption of the drugs. 
However, it was not established which among the two drugs was associated with those 
signs/symptoms. The majority (103 [62.0%]) of individuals experiencing any AEs 
reported symptoms happening during the first day of drug distribution and only a few 
                                                 
13
 Adverse Event is defined as medical incident that takes place following receiving of medical 
intervention (such as drug(s) or vaccination) that is suspected to be, but it is not necessarily - caused by 
the medicine used in the intervention”. 
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individuals reported onset of AE between the second day and one week after drug 
distribution. All AEs resolved without requiring any medical attention. No perceived 
life-threatening AEs were observed during the campaign. 
 154 
 
5.5 Discussion 
5.5.1 Drug Coverage  
This is the first study to be conducted in Zanzibar since 2006 that analyses in some 
detail the National coverage of an NTD Control Programme. Analysis of the National 
data set for coverage as reported by CDDs, showed high drug coverage overall (80.7%) 
but there were quite marked differences between the districts (69.3-88.2%). Notably, 
Chake-chake district had the lowest coverage rate with the lack of coverage due to: a 
high proportion (69.4%) of the overall individuals refusing the drugs from CDDs; 
having moved (39.1%) from their residence; high pregnancy rate (46.1%) and chronic 
illnesses (41.7%). In contrast, in Mkoani district<2% of individuals either denied the 
drugs or had moved from their residence. The reasons for the overall lower coverage 
and increased proportion of individuals who did not take the drugs for various reasons 
at Chake-chake district are unclear but increased population movement due to the 
presence of many government offices and businesses along with temporary residences 
may have a role in this. Other studies have reported that individuals living in the urban 
settings are most likely to resist treatment -resulting to lower coverage than in the rural 
areas (Ranganath and Reddy, 2012). Although the entire Pemba Island is considered as 
rural, it is certainly that case that Chake-chake is the most “urban” area of the island. 
The possible explanations for motivation or de-motivation of individuals to accept drugs 
during MDA have been considered by others. In some countries, political persuasions 
(Parker and Allen, 2013), misconceptions about the drugs delivered under MDA 
(Joseph et al., 2011), mistrust of international aid, relationships between CDDs and the 
drug recipients, and other social aspects have been linked with low coverage (Parker 
and Allen, 2013).  
In spite of the regional variation in coverage, the overall finding of 80.7% coverage is 
encouraging as it is higher than that found is some other studies e.g. in the Philippines 
(48.3%) and Kenya (58.2%) (Tallo et al., 2008, Mwinzi et al., 2012). However, these 
latter studies were more restricted than the current one which involved 121 shehias with 
several villages whilst the Philippine and Kenyan studies covered only 50 and 25 
villages, respectively. In fact, in this setting, most of the CDDs have been repeatedly 
involved in the distribution of PC based drugs, PZQ and ALB, during MDA campaigns; 
hence they have gained reasonable knowledge, experience and became more organised 
 155 
 
and accepted in the communities. These reasons have, perhaps, contributed to higher 
coverage rate demonstrated in this study. 
Despite the apparently high coverage achieved it should be noted that the drugs were 
delivered house-to-house but the actual swallowing of the drugs was not witnessed as 
direct observed therapy (DOT) was not incorporated in the programme. Therefore, it is 
unverified whether this programme coverage coincided with therapeutic coverage (i.e. 
the proportion of individuals who swallowed the drugs). Since drug taking was not 
witnessed it is possible that a considerable number of individuals were untreated and 
hence increase the potential of disease transmission.  Furthermore, there is evidence that 
it is challenging to obtain the comprehensive understanding of the proportion of adult 
population who were taken the drugs delivered under MDA (Parker and Allen, 2013). 
The unexpected low drugs coverage experienced in community-based treatment during 
MDA campaigns has raised concerns over the effectiveness of this strategy particularly 
if schistosomiasis elimination is targeted (Tallo et al., 2008). 
Since helminth control using MDAs is likely to continue in Pemba, consideration must 
be given to possibilities to improve coverage further. In particular consideration should 
be given to the reasons for the poor coverage in certain shehias. Certain causes, notably 
population mobility, as observed in Chake-chake, are more difficult to overcome but 
other aspects related to compliance could perhaps be improved. Further work could be 
done to establish possible reasons associated with low coverage in subsequent MDAs. It 
is relevant that studies have demonstrated that SBT usually attain high drug coverage as 
compared to community-based treatment (Kabatereine et al., 2006, Mwinzi et al., 2012). 
For example, in Uganda, coverage of 91.4% in schools compared with 64.7% in 
communities has been demonstrated (Kabatereine et al., 2006). Other studies have 
suggested that community sensitization i.e. meeting with community members to 
discuss about MDA program aiming at increasing their awareness regarding the target 
disease, impact of the intervention(s) or any expected side effects would improve 
coverage (Fleming et al., 2009). Unfortunately, in this setting, community sensitization 
directed towards MDA, in most cases, has not been undertaken comprehensively.  
The studies on compliance discussed below were intended to give further insight into 
coverage issues.  
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5.5.2 Drug compliance - PZQ 
There is overwhelming evidence that for chemotherapy based control strategies such as 
that implemented for schistosomiasis and STH infections, compliance (adherence) to 
treatment is fundamental for ensuring and sustaining good coverage (Joseph et al., 
2011). In this study we have assessed compliance with single dose ALB and PZQ 
delivered through an MDA campaign complemented by other control measures in 
fighting against STH infection and schistosomiasis that are currently underway in 
Zanzibar. Overall, 10.2% of individuals were found to be non-compliant to PZQ but 
there was remarkable variation between the districts similar to what has been detected in 
coverage. The reason for the lower proportion of PZQ non-compliance observed in 
Mkoani district is unclear but could be related to the high prevalence of schistosomiasis 
infection there resulting in increased awareness of the consequences of the infection. As 
described previously, there is limited data regarding compliance to PZQ and ALB in the 
context of MDA but other studies have demonstrated similar figures i.e.11.1% and 
14.7% for non-compliance to PZQ syrup and tablet formulation respectively 
(Navaratnam et al., 2012). Nevertheless, the latter study was carried in young children 
aged between 1-5yrs who are likely to be distracted and ready to cry resulting in non-
compliance. Other factors have been related to poor compliance in the wider age range 
such as the characteristic nature (choking smell, size of the tablet and taste) of PZQ, fear 
of the occurrence of side-effects (Cao et al., 2011) mistrusting of dose pole (as measures 
height instead of weight) to define dosage (Fleming et al., 2009, Parker et al., 2008, 
Parker and Allen, 2011). The fear of development of side-effect of drugs, for instance 
PZQ, has been associated with low compliance (Woelfle et al., 2011, Parker et al., 2008, 
Fleming et al., 2009).  
As mentioned it has been hypothesized that side-effects resulted from ingestion of PZQ 
can hamper compliance (Cao et al., 2002). In this current study investigation of side-
effects related to consumption of PZQ revealed a wide range of symptoms. Dizziness, 
abdominal pain, nausea, headache and tiredness were the frequent symptoms 
experienced by most individuals. The less frequent treatment-attributed symptoms were 
bloody diarrhoea, sweating, abdominal cramp, vomiting and night fever. None of these 
symptoms persisted or threatened an individual’s life or led to hospitalization. The side-
effects reported here correspond to those described  by other workers (Erko et al., 2012, 
Berhe et al., 1999, Garba et al., 2013) and are reported to be avoided if the drug is taken 
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along with food (Muhumuza et al., 2015). In addition, our study population has been 
subjected to several rounds of PZQ and ALB treatment and given the low intensity of 
helminth infection, side effects which are mainly due to the allergens of dying of 
parasites, were minimised compared to naïve endemic areas with high intensity of 
schistosomes and STH infections (WHO, 2011a). 
It was postulated that knowledge of the disease (transmission or signs and symptoms) 
would increase drug compliance, however; this was not necessarily the case in the 
current study which showed overall 10.5% of those with knowledge of schistosomiasis 
were non-compliant to PZQ. Possibly such individuals did not see treatment as 
important for them for different reasons including apparent absence of the disease or not 
considering themselves as exposed to the infection in terms of engagement with risk 
behaviour for the disease. This might in fact be more or less true as the MDA is carried 
in the whole community regardless of infection status and to all individuals at risk of 
infection. The linkage of the absence of overt disease and non-compliance to drugs has 
been demonstrated by other workers (Christensen, 1978). The proportion of individuals 
who were unaware of schistosomiasis and were non-compliant to PZQ was comparable 
to those with awareness and there was no association of awareness of schistosomiasis 
and compliance. These findings are in agreement with those observed by (Nujum et al., 
2012) and  highlighted the need for increasing and consolidating efforts focusing on 
awareness campaigns and the importance of treatment among the community members. 
MDA directed to the control of schistosomiasis focuses on a wide population at risk of 
infection, although, the infection is predominantly found in school-children aged 
between 5-15yrs. Awareness of this age/intensity relationship might increase sentiments 
and beliefs among the adult population that they are free of infection and so more likely 
to be non-compliant to treatment. Greatest compliance was found in the age-group 16-
20yrs (93%) but lower again for the younger age-group (≤15yrs). It is possible that this 
younger age group were influenced by their elders who were not compliant as it is very 
likely that if parents resisted treatment they may also be unwilling for their children to 
be treated. Overall, these results are not in agreement with those observed by (Brieger et 
al., 2011) and (Abd Elaziz et al., 2013) who found high compliance rate among 
individuals’ ≥24yrs of age. Further, wider, study would be needed to confirm if the age 
pattern reported above is true and to establish the reasons if so. 
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5.5.3 Drugs compliance - ALB 
Schistosomiasis and STH infection usually co-exist in most schistosomiasis-endemic 
countries and for this reasons WHO has urged endemic countries to take advantage of 
integrated implementation to control more than one NTD with the PC strategy (WHO 
2011). Unlike schistosomiasis where in some countries like in Zanzibar there is an 
attempt towards eliminaton, the objective for STH remains  morbidity control through 
provision of BZ derivates. Todate, in many endemic countries, ALB is the most 
common antihelminthic drug used for STH morbidity control based on its efficacy 
against a variety of STH species. Currently, Zanzibar is focussed on controlling STH 
using MDA including administration of ALB, and therefore the assessment of drug 
compliance is of utmost importance. This is believed to be the first study carried out in 
this setting to assess compliance of individuals towards PC-based control for STH. 
Overall, a high ALB compliance rate (97.5%) was found across the island  with some 
district (Mkoani) reaching 100%. The particularly high compliance rate for ALB 
relative to PZQ is believed to be related to: the relatively sweet and aromatic smelling 
characteristic nature of ALB, the fact that treatment involves taking a single tablet, less 
fear for the development of side-effects, and awareness of the higher prevalence of STH 
infection in the societies.  
This present study found an overall very promising coverage in the MDAs running in 
Pemba. However, the lower than average coverage in some areas may hamper acheiving 
the expected program goal, interruption of disease transmission and ultimately 
elimination. Furthermore there was a significant proportion of individuals who did not 
take the drugs for various reasons highlighting the need to strengthen community 
mobilization strategies so as to increase coverage and adherence and hence eliminate 
residual untreated individuals. Additionally further studies are required to establish the 
demotivation factors associated with low coverage. 
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Chapter 6 Investigation of the transmission of S. 
haematobium infection in infants <6yr  
 
6.1 Introduction  
Studies have demonstrated that in endemic countries, school children aged between 5-
15yrs are the most infected population (Hotez et al., 2006a) and harbour heavy disease 
burdens (Chan et al., 1999, Betson et al., 2010). Thus, control efforts to combat the 
disease are focused in this age group (Betson et al., 2010). However, a few studies have 
indicated the importance of schistosomiasis in young children before the age of school. 
Most of these have been concerned with S. mansoni infection e.g. in a study carried out 
in Uganda, it was shown that 27.2% of pre-school children (mean age 3yr, range 4 
months to 6.5yr) had infection (Betson et al., 2010). However, a study on S. 
haematobium was conducted in Mali and found that 51.2% of the pre-school children 
(mean age 2.9yr, range 1-4 years) were infected (Dabo et al., 2011). For decades, 
Zanzibar has been identified as an endemic country for S. haematobium infection but 
only one small study has been carried out in preschool children there, on the Island of 
Unguja, and it showed a very low prevalence (3.9%). No such study has been carried 
out in Pemba and so the aim of this work was to assess the prevalence of S. 
haematobium infection in a relatively large cohort of pre-school children so as to inform 
decisions on the target population for the introduction of the ZNCP/SCORE MDA 
described above.  In parallel to the parasitological testing, a further sub-study involved 
assessing the use of haemastix for diagnostic and morbidity indications in this infant 
population. 
It was also of interest to get some insight into the likely circumstances associated with 
exposure to schistosome infection in the infants and so information was gathered from 
the mothers by means of a questionnaire. 
6.2 Results  
6.2.1 Assessment of the prevalence and intensity of S. haematobium in infants  
A community survey was carried out in pre-school children living in seven shehias 
around the cohort 24 schools (|Chapter 3: survey_1) found to have high schistosomiasis 
transmission. The list of the Shehia with the number of children enrolled is shown in 
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Table 13. A total of 911 children were enrolled in the study. The children were aged 
between 24-71months (mean 3.8 yrs, median 4yrs) according to birth 
certificate/reported age by parents.  Amongst the children 407 (44.7%) were girls and 
504 (55.3%) were boys. 909 (99.8%) of the children produced urine samples.  
Table 13: List of Shehias surveyed for determination of schistosomiasis in pre-school 
children in Pemba 
 
 Shehia    N    (%)  School surrounded 
______________________________________________________________________ 
 Chambani      132         (14.5)  Chambani 
Kiuyu Minungwini    131  (14.4)  Kiuyu Minungwini 
Mgagadu             131       (14.4)  Mizingani   
Mtambile          129  (14.2)  Mtambile 
Piki       130  (14.3)  Piki 
Uwandani        130    (14.3)  Uwandani 
Ziwani                      128  (14.1)  Ziwani 
 
6.2.2 Prevalence of infection 
Schistosomiasis was found in 64 (7.04% [95%CI = 5.3-8.7]) of the 909 children (2/150 
[1.3%] in the age range 24-35 months, 7/208 [3.4%] (aged 36-47 months), 18/258 [7%] 
(aged 48-59) and 37/256 [14.4%] (aged 60-71 months).  Among the enrolled boys, 37 
(7.3% [95%CI = 5.1-9.6]) had schistosomiasis compared to 27 (6.7% 95%CI = 4.2-9.1]) 
girls. The infection rate clearly increases with age as shown in Figure 57.  
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Figure 57: Prevalence of schistosomiasis in different age ranges 
24
-3
5
36
-4
7
48
-5
9
60
-7
1
0
2
4
6
8
10
12
14
16
18
20
Age in Months
P
re
va
le
n
c
e
 (
%
) 
o
f
s
c
h
is
to
s
o
m
ia
s
is
 
When comparing schistosomiasis between different villages, Uwandani had the highest 
prevalence as shown in Figure 58 whilst other areas showed very low prevalences. This 
pattern generally reflects the prevalences also seen in school-aged children (Chapter 3). 
 
Figure 58: Prevalence of schistosomiasis in under 3-5yrs children in the seven shehias 
of Pemba 
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6.2.3  Intensity of schistosomiasis  
Among the infected children, 14 (21.9%) and 50 (78.1%) had severe and light infections 
respectively. The children with light infection had a mean egg count of 12.1 ± SD 10.7 
eggs/10ml of urine (range: 1-46 egg/10ml) while those with severe infection had a mean 
egg count of 185.3 ± SD 175.1 egg/10ml of urine (range: 50-700 egg/10ml of urine). 
Severity of infection was not statistically associated with sex (χ
2 = 0.30 p = 0.57) (35.7 
[female] vs. 64.3% [male]). The percentages of severe infections in each of the age 
bands were: 2yr – 0%; 3yr – 7.1%: 4yr – 42.9% 5 yr - 50%. 
6.3 Performance of hemastix for detection of schistosomiasis and evaluation of 
morbidity (haematuria) in pre-school children 
The presence of micro-haematuria was also analysed and its performance for diagnosing 
schistosomiasis in young children was compared against the gold standard method, 
microscopy (Table 13). 
 
Table 14: Comparison of urine filtration and haemastix for schistosomiasis diagnosis in 
children 
 Haemastix 
Microscopy +ve -ve Total Sensitivity Specificity PPV NPV 
+ve 50 14 64 78.1 96.4 62.5 98.3 
-ve 30 814 847     
Total 80 828      
 
Of the samples examined, 815 were true negatives (detected negative by the two 
methods), 14 were false negatives (detected as negative by haemastix method alone), 30 
samples were false positive (detected as positive by haemastix method alone) and 50 
were true positive (detected as positive by the two methods). The sensitivity and 
specificity of the haemastix for the detection of S. haematobium infection in young 
children was 78.1% and 96.4% respectively. Additionally, the positive predictive value 
(PPV) for haemastix was 62.5% and negative predictive value (NPV) was 98.3%. The 
detection rate difference between haemastix and microscopy was -1.8% (95%CI= 0.2—
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3.2). There was a statistically significant difference in the diagnosis of schistosomiasis 
between the two methods (McNamara’s χ
2 = 5.8 p = 0.01). The detection of haematuria 
as indicated by haemastix demonstrates a significant level of morbidity in these young 
children. 
 
6.4 Investigation of risk factors for infant infection by questionnaire to mothers.  
The mothers or guardians of the children enrolled in the survey were questioned about 
the risk behaviours leading to transmission of schistosomiasis to their children. The 
questionnaire used is shown in the Appendix 6.1. A total of 911 mothers/guardians were 
enrolled. The mothers/guardians had a mean age of 32.1yrs with a range of 15-70 yrs 
(median 30yrs). Among the mothers/guardian enrolled, 9 (1%) had higher education 
(finished college/university), 229 (25.2%) had secondary education, 293 (32.2%) had 
primary education, 339 (37.3%) had Koranic knowledge alone and 40 (4.4%) were 
illiterate. Interestingly none of the child whose mother/guardian had higher education 
was infected with schistosomiasis although this relates to just 9 mothers. Of the children 
whose mothers/guardians had Koranic knowledge alone, were illiterate, had primary or 
secondary education, respectively, 26 (7.7%), 3 (7.5%), 23 (7.9%) and 12 (5.2%) were 
infected with schistosomiasis. Based on this data there was no statistically significant 
association with educational experience (χ2 = 2.4 p = 0.67). Surprisingly, the majority 
of mothers/guardians of the infected infants (58 [90.6%]) had heard about the disease 
and indeed there was no significant difference in infection prevalence whether the 
mothers reported knowing how the disease is transmitted or not (Table 15). However, 
Table 15 also clearly demonstrates the heightened risk from water contact but the data 
did not identify any significantly greater risk associated with different types of water 
contact and did not establish a link with frequency of water contact.  
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Table 15: Risk behaviours of the mother/guardians associated with transmission of schistosomiasis  
 Risk factor    N   %  Children infected    Children not infected 
               N         %  N    %  OR         P 95%CI 
Knowing how disease is transmitted  
 Yes     376  41.5  28         7.45 348 92.55 1.1 0.69  0.7 - 1.9 
 No     532  58.5  36          6.8 496 93 
Use pond/stream water for washing utensil  
 Yes     250     27.6      31        12.4 219 87.6 2.67 0.0001    1.6 - 4.5 
 No     656  72.4  33         5.03 623 94.97 
Use pond/stream water for washing clothes 
 Yes     453  49.9  46       10.15 407 89.85 2.7 0.0003    1.6 - 4.8 
 No     455  50.1  18        4  437 96 
Go to pond/stream with their children 
 Yes     358  39.4   47       13.1  311 86.9 4.7 0.00001    2.6 - 8.5 
 No     550  60.6   17        3.1  533 96.9 
Frequency of going to pond/stream with their children 
 Every day    160  17.7  22      13.75 138 86.25 0.8 0.8    0.07 – 6.6  
 Once/week    9  1  1      11.1  8 88.9 
 Twice/week    90  10  10       11.1 80 88.9 
 Whenever possible   644  71.3   31       4.8  613 95.2   
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6.5 Discussion 
The current efforts toward controlling schistosomiasis are largely focused on school-
aged children and national control programmes in endemic countries have not involved 
pre-school children in the treatment campaigns. This has been attributed to (i) 
insufficient convincing prevalence data as well as safety records on the use of 
praziquantel in this age population; (ii) practicality and (iii) speculation that younger 
children are infrequently in contact with freshwater bodies (Mutapi et al., 2011). With 
recent safety data together with modification of the dose pole used for the delivery of 
praziquantel (Sousa-Figueiredo et al., 2010b) there has been a growing interest to 
investigate the prevalence of schistosomiasis in pre-school children worldwide where 
the disease is endemic (Stothard et al., 2011). We report here the first study to 
investigate schistosomiasis in this age population in Pemba. Infection was detected in 
7.04% of the pre-school children, the majority (78.1%) being light infections but 
demonstrable in just 2 yr olds. This prevalence is lower than that observed by some 
workers (Dabo et al., 2011, Garba et al., 2010, Chu et al., 2010) but higher than that 
demonstrated by others (Mutapi et al., 2011, Sousa-Figueiredo et al., 2008). The latter 
study was conducted in similar epidemiological setting in Unguja (the other Island that 
makes Zanzibar). A possible explanation for the observed difference between the 
present study and that of Sousa-Figueiredo could be related to differences in the number 
and diversity of the villages/shehia involved. Here seven Shehias were investigated 
which included at least three villages in each (data for village level were not shown) 
whilst in Unguja three villages in one Shehia were studied, albeit in an area historically 
associated with significant schistosomiasis endemicity (Rudge et al., 2008). There is 
overwhelming evidence that schistosomiasis is a focal disease and so the restricted 
sampling may not have provided a representative prevalence value for the wider 
distribution. Another possibility could be timing (season) on which the investigation has 
been conducted as schistosomiasis transmission varies with season (Chandiwana and 
Christensen, 1988). It has been shown that transmission of S. haematobium infection 
often occurs during the hot dry season (Chandiwana et al., 1987). In this instance the 
hot dry season is between September- November which is the similar time that the 
present study has been conducted. Nevertheless, this situation might be different in 
Zanzibar as the dry hot season is between December to early March. A further plausible 
explanation could be difference in sample size. Sousa-Figueiredo et al. (2008) and 
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Mutapi et al. (2011) (Sousa-Figueiredo et al., 2008, Mutapi et al., 2011) examined only 
102 and 104, respectively, while in the present study 911 children were sampled.  
The study showed a clear albeit expected increase in prevalence and intensity of 
schistosomiasis with age from 2-5 years with older children being more frequently and 
heavily infected.  
6.5.1 Risk behaviour for transmission of schistosomiasis   
Contact with freshwater bodies where the snail intermediate host resides has been long 
recognized as the main risk factor and essential pre-requisite for acquisition of 
schistosomiasis. In interviews with mothers/guardians of the children participating in 
the pre-school survey it was found that a substantial proportion of respondents use 
pond/stream water for various reasons including washing of utensils, clothes or bathing. 
The data shows a strong significant association of schistosomiasis with these risky 
behaviours which is consistent  with other studies (Lima e Costa et al., 1987). In the 
present study we found that frequency of water contact for mothers/guardians who 
accompanied their children in water bodies was statistically associated with acquisition 
of schistosomiasis by the children. Children whose mothers reported visiting water 
bodies with children everyday were more likely to be infected (13.75%) than mothers 
who visit once/week (11.1% [the absolute number of mothers in this category was 
extremely low [1]), twice/week (11.1%) and whenever possible (4.8%). However, the 
Mantel-Haenszel analysis revealed low odds ratio (OR = 0.8, p = 0.8). Notwithstanding, 
visiting of mothers along with children to water bodies put children at risk of acquiring 
schistosomiasis as children are inclined to want to spend significant time in the water. 
However, in the present study exposure times (duration) and frequency of individual 
mother’s water contact, which could be assumed as a proxy for their children, were not 
investigated. Nevertheless studies show that women spend much time in contact with 
water bodies (Sow et al., 2011, Scott et al., 2003) regardless of season (Sow et al., 
2011). Similarly, an association was observed between schistosomiasis and low 
education or illiteracy; none of the child whose mother/guardian had completed 
university/college had schistosomiasis. This observation is in agreement with that of 
(Firmo et al., 1996). 
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6.5.2 Usefulness of hemastix for the diagnosis of schistosomiasis in pre-school children 
The use of haemastix (chemical reagent impregnated on absorbent paper) to detect the 
presence of blood in urine has been widely applied as an alternative, indirect and rapid 
diagnostic aid for schistosomiasis in endemic areas and has been used in Pemba to 
direct treatment in individual cases and in treatment campaigns (Savioli and Mott, 
1989). Despite its usefulness in certain settings e.g. where parasitological diagnosis is 
lacking there are drawbacks i.e. its performance is influenced by age and sex as well as 
intensity of the infection (Etard, 2004). Also, it has been reported that haemastix have 
high sensitivity (97.8%) but low specificity (58.8%) in children aged between 5-10yrs 
(Robinson et al., 2009) whilst Kotb and colleagues (1986) have reported sensitivity of 
85.5% and specificity of 94.4% for children aged between 6-15yrs. (Kotb et al., 1996). 
In the present study a high sensitivity (96.4%) but somewhat lower specificity (78.1%) 
was seen in the pre-school children aged 2-5yrs. This sensitivity was lower than the 
100% sensitivity found in the 7-11 year olds in Std-1 (data not shown). The somewhat 
lower sensitivity may be related to the younger children having less bladder damage due 
to the shorter period of infection and so lower egg-induced blood loss. Overall, the 
findings support the earlier observations, above, that haemastix is a relatively reliable 
and useful tool in younger children. 
In view of our findings, it is clear that, even in Zanzibar setting, children become 
infected with schistosomiasis at a very young age. It is difficult to assess the impact of 
infections in this pre-school age population on maintaining transmission but they should 
be considered in the planning of PC MDA programmes. Given that the ZNCP/SCORE 
programme in Pemba was angled towards elimination of transmission, the above 
demonstration of significant prevalence in the pre-school children in Pemba led to 
inclusion of the 3-5 year old children in the MDA programme. Praziquantel is currently 
only available in pill form and a relatively large dose is required so its administration to 
small children is far from ideal. This combined with the increasing awareness of 
infection levels in young children has led to a widespread call for development of 
paediatric formulation, suitable for younger children <5yrs. The pharmaceutical 
company, Merck Serono, who currently manufactures and donates praziquantel for 
control programmes, is striving hard to develop a paediatric PZQ formulation 
https://www.merckgroup.com/en/company/responsibility/our-
strategy/health/schistosomiasis.html) 
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Chapter 7 Transmission dynamics of Schistosoma 
haematobium infections, and characterization of Bulinus 
populations prior to the implementation of the SCORE 
project 
 
7.1 Introduction  
Schistosoma haematobium is a blood fluke that is responsible for urogenital 
schistosomiasis and is predominantly found in Africa and the Middle East. Current 
estimates show that approximately 150 million people are infected with this parasite 
(Abbasi et al., 2007). Despite how widespread this parasite is, its transmission is 
considered to be focal and is dependent both on the presence of a suitable (or 
susceptible) intermediate snail host and fresh water contact. Additionally, 
environmental, ecological and socio-economic factors play a large role in transmission 
(McManus et al., 2010). Climatic changes may also favour extended transmission of 
schistosomiasis (Mas-Coma et al., 2009). For some time, the world has been 
experiencing global warming which can lead to a disruption in temperature and rainfall 
patterns (Martens et al., 1995) and the aquatic environment (Mas-Coma et al., 2009). 
Studies have demonstrated that increased rainfall leading to temporary surface water 
bodies, such as ponds and streams which constitute snail habitats and breeding sites can 
increase the snail’s range (Dennis et al., 1983, Mas-Coma et al., 2009, Cantrell, 1981). 
Increased temperature also has a direct impact on transmission as it accelerates cercarial 
development within the snail, and thus their release from the snails (Shiff et al., 1979, 
Lee and Lewis, 1977, Martens et al., 1995).  
It is of importance for any schistosomiasis control programme to establish which snails 
are responsible for transmission, their geographic location and where transmission is 
happening. This is vital in the planning and implementation of control measures. It has 
long been recognized that various Bulinus species serve as the intermediate host for S. 
haematobium in different parts of the world where schistosomiasis is endemic 
(McCullough, 1959). However, Bulinus species display differing levels of susceptibility 
to infection by S. haematobium in differing endemic locations. For instance, in Zanzibar 
and the nearby island of Mafia, B. nasutus has been proved as refractory to infection 
(Stothard et al., 2013a, Stothard and Rollinson, 1997a) whereas in coastal Kenya B. 
 169 
 
nasutus has been reported to play a role in transmission (Kariuki et al., 2004a). Another 
example of regional variation in schistosome/Bulinus compatibility comes from an 
experimental study which showed that B. globosus from Kinshasa, Zaire were only 
compatible with S. intercalatum from Zaire but not strains from Cameroon (Frandsen, 
1979). Therefore, snail-schistosome “incompatibility” and specificity are factors which 
must be considered with regard to schistosomiasis transmission (Rollinson et al., 2001, 
Allan et al., 2009).  
Traditionally, discrimination of snail species within the Bulinus genus was done by 
assessment of shell and reproductive organ morphology (Vidigal et al., 1998, Carvalho 
et al., 2001). Nevertheless, B. globosus and B. nasutus are morphologically very similar 
and are sympatric in some geographical areas (Barber et al., 2000). Additionally B. 
nasutus can also be infected by other schistosome species i.e. S. bovis (Barber et al., 
2000) thus reliable, specific and sensitive techniques are required to discriminate these 
snails and to establish the ‘real’ intermediate host role. So far, molecular methods have 
been used for the detection of genetic variability and to elucidate phylogenetic 
relationships especially using cytochrome oxidase subunit-1 (Cox-1). Allele specific 
amplification of the ribosomal internal transcribed spacer (ITS) has also been developed 
to differentiate and characterize Bulinus species (Rollinson et al., 2001, Akinwale et al., 
2011a, Jorgensen et al., 2013, Kane et al., 2008). Cox-1 is a highly conserved gene and 
has been utilized in assessing the relationship of parasites as well as their intermediate 
hosts and their differentiation (Kandil et al., 2010) and is thought to produce superior 
result to ITS-2 (Kane et al., 2008). 
Evaluation of the level of infection in wild snail populations is critical in understanding 
the distribution of schistosomiasis. This is often carried out by assessing snail 
populations for patent infections (i.e. the shedding of cercariae). The rate of prepatent 
infection (snails with immature infections not shedding cercariae) is usually neglected 
probably because of the lack of suitable, simple detection methods (Hamburger J, 
2004), although snails can be crushed between glass plates to observe developing 
parasites. Surveillance of snail populations is also helpful in the assessment of the 
effectiveness of the control strategies on parasite transmission (Hamburger et al., 2004, 
Rollinson et al., 2009). Therefore, specific and sensitive methods for identification of 
infection in the snails are required. The polymerase chain reaction (PCR) assay based on 
the detection of Dra1 (a tandemly repeated DNA sequence) in the genome of S. 
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haematobium, and loop-mediated isothermal amplification (LAMP) have shown 
promising results being able to detect a single cercaria (Hamburger et al., 2004, 
Hamburger et al., 2013). Both conventional PCR and LAMP have proved to be equally 
sensitive for the detection of schistosome parasite within the snail host (Kumagai et al., 
2010).  
The ZNCP/SCORE initiatives described in this thesis were aimed at schistosomiasis 
elimination through integration of snail control by molluscide (niclosamide), mass drug 
administration (MDA) and behavioural change. Given the importance of understanding 
which snail species are responsible for transmission, their geographic location and the 
foci of transmission, malacological surveys were carried out prior to embarking on the 
implementation of the control programmes in order to: (i) identify potential 
transmission sites (ii) assess transmission dynamics of S. haematobium infection (iii) 
characterize the Bulinus snail hosts involved in transmission. 
7.2 Results  
In a period of one year (October 2010- September 2011), six potential sites (water 
bodies) were visited once/month to assess transmission dynamics of S. haematobium in 
the snail intermediate hosts. The sites were arbitrary chosen based on high prevalence of 
schistosomiasis observed in our baseline survey described above in Chapter 3 (cohort 
24 schools, survey_1), historical data and easy accessibility of the areas. Table 11 below 
illustrates the nature and characteristics of the water bodies in each individual site. 
Table 7.2 indicates the geographical coordinates of the water bodies visited over a 1yr 
period. A total of 1831 (mean 32.12/sampling, range of 0-236) Bulinus snails were 
collected from all six sites. The distribution of the snails collected is shown in Figure 
60. There was marked variation in the numbers collected from the different sites with 
Mkungu yielding the highest number of snails as compared to other sites. The reasons 
for variation in number of the snails collected across different sites could be (i) 
ecological (with some water bodies had abundant vegetation), (ii) size (iii) nature 
(stream or ponds) of the water bodies and (iv) seasons- as some of the water bodies are 
temporary and tend to dry-up during dry seasons.  Of the collected snails, only 18 
(0.98%) shed cercariae. Of these 17 (94.4%) were from Kangagani and 1(5.6%) was 
from Mavungwa. Interestingly, most (16 [88.9%]) of the shedding snails were collected 
at Kangagani between the months of October and December. The only positive snail 
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from Mavungwa was collected in June. It should be noted that in this small study all 
shedding snails were recovered from large permanent ponds rather than streams.  Table 
16 also shows that Kangagani had somewhat different water characteristics than the 
other sites (lower salinity, TDS and conductivity) but the low number of sites studied 
means that no firm conclusions could be drawn from this regarding correlation with 
snail infection rates. 
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Table 16: Chemical characteristics of the water bodies surveyed for assessment of transmission of schistosomiasis over 1yr period (2010-11) 
 
Sampling Site   Nature    Chemical characteristics  Other characteristics 
      Salinitya         TDSb Tempc  pH conductivityd 
Kangagani  large pond  0.02  55.7 31.1 8.38 110.0  permanent  
Kimbuni  stream   0.19  203.8 28.3 7.86 429.9  temporary and dries during dry seasons 
Mavungwa  large pond  0.19  177.9 30.4 7.91 350.7  permanent 
Mkungu  stream   0.2  209.4 27.7 7.96 433.2  temporary and dries during dry seasons 
Piki    stream   0.25  250.6 29.2 7.98 516.8             permanent but large part dries during      
                                                                                                                                                            dry seasons  
Vitongoji  large pond  0.12  177.0 31.0 8.01 237.7  temporary and dries during dry seasons 
 
Concentration: 
The numbers represent mean values for the various sampling times and the units are: a (%), b (mg/l), c (centigrade) and d (µ/s). TDS = (Total 
Dissolved Salts)
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Figure 59: Potential schistosomiasis transmission areas sampled for snail host 
characterization  
 
Figure 5 is replicated to allow readily visualization of shehia where snail samples were collected 
for more detailed analysis 
The blue arrows indicate areas used for snail sampling Bg represents Bulinus globosus and Bn is 
B. nasutus  
Bg/Bn 
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Figure 60: Distribution of Bulinus snails in different water bodies 
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7.2.1 Expanded survey for definition of snail sampling sites for use in the SCORE 
evaluation 
In collaboration with Linzy Elton whose field work I supervised during her MSc project 
at LSHTM in 2011, additional sites were sampled to identify suitable sites for 
monitoring in the 15 shehias included in the snail control arm (mollusciciding) of the 
SCORE programme. The sites visited are shown below Table 17. 
In this study, a total of 52 sites were surveyed across the 15 shehias as shown in table 
17. The human activities resulting in water contact in these sites was recorded. Bathing 
and washing clothes were the most common activities, occurring in 90.3% of the water 
bodies surveyed. 82.7% of water bodies were used for playing (children). The other 
notable activities were rice farming (51.9%), washing dishes (42.3%), fording (40.3%), 
fishing (38.4%) and ablution (30.7%). Other, less common activities included use of 
water for building or gardening purposes (13.4%) and washing cars or bikes and water 
collection (both 5.7%). The chemical characteristics of water in those areas are 
indicated in table 18. A total of 281 snails were found in 14 of the sites visited 
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(highlighted in bold in Table 7.3). Only 3 (1.1%) of the snails collected were found to 
shed cercariae. The snail positive sites were equally likely to be streams or lakes.  
 
Table 17: Snail sampling sites visited in 2011  
Shehia Water bodies visited 
Mgogoni Kimbondeni, Juda, Kigenda, Makuwe Bondeni, Meno Pembe 
Mkanyageni Makorera, Kwaguni, Taasini bridge 
Msuka Mtowaungi, Kwakipande, Kwamakuku bridge, Meli 11, 
Kwamwanazabadi 
Shumba Viamboni Badala, Kijimbu Mali, Daragani, Kwamilango, Mtoni Msikitini 
Finya Selem, Mtatagoni, Kilima Punda, Bubujiko 
Piki Panganole, Bagoni, Tongoni, Piki Darajani 
Kisiwani Langoni, Shangafu, Fuoni, Nturuma 
Makangale Ziwalamakangale, Bondo 
Mbuzini Mavungwa, Kwamwanamwari 
Makombeni Kwakinyero 
Ziwani Ziwanimtoni, Kigogo 
Kinowe Kwamwamakuku, Kisange, Kicha 
Kwale Ziwani, Ziwakisasi, Nkibwemi, Kwakidume 
Kangagani Mboje, Mapungwi, Ziwalamkumgini, Kisiwaiwe Kubwa, 
Chogambwa 
Vitongoji Mkomani, Ziwe Kichanje 
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Table 18: Chemical characteristics of the water bodies.  
 
Shehia 
Number 
of sites 
Temperatur
e (°C) 
pH 
Salinity 
(% 
TDS 
(mg/l) 
Conductivity 
(µs) 
Finya 4 26.4 7.6 0.0 36.3 58.6 
Kangagani 6 26.9 7.8 0.1 81.0 169.6 
Kinowe 3 27.8 7.6 0.1 95..7 199.9 
Kisiwani 4 25.7 7.7 0.3 278.0 573.5 
Kwale 4 26.9 7.5 0.1 141.0 292.6 
Makangale 2 28.8 7.6 3.9 43.5 90.0 
Makombeni 1 26.0 7.8 0.1 109.1 228.0 
Mbuzini 2 27.7 7.6 0.4 216.4 447.5 
Mgogoni 5 26.6 8.4 0.2 195.8 404.8 
Mkanyageni 3 26.4 7.5 0.0 53.7 96.5 
Msuka 5 26.6 7.6 0.1 89.1 186.1 
Piki 4 27.8 7.9 0.3 263.0 542.3 
Shumba 
Viamboni 
5 26.0 7.1 0.1 78.8 126.6 
Vitongoji 2 26.6 7.7 0.1 64.8 135.9 
Ziwani 2 26.3 7.2 0.1 105.0 195.2 
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7.2.2 Identification of S. haematobium in snails by PCR (Dra-1 gene) 
Due to cost implications and accidental loss of the labelling of tubes resulting from 
breakdown of snail containers during transfer of the snail samples from Pemba to 
London, which were fixed in ethanol; it was not be possible to examine high numbers of 
samples. For reference, complete data relating to all 94 of these snails is given in 
Appendix 7.1.  
DNA was isolated from 96 snail samples of which 94 were tested further. Of these, 18 
(19.1%) were snails that had shed cercariae. Figure 61 shows representative PCR results 
for the Dra-1 repeat (121 bp) from a subset of tested snail samples. For the positive 
snails the characteristic tandem repeats lead to the ladder appearance (lanes B, C and E) 
absent from the negative snails (F). Overall, 53 (56.4%) of the snail samples were PCR 
positive for Dra-1, 28 (29.8%) were negative and 13 (13.8%) were undetermined 
apparently due to high concentrations of template DNA. Of the 18 snails which had 
been recorded as shedding cercariae after collection, 13 were PCR positive for Dra-1, 4 
were equivocal by PCR and one (snail 77 in Appendix 7.1) was negative. Ideally this 
negative sample 77 would have been repeated along with all equivocal samples (tested 
using lower DNA concentrations) but such retesting was not feasible in this study for 
logistical and financial reasons. Nevertheless, the Dra-1 PCR results for the “shedding” 
snails are not inconsistent with the PCR-defined infection status correlating pretty well 
with the known shedding status.  Interestingly, most (12 [92.3%]) of the samples with 
unequivocal results were from Kangagani. Indeed 11 (91.7%) were initially found to 
produce cercariae in the field. Comparing the number of snail samples tested S. 
haematobium-positive by Dra-1 PCR (n= 53) with the numbers that shed cercariae in 
the field (n=18), clearly indicates a high proportion of snails with prepatent infection.  
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Figure 61: Agarose gel separation of S. haematobium specific Dra-1 PCR reaction 
products from a representative subset of tested Bulinus snails 
 
 
Figure 60 Figure showing a sample of the PCR amplifications of the Dra-1 gene specific for S. 
haematobium from a proportion of the snail samples.  
 Lanes labelled A-F show examples of A: ladder markers; B,C,E: positive reactions 
showing the tandemly repeated 121bp subunit indicative of S. haematobium infection; 
D an equivocal result indicating a sample that would require further dilution of test 
DNA; F negative reaction from uninfected snail. The DNA fragments were separated on 
1.5% agarose gel in 1x TAE buffer. The gel was stained with gel-red dye and bands 
visualised on a UV transilluminator. 
 
Table 19 illustrates the distribution of the PCR (Dra1) positive sample in relation to the 
site of collection. Furthermore, of the Dra-1 positive samples, 45(84.9%) failed to 
produce cercariae when isolated from the field.  Only one snail sample that was 
negative for S. haematobium using the Dra-1 PCR assay shed cercariae. When 
comparing the two assessment methods for S. haematobium infection in snails, the use 
of PCR for detection of parasite DNA is far superior to assessment of cercarial 
production in the field (McNemar’s χ
2 = 45; p = 0.00001). The Dra-1 PCR assay is 
therefore valuable for detecting whether any transmission is likely to occur in the 
habitat under study. It is always possible that snails with pre-patent infections do not 
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become patent, the snails might die or the snail defence reaction might kill the 
developing parasite. 
Table 19: Positivity rate for the Dra-1 gene specific for S. haematobium in snail samples 
collected from various transmission sites  
 
Site                No. of snails tested  Dra- 1   No.shed cercariae 
                  Neg                 Pos          Unidentified        Bg      Bn 
Kangagani              33            3   18  12     17           1       12 
Kimbuni                 12            8                         4                    0     0              0       0 
Mavungwa              13           6    6   1     1              1       0 
Mkungu                  12            2    10   0      0              0      0 
Piki                         14            2    12   0     0              0       0 
Vitongoji                 10           7    3   0     0              0       0 
                            
Bg = Bulinus globosus and Bn = Bulinus nasutus 
7.2.3 Confirmation of the species of snail hosts by PCR  
7.2.3.1 Detection of the Cox-1 (Asmit-1) gene from snail samples: 
All the 94 snail samples which were screened for S. haematobium using the Dra-1 PCR 
assay were also used in PCR reactions to amplify the Cox-1 gene fragment the Cox-1 
gene product was generated for 92 (97.9%) of the snails. The reason for the failure to 
get PCR product from the other two (white arrows in Figure 61) is not known.  
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Figure 62: Amplification of the Cox-1 gene specific for determination of Bulinus spp 
 
Figure 62 Amplification of the Cox-1 gene specific for determination of Bulinus spp.  
Gel showing PCR products derived from the 96 snail samples. Wells marked M are the DNA 
ladder markers. The red arrow head indicates negative control (no target DNA and the green 
arrow head indicates positive control snail DNA. The 300bp Cox-1 PCR product is arrowed in 
black. The white arrow heads are samples which did not give a PCR product. The DNA 
fragments were separated on 1.5% agarose gel in 1x TAE buffer. The gel was stained with gel-
red dye and bands size were visualised on UV transilluminator. 
 
7.2.3.2 DNA sequencing of the amplified Cox-1 gene products to confirm snail 
species. 
A total of 32 DNA samples that were initially confirmed as Bulinus species were 
sequenced as described by Webster and colleagues (Webster et al., 2012b) and results 
are shown in Table 20 below. 
Table 20: Illustration of the Bulinus species as identified by Sequencing  
S/no   Snail #  Species identified site collected    Infection at field 
1  13  Bulinus globosus Mavungwa  Not infected 
2  14  B. globosus  Mavungwa  Not infected 
3  23  B. globosus  Kimbuni  Not infected 
4  24  B. globosus  Kimbuni   Not infected 
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5  33  Bulinus nasutus   Vitongoji  Not infected 
6  34  B. nasutus  Vitongoji  Not infected 
7  35  B. nasutus  Vitongoji  Not infected 
8  41  B. globosus  Piki   Not infected 
9  42  B. globosus  Piki   Not infected 
10  53  B. nasutus  Kangagani    Not infected 
11  65  B. globosus  Mkungu    Not infected 
12  66  B. globosus  Mkungu    Not infected 
13  78  B. nasutus  Kangagani    Infected 
14  79  B. globosus  Mavungwa    Infected 
15  80  B. nasutus  Kangagani  Infected 
16  81  B. nasutus  Kangagani  Infected 
17  84  B. globosus  Kangagani  Infected 
18  85  B. nasutus  Kangagani  Infected 
19  86  B. nasutus  Kangagani  Infected 
20  87  B. nasutus  Kangagani  Infected 
21  88  B. nasutus  Kangagani  Infected 
22  89  B. nasutus  Kangagani  Infected 
23  90  B. nasutus  Kangagani  Infected 
24  93  B. nasutus  Kangagani  Infected 
25  94  B. nasutus  Kangagani  Infected 
26  95  B. nasutus  Kangagani  Infected 
 
Of the 32 PCR products, only 26 (81.3%) were successfully sequenced or the 
chromatograms could be edited. Among these 16 (61.5%) were identified as B. nasutus 
and 10 (38.5%) were identified as B. globosus. Of the B. nasutus sequenced, 12 (75%) 
had produced cercariae in the field. Of the B. globosus 2 (20%) had produced cercariae 
in the field. Interestingly 6 (37.5%) snail samples identified as B. nasutus by sequencing 
had Dra-1 gene specific for S. haematobium. 
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Table 21: List of Shehia where snail samples were collected for the SCORE study 
             Shehia                         No. of water bodies   
               Finya      14 
   Kangagani     19 
Kinowe     6 
             Kisiwani     11 
            Kwale      5 
         Makangale     2 
Makombeni     5 
Mbuzini     5 
Mgogoni     5 
     Mkanyageni     9 
Msuka      6 
Piki      15 
S/viamboni     9 
Vitongoji     16 
Ziwani      9 
 
7.2.3 Follow-up 
7.2.3.1 Determination of the prevalence of S. haematobium infected snails following 
SCORE interventions.  
The identification of the water bodies (transmission sites) in the 15 shehias involved in 
the snail control arm of the SCORE project carried out in July 2011 provided the 
necessary baseline data for the assessment of snail populations as well as for monitoring 
the trend of S. haematobium infection within the snail host. This is the work described 
above.  
In order to monitor snail numbers and infection rates throughout SCORE, a protocol 
was established in which a defined area was measured and a specific time allocated for 
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searching snails .i.e 15 m in 15 minutes.  For this 4 collectors were generally involved. 
This was started in the 15 shehias in the snail control areas of SCORE in August, 2012 
before fully engaging with the application of niclosamide (snail control activities). A 
total of 136 water bodies were identified (Table 21). Overall 772 Bulinus snails were 
collected over a period of four months (Mid- July – early October). Only 4 (0.6%) of 
the snail collected were infected with S. haematobium as determined by production of 
cercariae in the field. Of the infected snails 3 (75%) were from Mkanyageni and 1 
(25%) was from Mgogoni shehias. 
 
7.2.3.2 Confirmation of species of snail hosts and of schistosome infection in the 
snails at follow-up by PCR. 
As mentioned above, due to the limited availability of funds it was not possible to 
determine prepatent S. haematobium infection within the snail host, and their 
discrimination using molecular methods (PCR). However, a sub-sample of snails from 
Kangagani, where B. nasutus were preliminarily found to be infected with S. 
haematobium, was collected for further analysis. 
 
7.2.3.3 Schistosoma haematobium infection in snails between 2011 and 2013. 
The proportion of schistosomiasis infection rate in snail (snail shed cercariae in the 
field) detected in 2011 was almost two-fold higher (1.1%) than in 2013 (0.6%) after 
application of two rounds of niclosamide. However, the actual number of infected snails 
was similar between the two time points; 3 infected snails 2011 vs. 4 infected snails 
2013.  
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7.3 Discussion   
Schistosomiasis is widely spread across tropical and sub-tropical countries but 
transmission of the disease is focal, it only happens in places where particular snail 
intermediate hosts exist coupled with environmental factors and human activities 
associated with fresh water contact. It follows that it is of paramount importance to 
understand the distribution of snail intermediate hosts in any particular geographical 
region if the control program is to achieve successful control for schistosomiasis. In this 
present study, methods have been implemented in Pemba to assess distribution of 
Bulinus species, their characterization and to determine the S. haematobium infection in 
the snails. The identification of transmission sites and assessment of the distribution of 
Bulinus species was carried out in different phases and locations. However, most of the 
work included here is based on the initial assessment carried out in 6 transmission foci 
shown in Figure 6.1. In that particular study a marked variation in the distribution and 
number of Bulinus snails among the water bodies (transmission sites) was found. This 
variation is likely to be explained by diversity in ecological factors between the sites for 
example some of the transmission foci had more vegetation and/or mud than others. 
However, such ecological diversity is difficult to quantify and there are controversial 
findings related to the association of vegetation and snail abundance. For example in 
some places the presence of vegetation was not considered to be significantly associated 
with the abundance of snails (Opisa et al., 2011) but in other locations the presence of 
water lilies and other aquatic grasses were found to be important for the presence and 
abundance of snails (Kariuki et al., 2004b) and indeed removal of vegetation has been 
used to control snails population (Boelee, 2006). Other possible factors could be the 
physical nature of the transmission foci and variations in water velocity (Webbe and 
Jordan, 1966) and temperature during the rainy season. Low temperature has been 
shown to inhibit snail production (Webbe and Jordan, 1966). In the setting in Pemba the 
heavy rains experienced during the months of April-June have an impact on the snail 
population densities although the intensity of the rains varies between the years. In fact, 
in this survey, in some occasions, the collection of snails was carried out during the 
rainy season (April-early June) and no snail was found during that period in most water 
bodies especially in the streams (data not shown). But the number of snails steadily 
increased after rains stopped. This finding is consistent to what has been reported 
elsewhere (Kariuki et al., 2004a). In addition, some of the sites were permanent whist 
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others were temporary which tend to dry-out during dry season (Jan- March) which led 
to interruption of snail sampling. With the exception of Mkungu which is a slow 
flowing stream, more snails were found in large permanent ponds as compared to 
streams.  
The distribution of the snail intermediate hosts is influenced by a range of 
environmental factors (De Meillon et al., 1958, Schutte and Frank, 1964). Regarding 
physico-chemical characteristics of the water bodies that might influence the 
distribution of snails all the transmission foci investigated had in average, alkaline pH, 
with salinity concentration ranging from 0.02-0.25% and moderate temperature (range: 
27.7- 31.1oC). Studies have shown high salinity concentration has a harmful effect on 
snail egg-masses and immature snails (Chu et al., 1968, Donnelly et al., 1983). 
Moreover, in experimental studies it has been shown that salinity concentration at 0.3% 
permitted survival of a large proportion (85%) of B. truncatus snails (Chu et al., 1968) 
but increased concentration of salinity to ≥ 5.25% was associated with significant 
reduction in egg hatching as well as fecundity and survival of adult snails (Donnelly et 
al., 1983). The harmful effect of the increased concentration of salinity towards survival 
and fecundity of snails might be true for any snail species including B. globosus. The 
water bodies investigated had an alkaline pH (range: 7.9- 8.4) with a varying levels of 
conductivity and total dissolved solids (TDS). The lowest average conductivity was 
recorded in Kangagani (110 µ/s) which is a permanent large pond. In fact, in this site, 
many of the characteristics recorded were low as compared to other sites. This 
complicates determination of the association of different chemical parameters with the 
distribution of snails. 
Overall the variation in phyisico-chemical characteristics was minor and there was no 
obvious correlation between any such characteristics and snail number collected. 
Indeed, in the paper by De Meillon et al. (De Meillon et al., 1958) it was stated that 
there was “no evidence that the chemical composition of natural unpolluted water plays 
part in determining vector snails habitat” (De Meillon et al., 1958). Other characteristics 
such as turbidity-that indirectly affect snail populations (De Meillon et al., 1958) were 
not investigated in the present study and it is clear that much more extensive and wide-
ranging studies would be needed to determine density and duration of snail populations 
in the various water bodies identified. 
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As mentioned previously, the understanding of the infection rate within the snail 
intermediate host is critical for the planning of the control program. In this present study 
both patent and prepatent infection with S. haematobium in snail intermediate hosts was 
investigated. Regarding patent infection, only a small proportion (1%) of the wild snails 
was found to be shedding cercariae when assessed microscopically. Most of these were 
found in Kangagani, notably during the months of October - December. Interestingly, 
snails that were recovered from ponds were more likely to shed cercariae than those 
collected from streams. Our finding of 1% infection rate in snails is somewhat lower 
than that observed by (Opisa et al., 2011) in Western, Kenya but the actual number of 
the infected snails was similar between the two studies. Nonetheless, most studies have 
detected similar, or even lower, proportions of shedding snails despite high prevalence 
of S. haematobium infection around the surveyed areas (Kariuki et al., 2004a, 
Hamburger et al., 2004). In the present studies cercarial shedding was observed 
following continuous shedding in natural light between 0830 - 1530hr without 
thermostatically control of temperature. Although experimental studies assessing the 
rhythm of cercarial shedding have shown that intermittent darkness stimulated 
emergence of cercariae from infected snails (Nojima and Sato, 1982) it is not considered 
that the low percentage shedding of cercariae observed here was  explained by 
experimental methodology. 
The advancement in the knowledge of molecular technology has overcome the 
challenges for the detection of many infectious agents. One such application is the 
detection of prepatent schistosome infection in snails (Rollinson et al., 2009). As 
indicated by (Kariuki et al., 2004b) field caught snails often fail to shed cercariae even 
if they are infected. In the present study we have such PCR-based techniques to detect 
the Dra-1 repeated sequence specific for S. haematobium parasite. Overall, such PCR 
identified many more (56.4% [n = 53]) infections from snails than conventional method 
of assessment of cercarial shedding (p = 0.00001). It has been shown that PCR is more 
sensitive and can detect infection in snails once they become infected (Hamburger et al., 
1998). Our results are in agreement with those  reported in Kenya by other workers 
(Hamburger et al., 2004) but were also higher than the 29.7%  reported in Nigeria by 
(Akinwale et al., 2011b). The use of PCR in detecting the true level of infection in 
snails proved is an invaluable tool for surveillance of schistosomiasis transmission 
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which is critical for the success of a control program particularly when disease 
elimination is the goal. 
Finally, in this present study, the species of Bulinus snails present and involved in S. 
haematobium transmission in Pemba has been determined by defining the Cox-1 gene 
sequences specific for Bulinus species.  Application of PCR for the Cox-1 gene of 
Bulinus was positive for the majority (97.9%) of the snails tested indicating that they 
belong to Bulinus species. Barcode DNA sequencing of the PCR products revealed two 
species of Bulinus snails (B. globosus and B. nasutus) exist in Pemba. Based on the 
combination of the results for the various experiments, it is clear that both species of 
Bulinus snails play roles in the transmission of schistosome infection in Pemba in that 
both species were shown to be infected with schistosomes as defined by shedding 
cercariae and/or Dra-1 typing. It should be noted that that the Dra-1 gene can be 
detected in other schistosome parasites such as S. bovis (Hamburger et al., 1998) which 
is closely related to S. haematobium. In certain countries e.g. Kenya these two species 
of schistosomes sometimes co-exit and also parasitize the same snail intermediate host, 
B. nasutus (Barber et al., 2000). However, ruminant schistosomiasis has not been 
documented in Pemba Island to date and so it is suggested that, in this setting, both 
species of Bulinus transmit S. haematobium. The finding of S. haematobium infection in 
B. nasutus (as confirmed by sequencing) is contrary to what has been reported earlier by 
other workers in Unguja Island, the sister island of Zanzibar where infection was 
demonstrated in B. globosus but not in B. nasutus (Stothard and Rollinson, 1997a, 
Stothard et al., 2002). Possible explanations for this difference include the utilization of 
different genetic markers to define the snail species. The earlier studies sequenced the 
ribosomal internal transcribed spacer (ITS) region whilst the present study sequenced 
the mitochondrial cytochrome oxidase sub-unit -1 (Cox-1). Studies have shown that 
sequencing of the Cox-1 gene for characterisation of Bulinus snails produced better 
result than use of ITS-2 (Kane et al., 2008). Another possible reason could be the 
different geographical locations where snails were collected i.e. Pemba vs Unguja. So it 
is possible that strain differences in the snail and/or S. haematobium itself mean that B. 
nasutus is involved in S. haematobium transmission in Pemba but not in Unguja. 
Certainly it has been demonstrated that B. nasutus are effective intermediate hosts for S. 
haematobium infection in Kenya (Kariuki et al., 2004a) and even some parts of 
Tanzania (Webbe, 1962, Lwambo, 1988). 
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In view of the interesting result of the present and past studies regarding the biology of 
the transmission of S. haematobium in Zanzibar, it would be necessary to carry out 
further intensive malacological studies to identify and characterize snail intermediate 
hosts and determine their transmission role. Furthermore, our results confirm the high 
superiority of the PCR in determining schistosomiasis infection rates in the snail host in 
Pemba and so could be invaluable as the tool for monitoring infection if and when 
elimination is achieved. 
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Chapter 8 The genetic diversity of S. haematobium in 
Pemba and the impact of praziquantel treatment 
 
8.1 Introduction  
Schistosomiasis is ranked second after malaria in terms of suffering caused by a 
parasitic disease (Webster et al., 2010, Caffrey, 2007). Furthermore, the disease is 
categorized as a neglected tropical disease (NTD) due to the large numbers of people 
requiring treatment and the relatively lack of resources for its control. Schistosomiasis is 
a debilitating disease responsible for some mortality and subtle pathology (Olds, 2013). 
Nevertheless, it is responsible for an estimated 1.7-4.5 million disability-adjusted life 
years (DALYs) (Utzinger et al., 2011, Chan, 1997, Fenwick, 2012, WHO Expert 
Committee on the Control of Schistosomiasis, 2002). Of the human schistosome 
species, Schistosoma haematobium is responsible for urogenital schistosomiasis and is 
predominantly found in Africa where an estimated 85% of all schistosomiasis cases 
exist (Steinmann et al., 2006) and where it is considered as one of the major public 
health problems.  
The long-term consequences of urogenital schistosomiasis are well understood 
(Fenwick, 2012). Several control measures, including behavioural change initiatives 
(Mwanga and Lwambo, 2013) and transmission control have been applied against this 
devastating disease, often  integrated with a preventive chemotherapy programme 
(Fenwick and Webster, 2006). However, chemotherapy-based control alone, using 
praziquantel, has been the main control strategy employed in recent years, primarily to 
reduce morbidity and many endemic countries largely depend on this strategy (Wang et 
al., 2012a, Doenhoff et al., 2009). There are multiple reasons towards this dependency:- 
1) increasing donation of PZQ tablets from the pharmaceutical company (Fenwick, 
2012); 2) observation of rapid impact on morbidity reduction, improved cognitive 
capacity and school attendance through provision of PZQ (Taylor-Robinson et al., 2012, 
Miguel and Kremer, 2004); 3) financial commitment from international development 
partners (Molyneux and Malecela, 2011); and 4) easy distribution of the drugs by non-
medical professionals during MDA or school based treatment (Montresor et al., 2010).  
On the other hand, over reliance on a chemotherapy-based control strategy, especially 
when delivered as monotherapy, as in the case of PZQ, has raised concern on the 
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potential development of drug resistance in the parasite population. Although low cure 
rate has been demonstrated (reviewed by Doenhoff et al., 2008) there have been no 
confirmed examples of schistosome parasites showing genetically stable resistance to 
PZQ (Doenhoff and Pica-Mattoccia, 2006) despite the earlier speculation reported 
elsewhere (Ismail et al., 1996, Picquet et al., 1998). The absence of well documented 
resistance should not discourage the effort for regular monitoring of PZQ efficacy. 
Resistance has been shown to develop in nematode infections of domestic livestock and 
one must be aware that increasing drug pressure acting on genetically diverse 
schistosome populations could select for resistant phenotypes (Doenhoff et al., 2009).  
Periodic drug efficacy monitoring can be used to confirm maintenance of drug efficacy 
levels e.g. for schistosomiasis in Pemba (Guidi et al., 2010) but is labour intensive and 
efforts are being made to develop genetic monitoring of the parasite populations for 
changes which might be associated with loss of susceptibility. The advent of 
schistosome DNA sequencing has increased the attention and opportunity of studying 
the evolutionary relationships of schistosomes (Le et al., 2000) and their genetic 
diversity which may confer variation in disease morbidity, transmission and 
immunological responses (Rollinson et al., 1997). So far, two major groups of S. 
haematobium have been identified using partial sequences of the mitochondrial 
cytochrome oxidase sub-unit 1 gene (Cox-1). These groups are designated as group 1 
(G1) that is found in mainland Africa and group 2 (G2) that is found in Indian Ocean 
Islands (Webster et al., 2012a). Surprisingly, in Zanzibar both groups exist (Webster et 
al., 2012a). Despite the understanding of the existence of the various groups within the 
species of S. haematobium, the consequence in terms of susceptibility to drug (PZQ) 
and its implication for the control have not yet been fully elucidated. Preliminary work 
suggests that genetic diversity may associate with displayed differences in schistosome 
susceptibility to PZQ. This possibility is supported by the fact that resistance to earlier 
other anti-schistosome drugs, oxamniquine and hycanthone has been associated with 
genomic change (Brindley et al., 1989, Brindley et al., 1991, Valentim et al., 2013). 
Concern about possible loss of PZQ efficacy increases worries for the control 
programmes particularly because PZQ is the only drug of choice for the treatment of 
schistosomiasis and is in large scale use for control. The genetic characterisation of 
schistosomes may address interesting questions: (1) what will be the alternative drug if 
PZQ becomes resistant to any of the existing S. haematobium groups? (2) Which of the 
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groups is highly transmissible? (3) Which of the groups displays serious diseases 
pathology?  
The studies and control effort for schistosomiasis in Zanzibar began in 1920s 
(McCarthy, 1930, Cawston, 1927, Mansfield-Aders, 1927), however, there was 
interruption of the program as a result of lack of fund. But in recent years, as for many 
other schistosomiasis endemic countries, Zanzibar adopted chemotherapy based control 
strategy to fight against schistosomiasis and even more recently there is a change of 
strategy aiming for elimination of the disease (Knopp et al., 2013). Thus, there is a need 
to regularly monitor drug efficacy and also assess schistosome genetic diversity in 
response to drug treatment. 
 
8.2 Results 
8.2.1 Establishing the baseline efficacy of PZQ in 2011 (pre-SCORE)  
8.2.1.1 Study site and population 
 The characteristic of the study site has been described elsewhere. In January 2010, all 
primary school-children aged from 7-13 yrs were treated with praziquantel (40 mg/kg 
body weight) for schistosomiasis. The treatment of the school-children was repeated in 
2011 following completion of this assessment (described below). 
Figure 62 illustrates the profile of the enrolled children. A total of 359 school children 
that were infected with schistosomiasis were followed-up to assess the efficacy of 
praziquantel. Of these 37 (10.3%) dropped out during the initial follow-up, 304 (84.7%) 
were found to be egg negative but 18 (5.0%) were still excreting eggs and were 
retreated. Amongst these 18, 8 (44.4%) passed live eggs (as they released miracidia). 
The overall cure rate (CR) at the first follow-up was 94.4% and the egg reduction rate 
(ERR) was 76.1%. Out of the 18 children who were egg positive after initial follow-up, 
only 2 (11.1%) still passed eggs on subsequent follow-up and in neither case were the 
eggs viable as judged by the failure to release miracidia. This resulted in 88.9% CR at 
this time point and a cumulative CR of 99.4%. The ERR at the second follow-up was 
59.9%. 
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8.2.2 Follow-up efficacy of PZQ in 2013 
The characteristics of the population for this assessment have been descried in section 
3.3.4 above. A total of 176 school-children were treated with PZQ 40mg/kg and 
followed as indicated in section 2.4. During the initial follow-up 4weeks post-treatment, 
154 children were cured as judged by not passing S. haematobium egg in their urines- 
giving a CR of 87.5% and ERR of 87.01%. All the 22 children that produced S. 
haematobium eggs at first follow-up were followed again at week 7 post treatment and 
were found negative i.e. they were not discharging eggs resulting in 100% CR 
cumulatively.  
8.2.3 Amplification of Cox-1 gene  
Initially it was essential to establish methodology and to determine the presence of the 
Cox-1 amplicon specific for S. haematobium from the miracidia collected from urine 
samples before investigating genetic variability as this would confirm the schistosome 
parasite species. A total of 160 potential miracidia collected pre- and post-treatment 
were tested for the presence of Cox-1 using PCR but only 89 were successfully 
amplified. The lack of amplification in 71 samples indicates lack of true presence of the 
samples rather than absence of the Cox-1 gene.  Cox-1 amplicons from 89miracidia 
from 5 children infected with schistosomiasis pre- and post- treatment with PZQ were 
obtained (Figure 63). Of these, 74 amplicons were successfully sequenced. The list of 
children with their schools where the study was carried out is shown in Table 22. 
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Figure 63: Enrolment and follow-up of the children examined for the schistosomiasis 
and praziquantel efficacy.  
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Table 22: Origin of the miracidia that were used for determination of Cox-1 gene and 
subsequent sequencing  
  
 ChildID            No. of miracidia   School   District 
  Pre-treatment     Post-treatment (4 weeks) 
NG 92   8   8 Ng’ombeni  Mkoani 
CB12   8   9 Chambani  Mkoani 
CB65   10   9 Chambani  Mkoani 
MT54   8   11 Mtambile  Mkoani 
CM55   10   8 Chanjamjawiri Chake 
  
 
Figure 64: Amplification of the cox-1 gene from S. haematobium miracidia 
 
Figure 64: Amplification of the cox-1 gene from S. haematobium miracidia. Lane M is the 
ladder. Samples are numbered from 1 to 15; numbers 16 and 17 are negative and positive 
 195 
 
controls respectively (NB the positive control strong band was off the end of the photograph). 
The DNA fragments were separated on 0.8% gel red agarose gel and visualised on a UV 
transilluminator. 
 
8.2.4 Sequencing and haplotype Analysis 
Of the 89 amplified Cox-1 genes for S. haematobium subjected for sequencing only 74 
(83.1%) were successfully sequenced. From these sequences, 20 different haplotypes 
(groups) were identified. When these groups were matched with the previous published 
data from Webster and colleagues, (2012), (Webster et al., 2012a) both Indian Ocean 
Islands (Zanzibar, Madagascar and Mafia) specific haplotypes, mainland Africa specific 
and uniquely (not previously described) haplotypes were identified as shown in Table 
23. Surprisingly some of the uniquely identified haplotypes were only found from one 
geographical location (Table 8.2: rows 4, 5 & 6- from Mtambile and Chambani 
respectively).         
 
Table 23: Grouping of S. haematobium haplotypes isolated in Zanzibar  
Individual  
Miracidia 
designation 
Matches to 
previous dataset* 
Group* Currently identified 
haplotype number on TCS  
and tree 
CM55.3 
CM55.6 
CM55.7 
CM55.8 
CM55.1F 
CB65.1F 
NB92.1F 
NB92.3F 
NB92.4F 
Zan10 Group 1 2 
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CB12.2F 
CB65.3 
MT54.1 
MT54.3 
MT54.2F 
NG92.1 
NG92.3 
NB92.2F 
NB92.6F 
Zan3 Group 2 1 
CM55.4F 
CM55.5F 
NG92.2 
NG92.4 
NG92.5 
NG92.6 
NG92.7 
NB92.5F 
Zan5 Group 2 3 
MT54.6 
MT54.3F 
MT54.5F  
MT54.6F 
MT54.7F 
Unique Group 2 4 
 197 
 
MT54.8F 
MT54.9F 
MT54.10F 
CB12.5 
CB12.6 
CB12.7 
CB12.4F 
CB65.7F 
Zan12 Group 2 5 
CB12.1F 
CB12.7F 
CB65.9 
CB65.4F 
Zan19 Group 2 6 
CB65.9F 
MT54.4 
MT54.5 
MT54.1F 
Zan2 Group 2 7 
CB65.2F 
CB65.6F 
Zan4 Group 1 13 
CB65.6 
CB65.8 
Zan8 Group 1 15 
CB12.1 
CB12.2 
Unique Group 2 8 
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CB65.7 
CB12.4 
CB12.3 
CB12.3F 
Unique Group 2 9 
CB65.1 
CB65.5 
CB65.3F 
Unique Group 2 10 
CB65.2 
CB65.4 
CB65.8F 
Unique Group 2 11 
CM55.1 
CM55.5 
CM55.2F 
Unique Group 2 12 
CB12.6F Zan11 Group 1 18 
CM55.2 
CB65.5F 
Unique Group 1 14 
MT54.2 
MT54.4F 
Unique Group 2 16 
CM12.5F Unique Group 2 17 
CM55.3F Unique Group 1 19 
CM55.4 Unique Group 1 20 
 
 * refers to data in Webster et al., 2012a   
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Interestingly within each of the previously known groups, there were haplotypes which 
have not been identified before (“unique”). For example, within the group of mainland 
Africa, initially identified as group 1 (G1) there were 7 different haplotypes (number of 
miracidia = 18), of which 3 haplotypes were newly observed. Similarly, within the 
group 2 (G2) there were 13 haplotypes (number of miracidia = 56) 8 of which were 
uniquely identified. Moreover, individual children shed a combination of parasite 
haplotypes, none of them produced single group haplotypes and the genetic diversity 
was high. Interestingly, some children shed eggs leading to more uniquely identified 
haplotypes post treatment with PZQ compared with pretreatment. Furthermore, each 
individual child displayed number genetic variants of S. haematobium pre- and post-
treatment as shown in Table 24 
 
Table 24: Genetic variants of S. haematobium parasites observed pre and post treatment 
with PZQ 
Child ID     Number of genetic variants*   Haplotype 
group 
    Pre-treatment      Post-treatment 
 
NG92            2   2    1
  
NG92       3    2 
NG92             4   2    3 
CB12       1    1 
CB12             2   2    5 
CB12       2    6 
CB12     2      8 
CB12     2  1    9 
CB12       1    17 
CB12       1    18 
MT54     1  2    1 
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MT54       8    4 
MT54     2  1    7 
MT54     1  1    16 
CM55     4  1    2 
CM55     2  1    12 
CM55     1      20 
CM55       1    19
   
CB65       1    5 
CB65     1  1    6 
CB65       1    7 
CB65       1    8 
CB65     2  1    10 
CB65     2  1    11 
CB65     2  1    12 
CB65       2    13 
CB65     1  1    14 
CB65     2      15 
 
Table 8.3 legend: * relates to the numbers of individual miracidia sequenced 
Furthermore, it was noted that some of the uniquely identified haplotypes were from 
eggs isolated from children that were initially uncured after an initial dose (40mg/kg) of 
PZQ although eggs were not detected from those children following retreatment during 
the subsequent follow-up 7weeks post treatment.    
 
8.2.5 Phylogenetic analysis 
As shown above, from the aligned sequence data, highly diverse haplotypes were 
detected which fall into the previously known two major groups. Some of those 
haplotypes have not been identified before. The TCS analysis revealed similar findings. 
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Using statistical parsimony an evolutionary network demonstrating the recognized 
genealogy of Cox-1 barcodes is shown in the Neighbour-joining (NJ) tree in Figure 63. 
Interestingly, most of the uniquely identified haplotypes of S. haematobium were from 
Mtambile, Chambani and Ng’ombeni. These schools are located in Mkoani district 
(Figure 64) and somewhat closer to each other indicating possibility of increased 
movement of children resulting in common genotypes. 
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Figure 65 Neighbour Joining tree incorporating all 
the Cox-1 haplotypes analysed in this study. The 
majority of the samples are closely clustered, single 
links and representing a single polymorphic position. 
G1 and G2 relate to the two groups identified in 
Webster et al 2012 
G1 
G2 
 
  
 
 
Figure 65: Neighbour Joining tree incorporating 
all the Cox-1 haplotypes 
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 Figure 66: A section of Pemba Island indicating schools where samples for barcoding 
analysis were collected. 
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8.3 Discussion  
The general goal of PC control for schistosomiasis is to mitigate the morbidity through 
administration of PZQ. However, as the strategy is implemented this may lead to 
intensive and persistent new selection pressures on the parasite population. Studies have 
shown that selection pressure can rapidly transform schistosomes’ infectivity, virulence 
phenotypes and population genetics within a few generations (Davies et al., 2001). This 
present study was set up to apply genetic population genetic analysis to determine 
baseline genetic diversity of S. haematobium in Pemba in relation to the potential 
effects of the subsequent ongoing administration of PZQ in community wide treatment 
or SBT through the ZNCP.  
Overall marked variation of S. haematobium genetic markers was demonstrated; with 
20 different haplotypes being identified which fell  into two major groups (G1 & G2) of 
S. haematobium similar to that described earlier by other workers (Webster et al., 
2012a). Moreover, each individual child produced a mixture of haplotypes (table 23) 
though some of them were predominantly produced by certain children and hence were 
more common from certain geographical area. For example the haplotypes designed as 
Zan10 were only found in children from Chanjamjawiri and Ng’ombeni whilst Zan3 
haplotypes was found in three locations (Chambani, Mtambile and Ng’ombeni). 
Likewise, haplotypes Zan12 and Zan19 were only observed from Chambani. It has been 
shown that parasite population diversity or genotype alteration is an expression of 
genetic exchange between parasite populations in diverse geographical locations 
(Norton et al., 2010). The striking observation revealed in this study is that some of the 
uniquely identified haplotype were only isolated from children failed to be cured with 
PZQ during the first follow-up at fourth week post PZQ administration.  
Cure rates assessed a few weeks following a single dose of PZQ are generally in the 
range 70-90% (Gryseels et al., 2001a) similar to the present study. Possible explanations 
for the presence of eggs and therefore persisting worms following PZQ treatment 4 
weeks previously include the presence of immature worms at the time of treatment 
which survive PZQ treatment and mature to egg production. Thus, studies have 
demonstrated that PZQ does not have an effect on immature schistosome worms 
(Caffrey, 2007, Fallon et al., 1996) as the tegument is not fully developed. Another 
plausible explanation is that that some children might carry both susceptible and 
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resistant schistosome genotypes. No such “resistance genes” have yet been identified in 
schistosomes and although genetic diversity was demonstrated in the present study any 
influence of this on PZQ susceptibility of the worms has not been established. 
Nevertheless, the occurrence of PZQ resistance is not expected any time soon due to 
various reasons: 1) the parasite’s obligate diecious sexual reproduction 2) Even with 
high drug distribution coverage usually there are individuals who escape treatment and 
so creating refugia 3) the long life-cycle of the parasite (King et al., 2000) (Botros and 
Bennett, 2007) 
 
Any such resistance genotypes would be subject to selection pressure and likely lead to 
reduced PZQ efficacy in the face of high level drug usage against the worm gene pool. 
Studies have suggested that MDA may lead to changes in the frequency of particular 
alleles and genotypes in the population which could be linked to genes involved in 
susceptibility to treatment (Norton et al., 2010). However, although such analysis may 
ultimately identify existence of genetic factors influencing PZQ efficacy, the present 
studies did not demonstrate loss if PZQ efficacy in practice. At baseline the CR and 
ERR at initial follow-up 4weeks post-treatment were 94.4% and 76.1% respectively. In 
the subsequent follow-up, the CR increased to 99.4% (cumulatively). An additional 
efficacy assessment carried out 2yrs later (2013) revealed slightly lower CR (87.5%) but 
higher ERR (87.01%) compared to baseline. On both occasions, efficacy was similar to 
that described previously by other workers in the same setting (Guidi et al., 2010).  
These efficacy indicators are within the acceptable ranges and comparable to the CR for 
S.mansoni of 70-90% (Gryseels et al., 2001a) and for S. haematobium (Kardaman et al., 
1983, Gryseels et al., 1987).  There was thus no evidence of loss of PZQ efficacy over 
time in Pemba or as a result of two years of twice-yearly MDA.  
Assessment of the phylogenetic relationships of the isolates studied found that most of 
them are clustered together, sharing common ancestors. This indicated that there is high 
movement of people across Pemba Island not only because of trade but also from other 
social reasons including high inter-marriage and that people tend to frequently visit 
families, although the travel history of the children was not established.  
In conclusion, high genetic diversity within S. haematobium across Pemba Island was 
identified at the start of the proposed ZNCP/SCORE initiatives. It would be valuable to 
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monitor stability/fluctuations in these haplotypes over the course of the continuing 
intensive PC but this was beyond the scope and resources of the present study. It would 
also be of interest to further determine S. haematobium population genetics using 
microsatellite markers so as to understand gene flow, allele frequency and 
accompanying mutation which might have implications for the control of the diseases. 
This is especially important as the preventive chemotherapy with PZQ is intensively 
distributed among the population which in turn increases the drug selection pressure and 
hence increases the potential for drug resistance.  
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Chapter 9 General Discussion 
 
Preventive chemotherapy (PC) is the main strategy for the control of morbidity due to 
schistosomiasis and soil transmitted helminths (STH). The crucial and immediate 
impact of PC based strategies was acknowledged in the Fifty-fourth World Health 
Assembly document “WHA54.19 Schistosomiasis and soil-transmitted helminth 
infections” which urged schistosomiasis endemic countries to attain a minimum target 
of regular administration of chemotherapy to at least 75%. The Schistosomiasis Control 
Initiative (SCI) in particular has provided support to control programmes in several 
countries in Sub-Saharan Africa to tackle morbidity due to these worms through the use 
of both SBT as well as MDA (Fenwick, 2015, Fenwick et al., 2009b, Garba et al., 
2009).  
Regarding STHs the 2020 WHO roadmap for neglected tropical diseases (NTD) (WHO, 
2015b) advocated implementing integrated approaches but largely due to financial 
constraints, the control of STH still also relies on PC to alleviate associated morbidities. 
Such control measures have been proved to be successful in maintaining intensity at low 
level and hence prevent development of subtle morbidity (Albonico et al., 2006), 
although a recent review by Campbell and colleagues (2016) raised concerns about the 
real impact of large scale chemotherapy (Campbell et al., 2016).    
Implementation and impact of the control interventions – urinary schistosomiasis 
In Pemba, Zanzibar, as summarized in Figure 6, intensive annual selective treatment 
with PZQ targeted at school-children (1986-1988) in which school-children aged 
between 5-19yrs were diagnosed and those found positive were treated, led to a marked 
decline in prevalence of haematuria as a measure of schistosomiasis from the baseline 
of 54.1% to around 13% (Savioli and Mott, 1989). After this there was a period (1989-
1998) of school-based treatments (SBT), twice a year but later, due to the high cost and 
limited availability of praziquantel, only once a year and restricted to high prevalence 
schools was delivered between the years 1994-2002.  
After this period, the prevalence had risen to 31% and following subsequent sporadic 
provision of SBT prevalence had rebounded by 2004 to 63% among the school-children 
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and 37% in the community (Mr Haji, Unpublished data). Then in 2004-2006 
reintroduction of intense treatment through CWT-MDA supported by the 
Schistosomiasis Control Initiative (SCI) again led to marked reductions in prevalence 
which in 2007 had fallen to 18% based both on haemastix testing and egg detection. It is 
clear from Table 3.1 that selective or mass chemotherapy can have a major impact on 
prevalence of schistosomiasis but the impact of the targeted SBT on prevalence had not 
been monitored in Pemba. At the outset of this thesis it was planned to monitor the 
impact on transmission of the introduction of a more consistent implementation of SBT 
with PZQ. Delivery of MBZ was included in this SBT and so monitoring of STH levels 
was also undertaken. As summarized in Figure 34, sporadic use of MBZ in Pemba had 
not had marked effects in reducing the high prevalence of STH although MDA using  
ALB in 2004-5 did reduce prevalence noticeably. It should be emphasized that it is the 
intensity of these helminth infections which relates to pathology and disease rather than 
prevalence per se and chemotherapy can dramatically reduce worm burdens and so 
disease in individuals even though they may not be “cured” and still pass eggs. This 
effect is most pronounced in areas with high prevalence of infections (notably >50%) 
(Albonico et al., 2006, King et al., 1988) The impact of PC with PZQ had been 
monitored in Pemba over the years by microhaematuria, a valuable index of disease and 
of intensity of infection (Warren et al., 1979). Because of the importance of both 
prevalence and intensity of infection in monitoring effectiveness of helminth control 
both parameters were measured in most of the work described in this thesis. 
Despite the lack of data on the effectiveness of SBT on helminth infection from Pemba 
this approach is widely implemented targeting treatment, with praziquantel and 
albendazole or mebendazole, to school-aged children, because this sub-population 
harbours heavy disease burdens and benefits most from improved development 
(Stothard et al., 2013b, Hotez et al., 2006a, Anderson and May, 1992, Brooker, 2010). 
So SBT was reintroduced in Pemba in 2009 although its implementation and monitoring 
was inconsistent until the initiation of this study and the implementation of the National 
Plan for Pemba in 2010 which initially involved annual SBT with ALB and PZQ.  
At the outset, the work in this PhD concerned monitoring the effectiveness of this 
reintroduction of SBT on transmission as a baseline for this thesis. A baseline survey (in 
2010), carried out in the first class of primary school children, Standard-1 (Std-1) from 
24 schools, showed Schistosoma haematobium infection in 9.5% of children with boys 
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having higher prevalence and intensity than girls, although the majority of infections 
were light. The prevalence of any STH worm was 93.9% and the prevalence of the three 
common STH species was 46.7%, 87.4% and 50.5% for Ascaris lumbricoides, Trichuris 
trichiura and hookworms respectively. For all of the STH species, girls were more 
infected than boys. Following implementation of SBT in 2010, the new cohort of Std-1 
children were tested in the same schools one year later (2011) and the prevalence of 
schistosomiasis recorded as 18.9%. The Std-3 children who had received the school-
based treatment in 2010 showed a lower prevalence (11.3%). The prevalence of STH 
was very similar in both years (90-93% for any STH and the majority of children had 
light intensity infections. The impact of a further round of SBT in 2012 showed no 
decline in the prevalence (17.6%) or intensity of S. haematobium or STH. Overall the 
prevalence and intensity of S. haematobium and of STH in the Std-1 children had not 
been measurably improved by the reintroduction of single annual SBT. Following 
shifting of treatment strategy, from single SBT to twice yearly MDA, further surveys 
for STH were carried out in 2013 that revealed inconsistent reductions in both the 
overall and worm-specific prevalences. Similarly, the intensity of infections was also 
inconsistently reduced although the majority of infected children had light infections. 
In view of the lack of effect of SBT on lowering prevalence or intensity it was proposed 
that the emphasis of the ZNCP be switched to use of MDA. Coincident with this the low 
prevalence of <10% initially recorded in the baseline survey in 2010 had alerted the 
attention of the SCORE programme managers. The SCORE programme secretariat 
based at the University of Georgia, Atlanta, United States of America, had solicited 
funds from the Bill and Melinda Gates Foundation in order to carry out operational 
research to assess strategies aimed at to elimination of schistosomiasis (Hotez and 
Fenwick, 2009, Colley, 2014). The SCORE secretariat – which comprised Prof Daniel 
Colley (Programme Director), Dr Carl Campbell, Dr Sue Binder, Mrs. Tammy Andros, 
Mrs. Jennifer Castleman, Mrs. Nupur Kittur and Prof Charles King initiated discussions 
through Prof David Rollinson of the NHM, London, in engaging the ZHCP in the fight 
against schistosomiasis. Given the complexity of eliminating schistosomiasis, SCORE 
aimed at assessing the effectiveness of combinations of various interventions and also 
demonstrating their feasibility and associated cost. It was acknowledged that, for 
various reasons including limited funds (Fenwick et al., 2009c), elimination of 
schistosomiasis might take time to be achieved in many settings such as Pemba and so 
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PC may well remain as the main control strategy. Therefore, the SCORE programme 
joined forces with the ZNCP by also assessing the effectiveness of MDA alone in this 
endeavour. This approach was consistent with WHO policy to shift focus from 
morbidity control to interruption of transmission and elimination where feasible (WHO, 
2012, WHO, 2015b)  
[http://www.who.int/neglected_diseases/London_Declaration_NTDs.pdf]   
[http://www.who.int/neglected_diseases/9789241564540/en/]).  
Zanzibar resolved to try to eliminate schistosomiasis as a public health problem 
(Zanzibar Elimination of Schistosomiasis Transmission programme, ZEST) through 
implementation of integrated approaches (Knopp et al., 2012). The potential for the 
elimination was considered feasible because: 1) only one species of schistosome, S. 
haematobium, exists in Zanzibar 2) the prevalence of infection was not high (15.114% in 
Pemba and 8.0% in Unguja), at the time of the initiation of the project.  Thus in 2010 
preliminary discussions between the Ministry of Health – through ZHCP, SCORE and 
NHM were started and finally an agreement was reached. Based on these prevalences 
the project set different aims between the two Islands. For Unguja the aim was to 
eliminate schistosomiasis as a public health problem for 3 years and interrupt 
transmission in 5 years whilst for Pemba the aim was to control schistosomiasis 
throughout the Island and specifically, to reduce prevalence to below 10% in 3 years 
and eliminate it as a public health problem in 5 years (Knopp et al., 2012). The SCORE 
secretariat agreed to fund the project which started its implementation in 2012. In 
particular, the project trialled implementation of MDA alone or MDA in combination 
with snail control or behavioural modification in defined areas. The implementation of 
snail control activities which involved application of molluscicide, niclosamide, started 
effectively in August, 2012, two months after the heavy rains and was only carried out 
for 3months.  The application of niclosamide was done focally i.e only in areas where 
there is human contact. This implementation period was deemed insufficient to 
effectively reduce snail population to positively interrupt schistosomiasis transmission. 
Hence it was agreed to increase field time to cover 8month/year and halt activities 
during heavy rains seasons (April-July).  
                                                 
14
 This prevalence was obtained in 2011 –described in detail in chapter 3 (survey_2 cohort 24) 
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The behavioural change strategy was considered as a bottom-up approach (Person et al., 
2016) and consisted of various major (football, netball) and minor (tosse game, drama) 
sport games. The games were meant to engage children to move them away from risky 
behaviours which can lead to acquisition of schistosomiasis. Furthermore, there were 
series of training sessions given to school and madrasa teachers.  Additionally, in some 
occasions the team organized “Kichocho day”- specific day in which children competed 
in different sport games. Minor sport games carried health education information –and 
explained dangers of engaging in risk behaviours. Nevertheless, behavioural changes 
evolved over the years and new approaches were incorporated based on the results of 
periodic surveys (Person et al., 2016). For instance, installation of washing platforms 
came later during the course of implementation of the strategy.  
As aforementioned, in 2012, the ZHCP implemented the multi-year project aimed at 
eliminating schistosomiasis as a public health problem by application of MDA across 
the island supplemented by snail control and behavioural modification in defined areas. 
Prior to implementation of this MDA a new extensive baseline survey of Std-3 and Std-
4 children in 2012 gave a prevalence of 8.3% of schistosomiasis. At the beginning of 
the project, the MDA was administered twice/year in the communities alone but 
following disappointing results at the first follow-up survey (2013), the strategy was 
changed to include twice/yearly MDA in communities and also SBT in schools.  
Monitoring of the schoolchildren over 2012-2014 showed a progressive reduction to 
5.3% overall prevalence in 2014. However, the different interventions of ZEST revealed 
variable reductions in prevalence, with the Behavioural change cohort showing the most 
positive downward trend (Behaviour > Snail control > MDA alone). The intensity of 
schistosomiasis also showed downward trends in the mean egg count over the years 
although reduction in the proportion of children with heavy infection was inconsistent. 
Survey data carried out at the end of the SCORE intervention in 2017 (after completion 
of the work in this thesis) showed prevalences of 1.4% for MDA, 2.8% for Behaviour 
and 1.8% for the Snail arm suggesting that the Snail control arm may have been the 
most effective interventions.  Regarding the fact that the Behaviour arm seemed to be 
the most effective during the period when this thesis data was collected (2012-2014) 
may be explained by the fact that the Behavioural initiatives were initiated and 
implemented much earlier compared to Snail control activities in this period.  
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Implementation of Snail control and Behavioural interventions were novel in Pemba 
and much of value was learnt about their use and about how this could be improved.  
Washing platforms were not necessarily installed adjacent to surface water bodies-
almost all were installed around taps or wells and the numbers varied in the different  
shehias (ranging from 2-4/shehia). The installation of washing platform was a novel 
idea that aimed at keeping away children and community members from risky 
behaviour and reducing frequent contact with surface water bodies but installation 
adjacent to other sources of water supplies may complicate the effectiveness of the 
education campaign provided. It is considered likely that individuals who used installed 
washing platforms were not those who used surface water bodies for domestic purposes. 
For various reasons, women tend to prefer using surface water bodies for washing 
clothes and utensils rather than tap water or wells. One reason for this is that it is 
perceived that less soap is required in natural water sources. The true impact of the 
washing platforms is also difficult to assess since they were inconsistently and 
progressively constructed during the course of the SCORE interventions.  
Based on the results of SCORE it would seem feasible to interrupt schistosomiasis 
transmission and achieve elimination of schistosomiasis as a public health problem in 
Zanzibar. It is likely that this would require maintaining components of the various 
interventions trialled in SCORE although what this would need to consist of is uncertain 
as it should also be noted that during the project period there has also been a remarkable 
increase in the distribution and so availability of safe water supplies in many 
communities. Several countries in the world where low transmission exists or has been 
achieved have targeted elimination of transmission using integrated approaches. The 
successes in these areas and the challenges still posed have been reviewed in two 
workshop manuscripts (WHO, 2007, WHO, 2009)  
Recommendations: Integrated interventions could be the long-term solution for 
interrupting transmission of schistosomiasis in Pemba and eventually lead to 
elimination. Continued evaluation of the washing platforms built during SCORE will 
provide useful insight into their value. However, the other components of the Behaviour 
and snail control interventions of SCORE have now ceased in Pemba and in such poor 
resource areas, it would be difficult to maintain such integrated control measures at the 
same and so focusing on PC in areas with high transmission coupled with low-cost 
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behavioural changes and strengthening of diagnostic capability of health facilities could 
be essential. 
Implementation and impact of the control interventions – STH 
The control measures against STH infection were solely based on PC as for 
schistosomiasis (initially with SBT and later with MDA) and implemented in parallel 
for the two infections. So the changes in the strategies imposed for schistosomiasis also 
affected the control of STH. Monitoring of impact of those strategies was carried out 
through investigation of the prevalence and intensity in the newly Std-1 children from 
2010-2013. On one occasion, 2011, Std-3 children were also sampled. This allowed 
comparison of worm burden between younger (Std-1) and older aged children (Std-3) 
and provided opportunity to assess the effect of the treatment in the community. At 
baseline (2010), the prevalence of any STH worm was 93.9% and the prevalence of the 
three common STH species was 46.7%, 87.4% and 50.5% for Ascaris lumbricoides, 
Trichuris trichiura and hookworms respectively. For all of the STH species, girls were 
more infected than boys. A substantial proportion of children had polyparasitoses- with 
double (20.8% had T.trichiura and hookworm and 18.2% has A. lumbricoide and T. 
trichiura) or triple (25%) infections. The survey carried out in 2011, after 
implementation of one round of annual SBT, overall, showed slightly lower mean 
prevalence (89.79%) compared to baseline.  Std-1 (younger) children who were not 
treated in 2010 were more infected (90.71%) than Std-3 (88.86%) (older) children who 
received treatment in 2010. This indicates that single annual SBT did not interrupt 
transmission of STH infection in the communities but had some impact in the older 
children.    
As explained above, there was a shift of strategy – from single SBT to twice yearly 
MDA which was carried out in 2012. As for SBT, the monitoring of impact was carried 
out by sampling newly Std-1 children in 2013. The prevalence of any STH worm was a 
little lower at 86.2% and again a substantial proportion of children had either double or 
triple infections. On all occasions, the majority of the infected children had light 
intensity infections with any of the three worms (A. lumbricoides, T. trichiura or 
hookworm), although, there was no consistent change in intensity over the years. The 
observation of mixed infection with STH and significant prevalences of all three species 
in this setting was not a surprising finding as it has been previously reported in other 
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studies in Pemba (Albonico et al., 1997, Albonico et al., 1993).  A similar situation was 
reported in Unguja (Knopp et al., 2009) where epidemiological and environmental 
factors are very similar. The occurrence of multiple parasites has been reported 
elsewhere, though at varying levels (Gabrielli et al., 2005, de Gier et al., 2016, Odiere et 
al., 2011, Tchuem Tchuente et al., 2003) although many of the studies carried out in the 
other parts of Tanzania have shown low prevalences of infections with sometimes only 
one or two species of the STH worms detected (Mugono et al., 2014, Siza et al., 2015, 
Kaatano et al., 2015). This consistently high prevalence of STH infection in Pemba 
could be explained by the diversity of ecological niches facilitating the different life 
cycles with the peridomestic setting (around the houses/schools) maybe favouring the 
transmission of Ascaris and Trichuris and the high level of rural agriculture with which 
children from a young age help, facilitating hookworm. In this present study the effect 
of multiple parasites in terms of development of anaemia or other morbidity indicators 
was not established but it is apparent that occurrence of poly-parasites has adverse 
effect on the health of the infected individuals especially young children (de Gier et al., 
2016).   
Recommendations: As advocated in the 2020 WHO roadmap for neglected tropical 
diseases (NTD) (WHO, 2015b) helminth control is integrated in many endemic 
countries.  As demonstrated in a limited number of schistosomiasis and STH co-
endemic countries, elimination of these infections can be achieved through 
implementation of integrated control measures such as snail control with 
mollusciciding, environmental modification education aimed at behavioural changes 
and chemotherapy supplemented with WASH strategy. However, for many reasons, 
concurrent implementation of these strategies cannot be realized in most endemic 
countries and PC is advocated (Gabrielli et al., 2011, Utzinger et al., 2003, WHO, 2006, 
WHO, 2002b) especially following endorsement of WHA 54.19 (Savioli et al., 2009, 
Stothard et al., 2009a) The PC approach has proved effective in reducing and/or 
preventing development of disease sequel resulting from schistosomiasis or STH 
(Webster et al., 2014, Fenwick et al., 2009a). The data in this thesis from Pemba shows 
that MDA/SBT proved to be useful strategies in sustaining infection intensity at low 
level (light intensity) and so reducing morbidity related to STH. Thus, such PC should 
be continued along with low cost health education to improve the “H” (hygiene) 
 215 
 
component of WASH  to target reduction in the transmission of STHs.  The use of SBT 
or MDA will be dependent on available funding.  
MDA coverage and compliance 
Evaluation of drug coverage and compliance during the above MDA had not been 
carried out previously for PZQ and Albendazole in Pemba. It showed ~80% of the 
population received the drugs, although the therapeutic coverage was uncertain as direct 
observed therapy was not ensured. Nevertheless, 10.2% of the surveyed population 
were non-compliant to praziquantel and this differed between the districts. Albendazole 
compliance was better with a very low proportion (2.5%) of individuals non-compliant, 
these being similar in the different age-groups. 
Recommendations: For any future MDA careful thought needs to be given concerning 
the variation in compliance observed across the different areas of Pemba. There is a 
need to intensify sensitization meetings in the communities with discussion of the safety 
and also the potential side effects which may develop. There should be engagement of 
religious and other influential leaders during sensitization meetings. Ideally the number 
of personnel should be increased so as to ensure DOT is observed and to follow-up 
absentees.  
S. haematobium infection levels in <6yr old children 
A survey was carried out prior to the above implementation of MDA to assess the 
contribution of transmission of schistosomiasis in pre-school children (3-5yrs). This 
revealed 7.04% to be infected, some of them (21.9%) with severe infection. As a result, 
the above MDA was administered to >3yr olds. A questionnaire to mothers/guardians of 
such infants investigated the risk factors for such infection, notably water contact. The 
importance of infection in younger children has been emphasized by others (Sousa-
Figueiredo et al., 2010b) (Stothard et al., 2011) and  requires attention for 
implementation of concrete control measures and appropriate treatment strategies to 
prevent progressive development of disease pathology during childhood. 
Recommendations: In order to deliver treatment to younger children, safety data 
together with modification of the dose pole has been published describing its use for the 
delivery of PZQ (Sousa-Figueiredo et al., 2010b). Until a PZQ paediatric formulation 
for use in community wide treatment is available, effort should be made to ensure there 
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are adequate PZQ supplies in health facilities to treat pre-school aged children. This can 
be supported by strengthening of the respective health facilities. The government should 
be ready to register and order paediatric formulation once it becomes available. 
 
Schistosome transmission dynamics  
To improve understanding of transmission dynamics of schistosomiasis in Pemba, 
infection in snail intermediate hosts was initially monitored by cercarial shedding. A 
total of 1831 Bulinus snails were collected over 1year (2010-2011) from 6 sites. Only 
~1% shed cercariae, all from only 2 transmission sites. Confirmation of infection within 
the snails collected as well as identification of the Bulinus species was investigated 
using polymerase chain reaction (PCR) and DNA sequencing techniques in a sub-
population of the snail samples. This revealed that 56.4% of the Bulinus snails were 
positive for the Dra-1 gene of S. haematobium. Furthermore, partial sequencing of the 
cytochrome oxidase sub-unit 1 gene (Cox-1) of the Bulinus snails indicated the 
existence of B. nasutus and B. globosus and indicated that both species were implicated 
in the transmission of S. haematobium infection in Pemba. Of particular interest was the 
detection of Dra-1 gene characteristic of S. haematobium in B. nasutus as demonstrated 
by PCR and subsequent sequencing of Cox-1 gene; as well as the existence of B. 
globosus and B. nasutus in the same water body, (Kangagani). Studies have shown 
these two snail species are usually allopatric in nature (Stothard et al., 2000). Moreover, 
the previous studies carried out in a similar setting found that B. nasutus is not 
responsible for the transmission of S. haematobium infection and was also refractory to 
this schistosome species in experimental conditions (Stothard et al., 2000). Despite that, 
in the neighbouring country, Kenya, it has been shown that B. nasutus can transmit S. 
bovis (Barber et al., 2000) as well as S. haematobium infection (Kariuki et al., 2004a). 
At the time of the present study, S. bovis infection had not been demonstrated in Pemba. 
It should be noted that some detection systems such as PCR and enzyme-linked 
immunosorbent assay (ELISA) have shown cross-reactivity between S. bovis and other 
schistosome species which infect humans (Pardo et al., 2004, Hamburger et al., 2001). 
Thus the apparent finding of the S. haematobium infection in B. nasutus in Pemba is 
novel and warrants further research to elucidate the real transmission role of the B. 
nasutus with this parasite. 
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Recommendations: Further studies are needed to confirm the potential role of B. 
nasutus in the transmission of urogenital schistosomiasis in Pemba. This could be 
investigated by experimental exposure of morphologically characterised B. nasutus with 
miracidia of S haematobium derived from eggs passed in the urine of patients in Pemba 
in order to establish if they are susceptible to the human parasite  (Stothard et al., 2000). 
Infection of the snails would be monitored by cercarial shedding and/or molecular 
techniques undertaken to confirm the schistosome and snail species. Similar methods 
could be applied to confirming the existence of B. globosus and B. nasutus in the same 
water body, (Kangagani) and other water bodies in Pemba.  
 
Schistosome population dynamics (genetic diversity) 
Analysis of population genetic diversity of S. haematobium in relation to treatment 
pressure was initiated by PCR and partial sequencing of the Cox-1 gene from miracidia 
recovered from subjects. This revealed the existence and circulation in the communities, 
of highly diverse haplotypes of S. haematobium some of which had not been described 
previously but which fell into the two major groups (G1 & G2) of S. haematobium as 
described earlier (Webster et al., 2012a). However, PZQ efficacy in terms of cure rate 
and egg reduction rate were comparable at baseline and after two years of biannual 
MDA with PZQ and also comparable with earlier assessments of efficacy. This is an 
encouraging finding as currently PZQ is the only approved drug used for the treatment 
of schistosomiasis at individual level as well as for morbidity control. Furthermore, it is 
believed that development of PZQ resistance may take longer, if happens, because of 
the diecious nature and longevity of the parasite along with the existence of refugia 
from drug coverage (King et al., 2000, Botros and Bennett, 2007). 
Recommendations: Praziquantel should still be used for the treatment of 
schistosomiasis at the individual level and community wide or SBT. More studies are 
needed to assess the significance of the different parasite haplotypes and the G1 and G2 
groups on S. haematobium biology and notably possible influence on susceptibility to 
PZQ 
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Concluding statement 
Overall this work has helped establishment, implementation and monitoring of diverse 
strategies for improved control of helminth infections in Pemba and provided early 
evaluation of their relative efficacy. Completion of the ZNCP/SCORE initiative should 
help consolidate this work. There were a number of interesting other findings which 
merit follow-up. 
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Appendix 3.1 List of the schools in schistosomiasis assessment under the auspice of 
the SCORE initiative in 2012 
 
S/no School Name Status 
 
Baseline (2012) 
Prevalence  
Intervention  
  Old (Among 
cohort 24) 
New   
1 Chambani Yes  28.5 Behaviour 
2 Chanjamjawiri Yes  3.8 MDA 
3 Daya  Yes 0 Behaviour 
4 Finya  Yes 9.2 Snail control 
5 Jadida  Yes 4.4 Behaviour 
6 Kangagani Yes  16.9 Snail control 
7 Kangani  Yes 2.6 MDA 
8 Kengeja  Yes 3.9 Behaviour 
9 Kinowe Yes  11.7 Snail control 
10 Kinyasini  Yes 32.5 Behaviour 
11 Kisiwani  Yes 15.3 Snail control 
12 Kiwani  Yes 3 MDA 
13 Kizimbani Yes  28.8 Behaviour 
14 Konde A Yes  6.7 MDA 
15 Kwale  Yes 16.3 Snail control 
16 Madungu  Yes 0 MDA 
17 Makangale  Yes 3.6 Snail control 
18 Makombeni  Yes 0 Snail control 
19 Mbuzini  Yes 4 Snail control 
20 Mchangamdogo  Yes 2 Behaviour 
21 Mgogoni  Yes 16.9 Snail control 
22 Michenzani  Yes 3.8 Behaviour 
23 Miti ulaya  Yes 1.5 MDA 
24 Mkanyageni Yes  8.9 Snail control 
25 Msuka  Yes 1.5 Snail control 
26 Mtambile Yes  8.3 Behaviour 
27 Ng’ambwa  Yes 0.7 Behaviour  
28 Ng’ombeni Yes  0 Behaviour 
29 Ngwachani Yes  11.7 Behaviour 
30 Ole  Yes 5.8 MDA 
31 Pandani  Yes 6 MDA 
32 Piki Yes  23.8 Snail control 
33 Pondeani  Yes 2.2 MDA 
34 Pujini Yes  20.8 Behaviour 
35 Shumba Viamboni Yes  26.4 Snail control 
36 Shungi  Yes 5.5 Behaviour 
37 Sizini  Yes 2.7 Behaviour 
38 Tumbe Yes  3.2 MDA 
39 Ukutini  Yes 17.4 MDA 
40 Uwandani Yes  28.7 MDA 
41 Vitongoji  Yes 20 Snail control 
42 Wambaa  Yes 17.5 MDA 
43 Wawi  Yes 2.1 MDA 
44 Wesha Yes  3.3 MDA 
45 Ziwani Yes  13.5 Snail control 
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Appendix 3.2 Analysis of the score test for trend of schistosomiasis in Std-1 
children in cohort 24 schools from 2010-13 
. 
                                     Pr>chi2   =  0.0025
Test of homogeneity of ORs (approx): chi2(23)  =   46.67
                                                                    
       0.825898      25.24        0.0000         0.766509   0.889889
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for School
                                                                               
   Ziwani     0.592494          10.52         0.0012         0.43182    0.81296
   Wingwi     1.081337           0.12         0.7320         0.69121    1.69166
    Wesha     0.856926           0.08         0.7769         0.29452    2.49330
 Uwandani     0.907808           0.64         0.4220         0.71691    1.14953
    Tumbe     1.475318           0.76         0.3830         0.61587    3.53412
 S/viambo     1.041557           0.06         0.8076         0.75055    1.44539
   Pujini     0.945776           0.13         0.7225         0.69524    1.28659
     Piki     0.733603           5.21         0.0224         0.56231    0.95708
 Ngwachan     0.594007          11.14         0.0008         0.43748    0.80655
 Ng'omben     0.827007           0.57         0.4503         0.50504    1.35423
 Mzambara     0.763881           0.76         0.3829         0.41714    1.39885
 Mtambile     0.591267           7.65         0.0057         0.40746    0.85798
 Mkanyage     0.637883           4.24         0.0396         0.41571    0.97880
 Mizingan     0.654175           7.66         0.0056         0.48440    0.88345
 Michakai     0.631539           0.38         0.5383         0.14614    2.72922
  Konde B     1.004639           0.00         0.9795         0.70599    1.42963
  Konde A     1.142604           0.21         0.6505         0.64188    2.03392
 Kizimban     0.651761           3.54         0.0601         0.41715    1.01833
   Kinowe     1.399912           2.16         0.1416         0.89392    2.19232
 Kangagan     1.460451           5.90         0.0152         1.07584    1.98256
 K/minung     0.855593           1.11         0.2925         0.63995    1.14389
 Chanjamj     0.788257           1.16         0.2805         0.51168    1.21433
 Chambani     0.746502           5.97         0.0145         0.59045    0.94380
 Bagamoyo     0.565204           1.95         0.1627         0.25371    1.25915
                                                                               
   School   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by School
Score test for trend of odds with year
. mhodds schisresult year, by(School)
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Appendix 3.3A Score test for trend of Odds of infection in schools subjected to 
repeated treatment from 2010-2014 
 
 
 
                                     Pr>chi2   =  0.5429
Test of homogeneity of ORs (approx): chi2(4)   =    3.09
                                                                    
       0.922286       0.75        0.3857         0.768202   1.107275
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for school
                                                                               
    Wesha     0.979491           0.00         0.9590         0.44416    2.16005
 Uwandani     0.893601           0.88         0.3489         0.70619    1.13075
    Tumbe     1.405533           0.76         0.3842         0.65292    3.02569
  Konde A     1.143323           0.28         0.5935         0.69914    1.86971
 Chanjamj     0.715026           1.92         0.1658         0.44491    1.14915
                                                                               
   school   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by school
Score test for trend of odds with year
. xi:mhodds schisresult year, by(school)
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Appendix 3.3B Score test for trend of Odds of infection in schools subjected to 
repeated treatment from 2010-2014 
 
                                     Pr>chi2   =  0.0255
Test of homogeneity of ORs (approx): chi2(4)   =   11.10
                                                                    
       0.786834       4.92        0.0266         0.636567   0.972572
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for school
                                                                               
    Wesha     0.542170           1.58         0.2082         0.20898    1.40661
 Uwandani     1.010851           0.01         0.9400         0.76304    1.33914
    Tumbe     0.568437           1.39         0.2386         0.22218    1.45432
  Konde A     0.813155           0.64         0.4232         0.49017    1.34897
 Chanjamj     0.382085          12.39         0.0004         0.22363    0.65281
                                                                               
   school   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by school
Score test for trend of odds with year
. xi: mhodds schisto_infection year, by(school)
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Appendix 3.5 Score test for trend of schistosomiasis for combined Std-3&4 
schoolchildren from 2012- 2014 in different schools (cohort 45) in Pemba. 
 
  
                                     Pr>chi2   =  0.0000
Test of homogeneity of ORs (approx): chi2(43)  =  106.85
                                                                    
       0.798806      29.23        0.0000         0.736329   0.866584
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for school
                                                                               
   ZIWANI     0.635310           5.34         0.0208         0.43243    0.93337
    WESHA     0.324121           4.99         0.0255         0.12059    0.87116
     WAWI     1.665499           1.86         0.1724         0.80050    3.46519
   WAMBAA     1.403028           2.01         0.1563         0.87853    2.24067
 VITONGOJ     1.387868           3.67         0.0553         0.99266    1.94042
 UWANDANI     0.906233           0.36         0.5460         0.65832    1.24751
  UKUTINI     0.881560           0.33         0.5651         0.57374    1.35452
    TUMBE     0.505778           1.44         0.2297         0.16631    1.53818
   SIZINI     0.427064           2.32         0.1279         0.14281    1.27708
   SHUNGI     0.633010           1.58         0.2086         0.31038    1.29100
 SHU/VYAM     0.773928           2.60         0.1069         0.56674    1.05686
   PUJINI     0.691262           2.72         0.0991         0.44575    1.07201
 PONDEANI     0.343355           2.29         0.1301         0.08602    1.37053
     PIKI     0.624196           6.37         0.0116         0.43292    0.89998
  PANDANI     0.466197           2.58         0.1084         0.18363    1.18358
      OLE     0.933191           0.03         0.8518         0.45170    1.92794
 NGWACHAN     0.542856           3.68         0.0550         0.29085    1.01323
 NG'OMBEN     2.235676           0.89         0.3448         0.42128   11.86445
 NG'AMBWA     0.200138           1.67         0.1961         0.01746    2.29399
 MTAMBILE     0.332204          10.05         0.0015         0.16809    0.65656
    MSUKA     0.224793           3.06         0.0803         0.04219    1.19760
 MKANYAGE     0.582661           3.63         0.0567         0.33429    1.01555
 MITI ULA     1.173453           0.17         0.6827         0.54498    2.52668
 MICHENZA     0.520814           1.42         0.2334         0.17810    1.52299
  MGOGONI     1.151351           0.58         0.4473         0.80048    1.65602
  MBUZINI     2.169663           4.04         0.0444         1.01951    4.61733
 MAKOMBEN     3.832475           1.23         0.2668         0.35784   41.04559
 MAKANGAL     0.335544           3.54         0.0598         0.10764    1.04594
  MADUNGU            .              .             .               .          .
  M/MDOGO     0.204236           1.66         0.1970         0.01829    2.28109
    KWALE     0.200505          32.20         0.0000         0.11510    0.34927
  KONDE A     0.864975           0.24         0.6213         0.48650    1.53789
 KIZIMBAN     0.743962           3.43         0.0640         0.54404    1.01735
   KIWANI     0.900150           0.02         0.9018         0.16922    4.78839
 KISIWANI     0.681033           1.66         0.1973         0.37979    1.22123
 KINYASIN     0.707082           4.68         0.0305         0.51653    0.96793
   KINOWE     1.303461           1.03         0.3101         0.78136    2.17444
  KENGEJA     0.587966           1.16         0.2819         0.22347    1.54698
  KANGANI     1.136274           0.07         0.7880         0.44787    2.88279
 KANGAGAN     1.051407           0.10         0.7492         0.77317    1.42977
   JADIDA     1.314118           0.60         0.4390         0.65789    2.62493
    FINYA     0.354139           7.22         0.0072         0.16605    0.75530
     DAYA     2.942315           2.08         0.1491         0.67923   12.74569
 CHANJAMJ     0.659723           0.90         0.3424         0.27955    1.55692
 CHAMBANI     0.685104           4.54         0.0332         0.48374    0.97030
                                                                               
   school   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
      information about the effect of the explanatory variable
note: only 44 of the 45 strata formed in this analysis contribute
by school
Score test for trend of odds with year
. xi: mhodds schistoso_infect year, by(school)
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Appendix 3.4A Mantel-Haenzsel Score test for trends for schistosomiasis infection 
in different interventions in individual Stds (3 and 4) in cohort 45 schools over the 
years (2012-2014) 
 
 
                                     Pr>chi2   =  0.1237
Test of homogeneity of ORs (approx): chi2(5)   =    8.65
                                                                    
       0.795149      32.83        0.0000         0.735182   0.860008
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for intervention and standard
                                                                               
 Snail_co         4     0.818260        5.87      0.0154     0.69570    0.96241
 Snail_co         3     0.794336        7.24      0.0071     0.67170    0.93936
      MDA         4     0.814017        2.94      0.0864     0.64338    1.02991
      MDA         3     1.036365        0.09      0.7588     0.82505    1.30181
 Behaviou         4     0.713778       13.66      0.0002     0.59691    0.85353
 Behaviou         3     0.680544       11.68      0.0006     0.54575    0.84863
                                                                               
 interv~n  standard   Odds Ratio     chi2(1)      P>chi2   [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by intervention standard
Score test for trend of odds with year
. xi: mhodds schistoso_infect year, by(intervention standard )
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Appendix 3.4B MH Score test for trends for schistosomiasis infection in different 
interventions in cohort 45 schools over the years (2012-2014) 
 
                                     Pr>chi2   =  0.0537
Test of homogeneity of ORs (approx): chi2(2)   =    5.85
                                                                    
       0.798382      31.91        0.0000         0.738382   0.863257
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for intervention
                                                                               
 Snail_co     0.808073          12.90         0.0003         0.71936    0.90772
      MDA     0.921807           0.95         0.3300         0.78252    1.08589
 Behaviou     0.709000          23.91         0.0000         0.61770    0.81379
                                                                               
 interv~n   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by intervention
Score test for trend of odds with year
. xi: mhodds schistoso_infect year, by(intervention)
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Appendix 3.5A: Manten-Haenzsel analysis indicating the Odds of S. haematobium 
infection between 2010 and 2011 for Std-1 schoolchildren in different schools 
(cohort 24) in Pemba. 
Appendix 3.5B Score test for trend of schistosomiasis in Std-1 schoolchildren of 
from 2010- 2012 for Std-1 schoolchildren in different schools (cohort 24/17) in 
Pemba. 
 
                                     Pr>chi2   =  0.2309
Test of homogeneity of ORs (approx): chi2(23)  =   27.61
                                                                    
       2.346808      44.22        0.0000         1.811117   3.040945
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for School
                                                                               
   Ziwani     2.303571           2.91         0.0879         0.85901    6.17742
   Wingwi            .           7.61         0.0058               .          .
    Wesha     0.000000           0.98         0.3222               .          .
 Uwandani     2.373626           4.20         0.0404         1.01202    5.56720
    Tumbe            .           1.02         0.3124               .          .
 Shumba V     3.916667           4.29         0.0384         0.97093   15.79949
   Pujini     0.816667           0.13         0.7188         0.27070    2.46377
     Piki     1.319444           0.37         0.5409         0.54101    3.21794
 Ngwachan     0.833333           0.14         0.7087         0.31982    2.17133
 Ng'omben    12.782609           7.84         0.0051         1.27253  128.40182
 Mzambara     1.600000           0.21         0.6465         0.21069   12.15046
 Mtambile     4.040541           5.68         0.0171         1.16506   14.01298
 Mkanyage     1.559322           0.48         0.4889         0.43849    5.54511
 Mizingan     2.100000           2.46         0.1164         0.81410    5.41701
 Michakai            .           1.56         0.2113               .          .
  Konde B     9.800000           6.68         0.0098         1.16181   82.66381
  Konde A     2.177778           0.41         0.5235         0.18752   25.29182
 Kizimban     5.684211           5.47         0.0193         1.09597   29.48092
 Kiuyu Mi     2.479167           3.74         0.0532         0.95639    6.42653
   Kinowe            .           4.13         0.0423               .          .
 Kangagan     1.534091           0.40         0.5286         0.40124    5.86546
 Chanjamj     4.571429           3.96         0.0466         0.88217   23.68916
 Chambani     2.333333           4.27         0.0387         1.01976    5.33894
 Bagamoyo     1.980000           0.35         0.5569         0.19390   20.21848
                                                                               
   School   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
by School
Comparing year==2011 vs. year==2010
Maximum likelihood estimate of the odds ratio
. xi:mhodds schisresult year, by( School)
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                                     Pr>chi2   =  0.0000
Test of homogeneity of ORs (approx): chi2(16)  =   56.42
                                                                    
       1.102855       3.39        0.0657         0.993674   1.224033
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for school
                                                                               
   Ziwani     0.840525           0.76         0.3844         0.56824    1.24328
    Wesha     1.546129           0.81         0.3695         0.59699    4.00430
 Uwandani     0.932741           0.19         0.6606         0.68358    1.27272
    Tumbe     1.669089           1.14         0.2854         0.65207    4.27230
 S/vyambo     1.870537          11.73         0.0006         1.30716    2.67673
   Pujini     1.331160           2.19         0.1388         0.91145    1.94415
     Piki     1.016522           0.01         0.9261         0.71916    1.43683
 Ngwachan     0.634183           4.77         0.0290         0.42143    0.95434
 Ng'omben     0.371016           4.79         0.0287         0.15265    0.90175
 Mtambile     0.798555           0.94         0.3334         0.50625    1.25963
 Mkanyage     0.987506           0.00         0.9604         0.60101    1.62253
  Konde A     1.444666           1.32         0.2508         0.77110    2.70661
 Kizimban     2.036019          15.30         0.0001         1.42575    2.90750
   Kinowe     2.502214           9.88         0.0017         1.41229    4.43327
 Kangagan     1.369685           2.31         0.1283         0.91317    2.05442
 Chanjamj     0.647817           2.39         0.1218         0.37380    1.12271
 Chambani     0.838531           1.29         0.2565         0.61859    1.13667
                                                                               
   school   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by school
Score test for trend of odds with year
. xi:mhodds schisresult year, by( school)
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Appendix 4a: Mantel-Haenszel analysis of the Score test for trend of the odds of A. 
lumbricoide infection over the years (2010-2012) following two rounds of school 
based treatment with Albendazole 
 
 
 
                                     Pr>chi2   =  0.0000
Test of homogeneity of ORs (approx): chi2(23)  =   75.79
                                                                    
       1.115510       6.26        0.0123         1.023966   1.215237
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for school
                                                                               
   Ziwani     1.299868           1.27         0.2602         0.82346    2.05190
   Wingwi     1.317962           1.73         0.1880         0.87380    1.98789
    Wesha     1.509940           3.83         0.0504         0.99934    2.28143
 Uwandani     0.929212           0.13         0.7140         0.62744    1.37612
    Tumbe     2.713646          17.93         0.0000         1.70953    4.30755
 S/viambo     1.431237           3.50         0.0615         0.98293    2.08402
   Pujini     0.557005           9.02         0.0027         0.38023    0.81597
     Piki     1.134522           0.33         0.5675         0.73609    1.74861
 Ngwachan     1.825337           2.26         0.1327         0.83312    3.99926
 Ng'omben     0.759751           1.75         0.1853         0.50593    1.14091
 Mzambara     0.581614           6.76         0.0093         0.38657    0.87507
 Mtambile     1.049766           0.06         0.8120         0.70348    1.56651
 Mkanyage     0.903479           0.23         0.6329         0.59575    1.37017
 Mizingan     0.868967           0.53         0.4680         0.59466    1.26980
 Michakai     0.526627           6.12         0.0134         0.31681    0.87540
  Konde B     1.638013           6.15         0.0131         1.10903    2.41931
  Konde A     1.185483           0.75         0.3880         0.80561    1.74447
 Kizimban     1.379897           2.21         0.1370         0.90270    2.10935
   Kinowe     1.175126           0.50         0.4790         0.75169    1.83708
 Kangagan     1.394677           2.32         0.1278         0.90891    2.14007
 K/minung     1.824485           8.39         0.0038         1.21460    2.74062
 Chanjamj     1.174643           0.61         0.4351         0.78405    1.75982
 Chambani     0.752017           1.95         0.1628         0.50397    1.12214
 Bagamoyo     1.543894           3.73         0.0534         0.99372    2.39867
                                                                               
   school   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by school
Score test for trend of odds with year
. mhodds  asc_infection year, by( school)
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Appendix 4b: Mantel-Haenszel analysis of the Score test for trend of the odds of 
hookworm infection over the years (2010-2012) following two rounds of school 
based treatment with Albendazole 
 
. 
                                     Pr>chi2   =  0.0000
Test of homogeneity of ORs (approx): chi2(23)  =  117.54
                                                                    
       1.003056       0.00        0.9451         0.919689   1.093979
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for school
                                                                               
   Ziwani     0.958326           0.04         0.8371         0.63868    1.43794
   Wingwi     1.839199           9.15         0.0025         1.23933    2.72942
    Wesha     0.717492           2.69         0.1010         0.48252    1.06690
 Uwandani     0.853542           0.64         0.4231         0.57938    1.25744
    Tumbe     1.858327           6.37         0.0116         1.14834    3.00729
 S/viambo     1.843186           8.28         0.0040         1.21542    2.79520
   Pujini     0.555765           8.87         0.0029         0.37759    0.81803
     Piki     1.173118           0.62         0.4309         0.78850    1.74535
 Ngwachan     0.889289           0.09         0.7702         0.40471    1.95407
 Ng'omben     0.327259          23.81         0.0000         0.20895    0.51256
 Mzambara     1.354112           2.17         0.1412         0.90427    2.02773
 Mtambile     0.981104           0.01         0.9271         0.65184    1.47668
 Mkanyage     0.975684           0.01         0.9091         0.63938    1.48887
 Mizingan     0.776170           1.62         0.2037         0.52512    1.14725
 Michakai     0.362547          11.73         0.0006         0.20288    0.64788
  Konde B     1.580841           5.24         0.0221         1.06795    2.34006
  Konde A     1.516183           4.44         0.0352         1.02934    2.23328
 Kizimban     0.632821           4.05         0.0440         0.40537    0.98788
   Kinowe     3.059759          24.45         0.0000         1.96417    4.76645
 Kangagan     0.739169           1.71         0.1906         0.47007    1.16231
 K/minung     0.866239           0.50         0.4784         0.58241    1.28840
 Chanjamj     0.992676           0.00         0.9713         0.66480    1.48226
 Chambani     0.796540           1.04         0.3079         0.51439    1.23346
 Bagamoyo     0.982419           0.01         0.9418         0.61035    1.58129
                                                                               
   school   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by school
Score test for trend of odds with year
. mhodds   hwk_infection year, by( school)
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Appendix 4c: Mantel-Haenszel analysis of the Score test for trend of the odds of T. 
trichiura infection over the years (2010-2012) following two rounds of school based 
treatment with Albendazole. 
 
 
 
 
 
                                     Pr>chi2   =  0.0001
Test of homogeneity of ORs (approx): chi2(23)  =   56.60
                                                                    
       1.020288       0.10        0.7467         0.903232   1.152514
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for school
                                                                               
   Ziwani     1.171127           0.31         0.5801         0.66924    2.04940
   Wingwi     1.477414           1.84         0.1750         0.84059    2.59669
    Wesha     3.516381           9.89         0.0017         1.60592    7.69961
 Uwandani     0.931262           0.05         0.8157         0.51174    1.69470
    Tumbe     1.600530           0.87         0.3507         0.59601    4.29807
 S/viambo     0.919946           0.11         0.7364         0.56599    1.49527
   Pujini     1.055392           0.03         0.8567         0.58795    1.89448
     Piki     0.891931           0.14         0.7048         0.49360    1.61170
 Ngwachan     0.129868           2.06         0.1510         0.00801    2.10636
 Ng'omben     0.338223          17.54         0.0000         0.20364    0.56174
 Mzambara     1.176244           0.33         0.5643         0.67738    2.04249
 Mtambile     1.406382           1.49         0.2222         0.81342    2.43159
 Mkanyage     1.226408           0.25         0.6194         0.54819    2.74372
 Mizingan     0.470875           2.76         0.0966         0.19370    1.14469
 Michakai     0.681824           2.83         0.0926         0.43634    1.06542
  Konde B     1.112086           0.12         0.7304         0.60767    2.03521
  Konde A     1.158972           0.40         0.5295         0.73174    1.83564
 Kizimban     0.634017           3.34         0.0675         0.38900    1.03335
   Kinowe     2.375401           8.85         0.0029         1.34349    4.19990
 Kangagan     2.008956           2.82         0.0933         0.88946    4.53745
 K/minung     1.197277           0.40         0.5248         0.68742    2.08530
 Chanjamj     0.909733           0.13         0.7207         0.54162    1.52803
 Chambani     0.977408           0.01         0.9428         0.52349    1.82491
 Bagamoyo     1.175705           0.13         0.7169         0.49007    2.82057
                                                                               
   school   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by school
Score test for trend of odds with year
. mhodds    tri_infection year, by( school)
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Appendix 4.2d: Mantel-Haenszel analysis of the Score test for trend of the odds of 
T. trichiura infection over the years (2010-2012) following two rounds of school 
based treatment with Albendazole across the districts 
                                      Pr>chi2   =  0.0097
Test of homogeneity of ORs (approx): chi2(3)   =   11.41
                                                                    
       1.016013       0.07        0.7968         0.900314   1.146580
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for district
                                                                               
     Wete     1.027760           0.05         0.8269         0.80406    1.31370
   Mkoani     0.677814           7.25         0.0071         0.51073    0.89957
 Michewen     1.261887           3.97         0.0462         1.00391    1.58616
 Chake-ch     1.052769           0.21         0.6504         0.84285    1.31497
                                                                               
 district   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by district
Score test for trend of odds with year
. mhodds  tri_infection year, by(district)
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Appendix 4.2e: Mantel-Haenszel analysis of the Score test for trend of the odds of 
hookworm infection over the years (2010-2012) following two rounds of school 
based treatment with Albendazole across the districts 
 
 
 
 
 
 
 
 
                                     Pr>chi2   =  0.0000
Test of homogeneity of ORs (approx): chi2(3)   =   63.23
                                                                    
       1.018576       0.19        0.6662         0.936848   1.107434
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for district
                                                                               
     Wete     0.986692           0.02         0.8761         0.83372    1.16773
   Mkoani     0.780763           8.06         0.0045         0.65816    0.92621
 Michewen     1.781759          46.38         0.0000         1.50888    2.10399
 Chake-ch     0.778704           8.95         0.0028         0.66103    0.91733
                                                                               
 district   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by district
Score test for trend of odds with year
. mhodds   hwk_infection year, by(district)
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Appendix 4.2f: Mantel-Haenszel analysis of the Score test for trend of the odds of 
A. lumbricoides infection over the years (2010-2012) following two rounds of school 
based treatment with Albendazole across the districts 
 
 
                                     Pr>chi2   =  0.0004
Test of homogeneity of ORs (approx): chi2(3)   =   18.33
                                                                    
       1.116703       6.65        0.0099         1.026829   1.214444
                                                                    
     Odds Ratio    chi2(1)        P>chi2        [95% Conf. Interval]
                                                                    
    Mantel-Haenszel estimate controlling for district
                                                                               
     Wete     1.235676           5.90         0.0151         1.04170    1.46577
   Mkoani     0.904422           1.33         0.2485         0.76257    1.07266
 Michewen     1.424582          17.62         0.0000         1.20763    1.68051
 Chake-ch     0.970767           0.12         0.7244         0.82316    1.14485
                                                                               
 district   Odds Ratio        chi2(1)         P>chi2       [95% Conf. Interval]
                                                                               
for a one unit increase in year)
(The Odds Ratio estimate is an approximation to the odds ratio 
by district
Score test for trend of odds with year
. mhodds    asc_infection year, by(district)
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Appendix 5.1 Questionnaire used for assessing compliance for drugs administered 
in MDA compaigns  
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Appendix 6.1  Questionnaire administered to mothers/guardians whose children 
enrolled in the pre-school schistosomiasis study 
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Appendix 7.1 List of snails that were tested for cercarial shedding, Dra-1 gene and 
characterized by sequencing,   
Snail number  Shed cercariae Dra-1 (S.haem)+ve B nasutus/globosus  Site collected 
3 - +ve SND Kangagani  
4 - +ve SND Kangagani 
5 - uncertain SND Piki 
6 - +ve SND Piki 
7 - +ve SND Mavungwa 
8 - -ve SND Mavungwa 
9 - +ve SND Vitongoji 
10 - -ve SND Vitongoji 
11 - +ve SND KImbuni 
12 - -ve SND Kimbuni 
13 - +ve B.g Mavungwa 
14 - -ve B.g Mavungwa 
15 - +ve SND Mavungwa 
16 - +ve SND Mavungwa 
17 - +ve SND Mavungwa 
18 - -ve SND Mavungwa 
19 - +ve SND Mavungwa 
20 - -ve SND Mavungwa 
21 - +ve SND Mavungwa 
22 - -ve SND Mavungwa 
23 - +ve B.g KImbuni 
24 - +ve B.g KImbuni 
25 - +ve SND KImbuni 
26 - +ve SND KImbuni 
27 - +ve SND KImbuni 
28 - +ve SND KImbuni 
29 - -ve SND KImbuni 
30 - -ve SND KImbuni 
31 - -ve SND KImbuni 
32 - -ve SND KImbuni 
33 - -ve B.n Vitongoji 
34 - -ve B.n Vitongoji 
35 - -ve B.n Vitongoji 
36 - -ve SND Vitongoji 
37 - -ve SND Vitongoji 
38 - -ve SND Vitongoji 
39 - +ve SND Vitongoji 
40 - -ve SND Vitongoji 
41 - +ve B.g Piki 
42 - +ve B.g Piki 
43 - +ve SND Piki 
44 - uncertain SND Piki 
45 - +ve SND Piki 
46 - -ve SND Piki 
47 - uncertain SND Piki 
48 - +ve SND Piki 
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49 - uncertain SND Piki 
50 - +ve SND Piki 
51 - -ve SND Piki 
52 - -ve SND Piki 
53 - -ve B.n Kangagani 
54 - +ve SRU Kangagani 
55 - -ve SND Kangagani 
56 - +ve SND Kangagani 
57 - +ve SND Kangagani 
58 - +ve SND Kangagani 
59 - -ve SND Kangagani 
60 - +ve SND Kangagani 
61 - -ve SND Kangagani 
62 - +ve SND Kangagani 
63 - +ve SND Kangagani 
64 - +ve SND Kangagani 
65 - +ve B.g Mkungu 
66 - +ve B.g Mkungu 
67 - +ve SND Mkungu 
68 - uncertain SND Mkungu 
69 - uncertain SND Mkungu 
70 - +ve SND Mkungu 
71 - -ve SND Mkungu 
72 - uncertain SND Mkungu 
73 - +ve SND Mkungu 
74 - uncertain SND Mkungu 
75 - +ve SND Mkungu 
76 - +ve SND Mkungu 
77 +  -ve SRU Kangagani 
78 +  +ve B.n Kangagani 
79 +  uncertain B.g Mavungwa 
80 +  +ve B.n Kangagani 
81 +  +ve B.n Kangagani 
82 +  +ve SRU Kangagani 
83 +  +ve SRU Kangagani 
84 +  +ve B.g Kangagani 
85 +  +ve B.n Kangagani 
86 +  uncertain B.n Kangagani 
87 +  uncertain B.n Kangagani 
88 +  +ve B.n Kangagani 
89 +  uncertain B.n Kangagani 
90 +  +ve B.n Kangagani 
91 +  +ve SRU Kangagani 
92 +  +ve SRU Kangagani 
93 + uncertain B.n Kangagani 
94 + +ve B.n Kangagani 
95 - +ve B.n Kangagani 
96 - -ve SND Kangagani 
SND= sequencing not done;SRU = sequencing results unclear 
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